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Abstract
Fluorescence correlation spectroscopy (FCS) analyzes the ﬂuctuations in the ﬂuorescence
intensity, which is emitted from a tiny excition volume, to obtain information about
the concentration, the mobility, and the molecular interactions of labeled molecules.
The more advanced ﬂuorescence cross-correlation spectroscopy (FCCS) increases the
precision in the determination of ﬂow velocities and binding constants compared to
standard FCS.
The miniaturization in biomedical and chemical engineering has been developing ra-
pidly, propelled by the vision of a fully functional laboratory on a single chip and its use
in human therapeutics, for example, as implanted drug delivery system. A key require-
ment to fulﬁll this vision is the ability to handle small ﬂuid volumes. Handling liquids
using the electrohydrodynamical principle circumvents many of the disadvantages of
other systems. The complex ﬂow pattern in the active region of such a pump could not
be resolved by common tracking techniques. In this thesis, two-focus FCCS (2f-FCCS)
was used to map the ﬂow proﬁle inside a micropump. The high precision of 2f-FCCS in
the determination of ﬂow measurements even with small ﬂuorescent particles allowed the
measurement of the ﬂow velocities induced by electrohydrodynamic forces acting on the
solvent, while excluding the eﬀects of dielectrophoretic forces acting on larger particles.
Analysis of the ﬂow data indicates a ﬂow pattern that consists of two vortices of diﬀerent
size and opposite direction of rotation. The ﬂow pattern derived by 2f-FCCS explains the
observed complex particle trajectories in the force ﬁeld and the accumulation of particles
in well-deﬁned regions above the microelectrode array.
In the second part of this thesis, the mechanism of RNA interference (RNAi) was
studied by dual-color FCCS in vivo. RNAi is an evolutionary conserved gene silencing
mechanism, which uses short double-stranded RNA molecules, called short interfering
RNAs (siRNAs), as eﬀector molecules. Due to its speciﬁcity and simplicity, RNAi yields
a great potential for a widespread therapeutic use. To broaden the therapeutic applica-
tions, the in vivo stability of siRNAs has to be improved by chemical modiﬁcations, but
some of these modiﬁcations inhibit the gene silencing mechanism. The presented FCCS
assays are very well suited to investigate the individual assembly steps of RNAi machi-
nery with very high speciﬁcity and sensitivity in real time and to study the cleavage
activity of the activated RNAi machinery. A direct correlation between activity of the
RNAi machinery and the results from the FCCS measurements could be shown. The
inﬂuence of several chemical modiﬁcations on the assembly and activity of the RNAi
machinery was investigated with these assays.
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Kurzfassung
In vitro und in vivo Anwendungen der
Fluoreszenz-Kreuzkorrelation-Spektroskopie
Fluoreszenz-Korrelations-Spektroskopie (FCS) analysiert die Fluktuationen im Fluores-
zenzsignal eines kleinen angeregten Volumens, um Informationen über die Konzentration,
die Bewegung und die Interaktionen der markierten Moleküle zu erhalten. Die Fluores-
zenz-Kreuzkorrelations-Spektroskopie (FCCS) erhöht die Genauigkeit bei der Messung
von Fließgeschwindigkeiten und Bindungskonstanten im Vergleich zur Standard-FCS.
Die Miniaturisierung der Biomedizin und Chemie hat sich rapide entwickelt, angetrie-
ben von der Vision eines kompletten Labors auf einem Chip und dem Einsatz dieses
in der medizinischen Therapie, zum Beispiel als implantierter Medikamentenspender.
Ein Schlüsselelement zur Erfüllung dieser Vision ist der Transport von kleinsten Flüs-
sigkeitsmengen in diesen miniaturisierten Systemen. Der Transport von Flüssigkeiten
mittels des elektrohydrodynamischen Prinzips umgeht viele Nachteile von anderen Sys-
temen, allerdings zeigt eine solche Pumpe ein kompliziertes Strömungsbild in der aktiven
Region, welches sich mit herkömmlichen Methoden wie Teilchenverfolgung nicht vermes-
sen ließ. Hier wurde Zwei-Fokus-FCCS (2f-FCCS) genutzt, um das Strömungsbild in der
Pumpe zu vermessen. Die hohe Genauigkeit der 2f-FCCS bei der Bestimmung von Fließ-
geschwindigkeiten auch mit kleinen ﬂuoreszierenden Teilchen ermöglichte die Messung
der Fließgeschwindigkeiten, aufgrund der auf das Lösungsmittel wirkenden elektrohydro-
dynamischen Kräfte, unter Ausschluss der auf größere Teilchen wirkenden dielektropho-
retischen Kräfte. Die Analyse der Daten ergab, dass das Strömungsbild aus zwei ent-
gegengesetzt rotierenden unterschiedlich großen Wirbeln besteht. Dieses Strömungsbild
erklärt die komplizierten Teilchenbewegungsbahnen und die Anreicherung der Teilchen
in klar abgegrenzten Bereichen über den Mikroelektroden.
Im zweiten Teil dieser Arbeit wurde der RNAi-Mechanismus in lebenden Zellen mittels
Zwei-Farben-FCCS untersucht. RNA Interferenz (RNAi) ist ein evolutionär erhaltener
Geninaktivierungsmechanismus, der kurze doppelsträngige RNA Moleküle, so genann-
te kurze interferierende RNAs (siRNAs), als Eﬀektormoleküle nutzt. Die Speziﬁtät und
Einfachheit der RNAi hat ihr ein weites Feld in der medikamentösen Therapie geöﬀnet.
Zur Erweiterung dieses Feldes ist es nötig die Stabilität der siRNAs im Körper mittels
chemischer Modiﬁkationen zu erhöhen. Einige dieser Modiﬁkationen hemmen aber den
RNAi-Mechanismus. Die hier vorgestellten FCCS Experimente sind sehr gut geeignet,
um die einzelnen Schritte des Zusammenbaus der RNAi Maschinerie mit hoher Emp-
ﬁndlichkeit und Speziﬁtät in Echtzeit zu untersuchen und die Aktivität der RNAi Ma-
schinerie zu studieren. Es konnte ein Zusammenhang zwischen der Aktivität der RNAi
Maschinerie und den Ergebnissen der FCCS Messungen hergestellt werden. Der Einﬂuss
von verschiedenen chemischen Modiﬁkationen auf den Zusammenbau und die Aktivität
der RNAi Maschinerie wurde mit diesen neuartigen Methoden untersucht.
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1 Introduction and Outline
To determine mobility parameters such as diﬀusion coeﬃcients and ﬂow velocities,
several techniques like nuclear magnetic resonance spectroscopy (NMR) and dy-
namic light scattering (DLS) have been developed. Compared to these techniques,
ﬂuorescence correlation spectroscopy (FCS) has several advantages. FCS is a sin-
gle molecule sensitive technique, which analyzes the ﬂuctuations of a ﬂuorescence
intensity trace. Additionally to the measurement of the mobility parameters,
FCS measures the concentration and can be used to study molecular interactions.
The use of ﬂuorescence allows highly speciﬁc labeling of the molecules of interest,
thereby simplifying the complexity of the studied system.
Since the introduction of FCS, many advancements of FCS have been developed.
One of the most important one, the development of ﬂuorescence cross-correlation
spectroscopy (FCCS) analyzes the signal from two excitation volumes. The most
prominent examples are two-focus FCCS (2f-FCCS) and dual-color FCCS. In
2f-FCCS, the use of two spatially separated excitation volumes increases the mea-
surement accuracy of diﬀusion constants and ﬂow velocities dramatically. In con-
trast, dual-color FCCS uses two spectrally separated detection volumes. This
makes the measurement of molecular interactions independent from the precise
determination of mobility constants. Here both cross-correlation techniques are
applied to answer technical and biological questions.
The ﬁeld of semiconductor electronics was the ﬁrst discipline that proﬁted from
the miniaturization of its devices. Inspired from the huge advancements achieved
in this discipline, miniaturization was implemented in many other engineering dis-
ciplines, and today the technological development goes hand in hand with minia-
turization. In chemistry and biology one of the aims of miniaturization is the
creation of a fully functional laboratory on a single chip. This includes the ability
to handle small liquid volumes, which has turned out to be a complex problem.
A very recent attempt uses the electrohydrodynamical principle to pump liquids
through microchannels. The use of this principle avoids many of the disadvantages
from other pumping techniques, but such a pump displays a complex ﬂow pattern
which was unresolveable by common techniques. Therefore, 2f-FCCS was applied
to map the ﬂow proﬁle of such a pumping device.
The discovery that double stranded RNA (dsRNA) is able to inhibit the produc-
tion of a protein encoded in the complementary gene, has revolutionized loss-of-
function studies in many organisms. Short dsRNA molecules have emerged as the
key regulators in these evolutionary conserved gene silencing mechanisms. In one
of these mechanisms, called RNA interference (RNAi), 21 nucleotide long dsRNA
1
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molecules, called short interfering RNAs (siRNAs), trigger the degradation of the
complementary messenger RNA (mRNA). The RNAi machinery uses one of the
siRNA strands to scan for mRNAs with a matching sequence. In case of perfect
complementarity the mRNA is cleaved and the expression of the encoded protein
inhibited. Therapeutics based on RNAi to cure genetic diseases entered already
ﬁrst clinical trials. Yet for widespread therapeutic use, the properties of siRNAs
have to be improved, for example by the introduction of chemical modiﬁcations.
These modiﬁcations can improve the lifetime of the silencing triggers, but some
of these modiﬁcations display a reduced silencing activity. The mechanism be-
hind this reduction was unknown, because standard biochemical assays measure
only the silencing activity. Therefore, dual-color FCCS was employed to study
inhibition of the RNAi machinery in vivo.
The thesis is structured in four main chapters. Chapter 2 provides the theo-
retical background of FCS. It outlines the physical principle of ﬂuorescence and
diﬀusion and presents the theory of FCS and FCCS. The application of 2f-FCCS
to resolve the ﬂow pattern of a micropump is dicussed in chapter 3. Chapter
4 gives an overview over the current knowledge of RNA-induced gene silencing
mechanisms, describing the biogenesis of the eﬀector molecules, the gene regu-
lating mechanisms, and the inﬂuence of diﬀerent chemical modiﬁcations. The
mechanism of inhibition of RNAi by chemically modiﬁed siRNAs is investigated
in chapter 5. Two novel in vivo FCCS assays are presented and their use to study
the inﬂuence of various chemically modiﬁed siRNAs is depicted.
2
2 Fluorescence Correlation Spectroscopy
2.1 Introduction
Fluorescence correlation spectroscopy (FCS) is a single molecule technique, which
uses the ﬂuctuations in the ﬂuorescence intensity emitted from a tiny excitation
volume, to obtain information about the concentration and the mobility of the
labeled molecules. The development of FCS took place in the early eighties of
the last century by D. Magde, E. Elson, and W. W. Webb, who described a
ﬁrst application, the theory, and the experimental realization [13]. Although
there was some progress in the ﬁeld of FCS, the breakthrough did not come until
single molecule sensitivity was achieved by R. Rigler and coworkers in 1993 by
employing confocal detection [4]. Ever since, FCS is an exponentially growing
technique (from the number of FCS related publications per year), with many
advancements and applications [57].
One of the most important advancements was the development of dual-color
ﬂuorescence cross-correlation spectroscopy (FCCS), which oﬀers the possibility to
study the interaction of similar sized molecules. Dual-color FCCS was proposed
and the theory was outlined in 1989 [8], but it was not recognized until the vi-
sionary publication of M. Eigen and R. Rigler in 1994 [9]. The ﬁrst experimental
realization was done by Schwille et al. in 1997 [10]. Since that time, dual-color
FCCS is more and more used to study molecular interactions in vivo. Very re-
cent developments extended FCCS to more than two colors, amongst others using
grating and prism based separation of the ﬂuorescent light [1113].
Additionally to the spectral separation of light, also spatially separated light can
be cross-correlated. This technique, called spatial FCCS or two-focus FCCS (2f-
FCCS), was developed by Brinkmeier et al. for better resolved measurements
of ﬂow [14]. The distance between the two foci is an additional ruler, which is
independent from the size and the shape of the confocal volume. Recent devel-
opments use 2f-FCCS for absolute and calibration free measurements of diﬀusion
coeﬃcients [1517].
Many improvements concern the type of excitation. In 1995 excitation with
infrared light was introduced to FCS, where the ﬂuorescent molecule absorbs two
photons to reach the excited state [18]. The so called two-photon excitation was
studied for in vivo use by Schwille et al. [19] and ﬁrst employed in dual-color
FCCS by Heinze et al. [20]. It is applied mainly in vivo, because of the higher
penetration depth of infrared light compared to visible light in living tissue.
Scanning FCS was introduced to overcome the problems of immobilized and
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slowly diﬀusing molecules, especially the bleaching of the ﬂuorophore [21]. With
the recent combinations of laser scanning microscopes and FCS, in principle every
kind of scanning pattern is possible, but mostly lines [2224] and circles [2528]
are used.
Several techniques to reduce the size of the confocal volume in FCS are known.
The oldest and mostly used one is the combination of FCS with an excitation by
total internal reﬂection [29, 30]. The strong exponential decay of the evanescent
ﬁeld lead to a strong reduction of the confocal volume in the axial direction. The
combination was ﬁrst introduced by N. L. Thompson and coworkers [31, 32]. In
earlier times the evanescent ﬁeld was created by reﬂecting a laser inside a prism,
which was placed on the objective opposing side of the sample [3335]. In 2005
the technique to create the evanescent ﬁeld by reﬂecting the laser in the objective
[36] was applied by Hassler et al. to FCS [37, 38] and extended to dual-color FCCS
with objective based total internal reﬂection excitation [39].
For a long time the electronic signals of the detectors were directly fed into
hardware correlators. With the development of pulsed lasers and better data
registration electronics, the technique of time-correlated single photon counting
(TCSPC) was introduced and used together with FCS [4044]. Thereby the arrival
time of the ﬂuorescence photon relative to the lab time and to the excitation
pulse is saved and evaluated. With increasing time resolution of detectors and
electronics into the nanosecond range, the eﬀect of ﬂuorescence lifetime can be seen
as anti-bunching in so called full-correlation functions [45, 46]. The ﬂuorescence
lifetime can also be used to discriminate between diﬀerent ﬂuorescent dyes [47].
Techniques, which are similar to FCS and use the same data, are photon
counting histogram (PCH) [48, 49] and ﬂuorescence intensity distribution anal-
ysis (FIDA) [5053]. Both techniques analyze the brightness of the ﬂuorescent
molecules.
Another technique, which is similar to FCS, is image correlation spectroscopy
(ICS) [5456]. ICS uses correlation techniques to analyze spatial information from
laser scanning microscope images. Recently, ICS was extended to the time do-
main, as spatial-temporal ICS [57, 58] and as raster image correlation spectroscopy
(RICS) [59].
2.2 Physical Basics
2.2.1 Fluorescence
Principles of Fluorescence
The relaxation of a molecule from the ﬁrst excited singlet state under the emission
of a photon is called ﬂuorescence. The main path of excitation is the absorption
of light, but molecules can also be excited by thermal or chemical energy. If the
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excited state is a triplet state and the molecule relaxes to the ground state under
emission of a photon, the process is called phosphorescence.
Typically in organic molecules the electronic states which participate in the
absorption and emission of visible light are formed by a conjugated pi-electron
system. A simple example of a conjugated pi-electron system, benzene, can be seen
in Fig. 2.1. The atomic orbitals of carbon hybridize into the sp2 and pz orbitals in
benzene. While the sp2 orbitals form σ bonds, the pz orbitals form the conjugated
pi-electron system. Due to the four valence electrons of carbon all binding states
of the molecule are ﬁlled, and all anti-binding states are empty. The weakness of
the pi-bonds compared to the σ-bonds leads to a smaller energy diﬀerence between
the pi-binding and pi∗-anti-binding states compared to the energy diﬀerence of the
σ states. The energy diﬀerence between the pi-states lies in the ultraviolet and
visible range of light.
Under the assumption that the Born-Oppenheimer separation conditions are
fulﬁlled, the molecular wave function can be written as a product of the electronic,
vibrational, and rotational wave functions. Then the energy of a molecular state is
the sum of the occupied electronic, vibrational, and rotational states. Transitions
between electronic states have typically wavelengths in the ultraviolet and visible
part of the optical spectrum. The wavelengths of photons from vibrational state
transitions are in the near infrared, and those from rotational state transitions are
in the far infrared. In optical spectra at room temperature, transitions between
rotational states cause typically only a broadening of the spectral lines.
For ﬂuorophores other than organic molecules the energy diﬀerence between the
ﬁrst excited state and the ground state is deﬁned by other intrinsic properties of
these ﬂuorophores, but the rest of the discussion above applies as well.
Figure 2.1: Bonds and electronic states of benzene. Chemical bonds
inside benzene, with the conjugated pi-electron system (left). Electronic states
in benzene with the binding pi and σ states and the anti-binding pi∗ and σ∗
states (right) [60].
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Figure 2.2: Jablonski diagramm: Under Absorption of light, the ﬂuo-
rophore is excited in 10−15 s to the ﬁrst or higher excited state. There it returns
to the vibrational ground state of the ﬁrst excited state S1 in 10−13 s by vibra-
tional relaxation and internal conversion. From here it goes back to the ground
state under emission of a photon (ﬂuorescene) in 10−8 s or without a photon by
quenching or non-radiative decay. From the ﬁrst excited state the ﬂuorophore
can also jump into the triplet state by intersystem crossing (ISC). From there
it relaxes to the ground state by phosphorescence in more than 10−4 s or by
non-radiative decay. Adapted from [61].
The processes which are involved in ﬂuorescence and phosphorescence are often
depicted in a Jablonski-diagram (Fig. 2.2). The ﬂuorophore is exited by the ab-
sorption of one or more photons in 10−15 s. After fast electronic transitions, like
emission and absorption, the atomic nuclei are not in the equilibrium position,
due to the much slower relaxation (10−13 s) of the nuclear distances. Therefore,
electronic transitions often end up in higher vibrational states (Franck-Condon-
principle). By vibrational relaxation and internal conversion the ﬂuorophore re-
laxes into the vibrational ground state of the ﬁrst excited state S1 in around
10−13 s. From there the ﬂuorophore returns to the ground state under emission
of a photon (ﬂuorescence) in 10−8 s. This time is called the ﬂuorescence lifetime.
The ﬂuorophore can also return to the ground state via quenching or non-radiative
decay. From the ﬁrst excited state a quantum-mechanically forbidden transition,
called intersystem crossing (ISC), into the ﬁrst triplet state can occur with a much
lower probability than ﬂuorescence. From the triplet state the ﬂuorophore returns
into the ground state under emission of a photon (phosphorescence) in more than
10−4 s or via non-radiative decay and quenching.
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A ﬂuorophore is characterized by several physical properties. First, there are
the absorption and emission spectra, which characterize the typical wavelength of
the ﬂuorescent processes. The diﬀerence between emission and absorption wave-
length, due to the Franck-Condon-Principle, is called Stokes-Shift and allows the
separation of the ﬂuorescent light from the excitation light by dichroic mirrors.
The second characteristic is the molecular brightness, which is deﬁned by the ex-
tinction coeﬃcient σex and the quantum yield ϕ. The extinction coeﬃcient σex
describes the cross-section of the interaction between the ﬂuorophore and the ex-
citation light. It is a measure for the probability of the ﬂuorophore to become
excited. The quantum yield ϕ is the probability that an excited ﬂuorophore re-
turns to the ground state under emission of a photon and can be calculated from
the rates k of the diﬀerent processes shown in Fig. 2.2
ϕ =
kFluor.
kFluor. + kISC + knon-rad. Relax. + kQuenching(Q)
=
emitted photons
absorbed photons . (2.1)
The third characteristic is the bleaching probability. It deﬁnes the amount of
photons a ﬂuorophore can emit before its ﬂuorescent activity is destroyed by a
photochemical reaction.
Fluorescent Markers
Although many cells show some autoﬂuorescence in the green part of the visible
spectra, many interesting biological molecules and proteins are non-ﬂuorescent. To
study these molecules they have to be labeled with a ﬂuorophore. The labeling is
performed either chemically, by organic dyes and quantum dots, or genetically with
ﬂuorescent proteins. For all labeling techniques the functionality of the labeled
molecule or protein has to be veriﬁed afterwards, because the ﬂuorescent label can
hinder the molecule/protein in its correct function. The three most used groups
of ﬂuorophores are shown in Fig. 2.3.
Small organic dyes (Fig. 2.3(a)) are typically improved derivatives of ﬂuores-
cein, rhodamines, and cyanines, like the Alexa and Atto dye families (Invitrogen,
ATTO-Tec). These families cover a wide range of wavelengths and are function-
alized by a reactive group for labeling. Due to their small molecular mass of less
than 1 kDa they induce a lower steric hindering compared to ﬂuorescent proteins.
Autoﬂuorescent proteins are widely used for cellular studies. Interesting pro-
teins can be easily labeled by cloning the genetic information of the ﬂuorescent
protein to the genetic information of the protein of interest. Then the cells ex-
press a fusion protein, consisting of the ﬂuorescent protein and the protein of
interest. The best studied and mostly used ﬂuorescent protein is the green ﬂuo-
rescent protein (GFP) (Fig. 2.3(b)). From its discovery in the jellyﬁsh Aequorea
victoria in 1962 [65], it took more than 30 years until its genetic sequence and crys-
tal structure was resolved [6669]. GFP has a barrel like structure formed from
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Figure 2.3: Diﬀerent types of Fluorophores: (a) Two common examples
for small organic ﬂuorophores: Alexa488 (top) [62] emits green light, and Cy5
(bottom) [63] emits far red light. (b) Crystal structure of the most prevalent
ﬂuorescent protein GFP. (On the right side opened, to show the ﬂuorophore.)
[64]. (c) Schematic drawing of a quantum dot, consisting of core, shell, and
coating (from the inner to the outer). Pictures are not drawn to scale.
β-sheets, with an inside positioned ﬂuorophore. The ﬂuorophore forms automati-
cally after translation from three amino acids. Many mutants of GFP were created
and used [70]. The ﬁrst red ﬂuorescent protein DsRed was extracted [71] from a
coral, but due to its strong tendency to form oligomers [72] it was not widely used
until its monomeric form mRFP was found [73]. Also from DsRed/mRFP many
mutants were created with shifted absorption and emission wavelengths, like mOr-
ange and mCherry [74]. The properties of these ﬂuorescent proteins, especially for
ﬂuorescent imaging, were reviewed in [75]. A brighter red ﬂuorescent protein was
generated from a red protein of a sea anemone and called TagRFP [76]. These pro-
teins are still under development, so more photostable versions of these proteins
called mOrange2 and TagRFP-T were developed recently [77]. Proteins with spe-
cial features like a strong Stokes-shift or the possibility of photo-switching, called
mKeima [78], Kaede [79, 80] and Dronpa [81, 82], are also available. Many of
these ﬂuorescent proteins exhibit strong photo-physical behavior, like blinking on
the microsecond scale [8388]. For this reason the usability of these proteins for
the given application in FCS has to be checked carefully.
The third group of ﬂuorophores are anorganic semiconductor nanocrystals,
called quantum dots (Fig. 2.3(c)) [8991]. They typically consist of a semiconduc-
tor core with a size of 2 nm to 10 nm, a shell, and a coating, which provides the
bio-compatibility, like water-solubility, of these anorganic crystals. The complete
diameter is in the range of 20 nm. Quantum dots have broad absorption spectra, a
narrow, nearly symmetrical emission spectra and a superior photo-stability. The
emission wavelength is easily tuneable, by the size of the core, and due to the
narrow emission spectra and their superior photo-stability, they are well suited
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for multi-color applications. Quantum dots would be perfect ﬂuorescent labels
for multicolor FCCS, if they would not have a complicated photophysics, with
blinking times following a power law distribution [92, 93]. In a recent publication
a ﬁt model consisting of 1 bright and 5 dark states, following the power law, was
developed, which seems to be able to describe the blinking of quantum dots in
FCS even at higher excitation powers [94]. Another model using subdiﬀusion was
presented in [95], based on comparisons of FCS, ICS and simulations. Next to
the studies which use FCS to investigate the blinking behavior of quantum dots,
there exist only a small number of publications dealing with FCS and quantum
dots [9698]. They are reviewed in [99], and a comparison of the photophysical
properties of quantum dots and some organic dyes can be found in [100].
2.2.2 Diﬀusion
The movement of tracer particles due to elastic interactions with solvent molecules
is called Brownian motion. Although it was described before, even in the Antique
by Lucretius in his book Of the Nature of Things [101] and by other scientists,
Robert Brown is traditionally regarded as the discoverer of this motion [102].
The tracer particles moves due to collisions with solvent molecules, which diﬀuse
around. Free diﬀusion is described by the diﬀusion equation also known as Fick's
second law
∂C(~r, t))
∂t
= D∇2C(~r, t) (2.2)
with C(−→r , t)) as concentration. The diﬀusion coeﬃcient D can be calculated from
the Einstein-Stokes-equation
D =
kBT
6piηmR0
, (2.3)
with kB as Boltzmann constant and T as temperature. ηm is the viscosity of the
medium and R0 the hydrodynamic radius of the diﬀusing particle. The diﬀusion
coeﬃcient depends directly and indirectly via the viscosity ηm on the temperature.
Equation (2.3) assumes a homogenous, interaction-free and isotropic environment.
2.3 Theory of Fluorescence Correlation Spectroscopy
2.3.1 Principle of Autocorrelation
In a confocal FCS setup (Fig. 2.4(a)) a laser beam is focussed to a diﬀraction
limited spot by the objective. The emitted ﬂuorescence from molecules diﬀusing
through this spot is collected by the same objective. The ﬂuorescent light is
spectrally separated from the excitation light by dichroic mirrors and emission
ﬁlters and focussed through a pinhole. The pinhole conﬁnes the detection volume
predominantly in axial direction. An avalanche photodiode (APD) detects the
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ﬂuorescence signal F (Fig. 2.4(c)). This ﬂuorescence intensity can be written as
the sum of the average ﬂuorescence 〈F 〉 and their ﬂuctuations δF
F (t) = 〈F 〉+ δF (t) with 〈F 〉 = 1
tmeas
∫ tmeas
0
F (t) dt (2.4)
and the autocorrelation of the ﬂuorescence signal is deﬁned by
G(τ) =
〈δF (t) δF (t+ τ)〉
〈F (t)〉〈F (t)〉 =
〈F (t) F (t+ τ)〉
〈F (t)〉〈F (t)〉 − 1 . (2.5)
The ﬂuorescent signal is compared with itself for diﬀerent lag times τ by calcu-
lating the autocorrelation function, and thereby the self similarity of the signal is
tested. For small lag times the ﬂuorophore is still in the confocal volume, emitting
photons, so the similarity is high. For large lag times the ﬂuorophore has left the
volume, so the correlation curve decays to zero, because there is no similarity in
the signal anymore. The average residence time of the ﬂuorophore in the confocal
volume is found at the half maximum of the correlation curve, and this time is
related to the diﬀusion coeﬃcient D of the ﬂuorescent molecule (Fig. 2.4(d)).
The detected ﬂuorescence signal F from n diﬀerent ﬂuorescent molecules can
be described as follows
F (t) =
n∑
i=1
κi σex,i ϕi
∫
V
Iex(~r)S(~r)Ci(~r, t) d
3~r (2.6)
Figure 2.4: Principle of FCS: (a) A confocal volume is created by focusing
a laser through the objective. The emitted ﬂuorescence is collected with the
same objective, spectrally and spatially ﬁltered by a bandpass ﬁlter and a pin-
hole, respectively, and detected by an APD. (b) Molecules diﬀuse through the
confocal volume and give rise to a ﬂuctuating intensity trace (c). The auto-
correlation curve (d), which is a measure for the self similarity of the signal is
calculated from the intensity trace. By ﬁtting appropriate models to the curve,
physical parameters can be extracted.
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with κ the detector eﬃciency, σex and ϕ as the ﬂuorophore properties extinction
coeﬃcient and quantum yield, respectively. The excitation intensity proﬁle Iex(~r)
and the normalized collection eﬃciency function S(~r) characterize the confocal
volume, and C(~r, t) is the concentration of the ﬂuorescent molecules. With the
following deﬁnitions of the molecular brightness η and molecule detection function
W (~r)
ηi = κi σex,i ϕi I0 (2.7)
W (~r) =
Iex(~r)
I0
S(~r) (2.8)
the ﬂuorescence signal can be written as
F (t) =
n∑
i=1
∫
V
W (~r) ηiCi(~r, t) d
3~r (2.9)
and the ﬂuorescence ﬂuctuations as
δF (t) =
n∑
i=1
∫
V
W (~r) δ(ηiCi(~r, t)) d
3~r . (2.10)
For the case of τ=0 and only one species (n=1) in eq. (2.5) and with propor-
tionality of the ﬂuorescence signal to the concentration and thereby to the mean
particle number 〈N〉 (see eq. (2.6) and (2.9)), we ﬁnd
G(0) =
〈δF 2〉
〈F 〉2 =
〈δN2〉
〈N〉2 =
1
〈N〉 , (2.11)
because 〈δN2〉 = Var(N) = 〈N〉, due to the Poisson distributed number of
molecules in the detection volume (Fig. 2.4(b)). In reality ﬂuorophores show
photophysical eﬀects, which change the molecular brightness η and thereby lead
to ﬂuctuations in the ﬂuorescence intensity, which result in distortions of the
correlation curve.
The experimental molecular brightness ηexp is usually calculated from the mea-
sured and averaged ﬂuorescence intensity 〈F 〉 and the mean particle number 〈N〉
and corresponds to η deﬁned in eq. (2.7) in the following way (the deﬁnition of
the eﬀective volume Veﬀ can be found in eq. (2.20))
ηexp =
〈F 〉
〈N〉 = η
∫
W (~r) d3~r
Veﬀ
= η
V
Veﬀ
. (2.12)
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2.3.2 Derivation of the Model-Function for Autocorrelation
To extract physical parameters like concentrations and diﬀraction coeﬃcients from
correlation curves a model function has to be derived. A more general and more
detailed derivation of the correlation function can be found in [103]. Starting with
eq. (2.5) and inserting eq. (2.10) we get
G(τ) =
∑n
i=1
∑n
j=1
∫
V ′
∫
V
W (~r)W (~r ′)〈δ(ηiCi(~r, t)) δ(ηj Cj(~r ′, t+ τ))〉 d3~r d3~r ′(∑n
i=1
∫
V
W (~r) 〈ηiCi(~r, t)〉 d3~r
)2
(2.13)
and for the simpler case n=1
G(τ) =
∫
V ′
∫
V
W (~r)W (~r ′)〈δ(η C(~r, t)) δ(η C(~r ′, t+ τ))〉 d3~r d3~r ′(∫
V
W (~r) 〈η C(~r, t)〉 d3~r)2 . (2.14)
The ﬂuctuation term can be separated
δ(ηiCi(~r, t)) = Ci(~r, t) δηi + ηi δCi(~r, t) . (2.15)
Under the assumption that the molecular brightness η is constant (δηi=0) and
with the following deﬁnition of the concentration correlation function
Φi,j(~r, ~r
′, τ) = 〈δCi(~r, t) δCj(~r ′, t+ τ)〉 , (2.16)
eq. (2.13) can be simpliﬁed to
G(τ) =
∑n
i=1
∑n
j=1
∫
V ′
∫
V
W (~r)W (~r ′) ηi ηj Φi,j(~r, ~r ′, τ) d3~r d3~r ′(∑n
i=1
∫
V
W (~r) 〈ηiCi(~r, t)〉 d3~r
)2 (2.17)
and for the case n=1 to
G(τ) =
∫
V ′
∫
V
W (~r)W (~r ′) Φ(~r, ~r ′, τ) d3~r d3~r ′(∫
V
W (~r) 〈C(~r, t)〉 d3~r)2 . (2.18)
The molecule detection function W (~r) describes the detection volume and is
inﬂuenced by the focused laser beam and the pinhole. For the creation of a con-
focal volume a collimated laser beam with a radial gaussian intensity distribution
is focused with a high numerical aperture (NA) objective. If the back aperture is
underﬁlled, the lateral intensity distribution can be described by a gaussian. In
most cases the back aperture is overﬁlled, to achieve smaller detection volumes.
This leads to diﬀraction rings in the lateral excitation proﬁle. In the axial direc-
tion the detection volume is conﬁned by a pinhole in the image plane. The best
assumptions for real confocal volumes are Gauss-Lorentz models (examples can
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be found in [16, 18, 104]), but none of these models lead to a analytical expres-
sion of the model function. Therefore, the detection volume is approximated by
a 3D-Gauss model [4]
W (~r) = exp
(
−2(x
2 + y2)
ω20
− 2z
2
z20
)
. (2.19)
ω0 is the lateral radius of the detection volume, where the intensity of the laser
beam is fallen to 1/e2. Two times z0 is the axial length of the detection volume
and is often substituted by the structure parameter S (eq. (2.26)). To simplify
the model functions we deﬁne the eﬀective volume Veﬀ
Veﬀ =
(∫
V
W (~r) d3~r
)2∫
V
(W (~r))2 d3~r
= pi
3
2 ω20 z0 . (2.20)
To determine the concentration correlation function Φ(~r, ~r ′, τ), the diﬀusion-
transport-reaction-equation [103]
∂δCi(~r, t)
∂t
= Di∇2 δCi(~r, t) +
n∑
j=1
Tij δCi(~r, t)− ~v(~r, t)∇δCi(~r, t) , (2.21)
with Di the diﬀusion coeﬃcient of the molecular species i, Tij as the elements of
the reaction matrix T and ~v(~r, t) the ﬂow velocity (the relative velocity between
the ﬂuorescent particle and the detection volume), has to be solved.
Translational Diﬀusion
For the case of translational diﬀusion (~v(~r, t)=0) with one species (n=1) (eq.
(2.21)) the concentration correlation function (2.16) can be calculated [2, 103] to
Φ(~r, ~r ′, τ) =
〈C(~r, t)〉
(4piD τ)
3
2
exp
(
−(~r − ~r
′)2
4D τ
)
. (2.22)
Using this in eq. (2.18) gives the model function for the autocorrelation curve in
the case of translational diﬀusion with one species to
G(τ) =
1
〈C(~r, t)〉Veﬀ
1
1 + 4D τ
ω20
1√
1 + 4D τ
z20
. (2.23)
With the following equation for the mean particle number 〈N〉 and the deﬁnitions
of the diﬀusion time τD and the structure parameter S
〈N〉 = 〈C(~r, t)〉Veﬀ (2.24)
τD =
ω20
4D
(2.25)
S =
z0
ω0
(2.26)
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the model function can be further simpliﬁed to
G(τ) =
1
〈N〉
1
1 + τ
τD
1√
1 + τ
S2 τD
. (2.27)
In case of translational diﬀusion for multiple species (n>1) the concentration
correlation function contains only diagonal elements [103]
Φi,j(~r, ~r
′, τ) =
〈Ci(~r, t)〉
(4 piDi τ)
3
2
exp
(
−(~r − ~r
′)2
4Di τ
)
for i = j
Φi,j(~r, ~r
′, τ) = 0 for i 6= j .
(2.28)
The autocorrelation function is then written as the weighted sum of the correlation
functions of the diﬀerent species
G(τ) =
n∑
i=1
Λ2i Gi(Di, τ) (2.29)
with the brightness weighting factor
Λi =
ηi 〈Ci〉∑n
j=1 (ηj 〈Cj〉)
(2.30)
and the single species correlation function
Gi(Di, τ) =
1
〈Ci(~r, t)〉Veﬀ
1
1 + 4Di τ
ω20
1√
1 + 4Di τ
z20
. (2.31)
Because of the unknown molecular brightness of the single species ηi the squared
brightness weighting factor Λ2i is written as a fraction fi. This, together with the
deﬁnitions in eq. (2.24), (2.25), and (2.26), simpliﬁes the autocorrelation function
to
G(τ) =
1
〈N〉
n∑
i=1
fi 1
1 + τ
τD,i
1√
1 + τ
S2 τD,i
 with n∑
i=1
fi = 1 . (2.32)
Translational Diﬀusion and Active Transport
Additionally to the translational diﬀusion a relative velocity between the ﬂuo-
rescent particles and the observation volume can be found. The reason for this
directed motion is either the active transport of the ﬂuorescent particles, for ex-
ample due to active transport in cells or due to a ﬂow in capillary, or the motion
of the observation volume on the sample, for example due to scanning.
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Again the concentration correlation function is calculated from the diﬀusion-
transport-reaction-equation (2.21) for the case of one ﬂuorescent species (n=1)
[7, 14] to
Φ(~r, ~r ′, τ) =
〈C(~r, t)〉
(4 piD τ)
3
2
exp
(
−(~r − ~r
′ + ~v τ)2
4D τ
)
. (2.33)
Inserting this in eq. (2.18) and after the integrations, the model function for the
autocorrelation curve in the case of translational diﬀusion and active transport
with one species follows as
G(τ) =
1
〈C(~r, t)〉Veﬀ
exp
(−(v2x+v2y) τ2
ω20 +4D τ
)
1 + 4D τ
ω20
exp
(
−v2z τ2
z20 +4D τ
)
√
1 + 4D τ
z20
. (2.34)
Using the deﬁnitions in (2.24) and (2.26) and for the usual case that the ﬂow is
only perpendicular to the optical axis (vz=0), the model function can be further
simpliﬁed to
G(τ) =
1
〈N〉
1
1 + 4D τ
ω20
1√
1 + 4D τ
S2 ω20
exp
( −v2 τ 2
ω20 + 4D τ
)
, (2.35)
with
v = |~v| =
√
v2x + v
2
y (2.36)
the absolute value of the velocity. Note that the autocorrelation function depends
only on the magnitude of the ﬂow velocity ~v(~r, t) and not on the direction.
Triplet and Blinking
In the diﬀusion-transport-reaction-equation (2.21) the general case of reactions is
described, but for many cases the problem gets quickly too complicated. A simple
and solvable case is the change of a ﬂuorophore from the bright to the dark state
and back, without changing the diﬀusion coeﬃcient of the ﬂuorophore.
B
k1­
k-1
D
The concentration correlation function can be calculated [103] from eq. (2.21)
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to
ΦBB(~r, ~r
′, τ) =
〈CB(~r, t)〉
(4 piD τ)
3
2
k−1 + k1 e−(k1+k−1) τ
k1 + k−1
exp
(
−(~r − ~r
′)2
4D τ
)
ΦDD(~r, ~r
′, τ) =
〈CD(~r, t)〉
(4 piD τ)
3
2
k1 + k−1 e−(k1+k−1) τ
k1 + k−1
exp
(
−(~r − ~r
′)2
4D τ
)
ΦBD(~r, ~r
′, τ) =
〈CB(~r, t)〉
(4 piD τ)
3
2
k1 + k1 e
−(k1+k−1) τ
k1 + k−1
exp
(
−(~r − ~r
′)2
4D τ
)
ΦDB(~r, ~r
′, τ) = ΦBD(~r, ~r ′, τ)
(2.37)
Inserting these concentration correlation functions into eq. (2.17) gives the follow-
ing autocorrelation function
G(τ) =
1
(〈CB(~r, t)〉+ 〈CD(~r, t)〉)Veﬀ
1
1 + τ
τD
1√
1 + τ
S2 τD
·
(
1 +K
(
ΛB − 1
K
ΛD
)2
e
− τ
τb
)
(2.38)
with the deﬁnitions of the equilibrium constants K and the relaxation time τb
K =
k1
k−1
=
〈CD〉
〈CB〉 (2.39)
τb =
1
k−1 + k1
(2.40)
and the brightness weighting factor Λi (2.30).
For the case that the molecular brightness of the dark state is zero (ηD=0) the
autocorrelation function can be written in the usual form for triplet blinking with
τb = τT
G(τ) =
1
〈N〉
(
1 +
fT
1− fT exp
(
− τ
τT
))
1
1 + τ
τD
1√
1 + τ
S2 τD
, (2.41)
with the triplet fraction fT = K/(K + 1) = 〈CD〉/(〈CB〉+ 〈CD〉).
Eq. (2.41) is only correct for the case that the rate constants k1 and k−1 are
constant. In reality this is not fulﬁlled, because k1 is intensity dependent, and
therefore the probability to enter the dark-state is diﬀerent at diﬀerent places of
the confocal volume. The eq. (2.41) is still used as a good approximation. A more
detailed study can be found in [105] and another approach in [106].
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2.4 Two-Focus Fluorescence Cross-Correlation Spectroscopy
In two-focus ﬂuorescence cross-correlation spectroscopy (2f-FCCS), two separated
foci are created by focusing two laser into the sample(Fig. 2.5(a)). The laser beams
enter the objective under a slight angular diﬀerence. The ﬂuorescence signal F
from both foci is auto- and cross-correlated. Only molecules which visited both
detection volumes, either due to active transport/ﬂow or diﬀusion, contribute to
the cross-correlation curve (Fig. 2.5(c)). The distance R between the two foci
is an external ruler, which allows absolute measurements of diﬀusion constants
[16] and introduces direction sensitivity in ﬂow measurements [14]. With the two
ﬂuorescent intensities F1(t) and F2(t) the auto- and cross-correlation curves are
deﬁned by
GAC,1(τ) =
〈δF1(t) · δF1(t+ τ)〉
〈F1(t)〉〈F1(t)〉 (2.42)
GAC,2(τ) =
〈δF2(t) · δF2(t+ τ)〉
〈F2(t)〉〈F2(t)〉 (2.43)
GCC,1(τ) =
〈δF1(t) · δF2(t+ τ)〉
〈F1(t)〉〈F2(t)〉 (2.44)
GCC,2(τ) =
〈δF2(t) · δF1(t+ τ)〉
〈F1(t)〉〈F2(t)〉 . (2.45)
The model functions to ﬁt the autocorrelation curves are the same as for trans-
Figure 2.5: Principle of two-focus FCCS: (a) Two foci are created by ob-
jective focussed laser beams with a distance R. (b) Molecules diﬀuse through
the confocal volumes and give rise to two ﬂuctuating intensity traces. (c) Auto-
(green, darkgreen), and cross-correlation (blue) curves calculated from the in-
tensity traces [107].
17
2 Fluorescence Correlation Spectroscopy
lational diﬀusion and active transport in section 2.3.2. The derivation of the
cross-correlation model function follows in principle the same way as for the au-
tocorrelation, but we have to consider two diﬀerent molecule detection functions
W1(~r) and W2(~r). The analog equation to (2.18) for the case of cross-correlation
is shown here
GCC,1(τ) =
∫
V ′
∫
V
W1(~r)W2(~r
′) Φ(~r, ~r ′, τ) d3~r d3~r ′(∫
V
W1(~r) 〈C(~r, t)〉 d3~r
) (∫
V
W2(~r) 〈C(~r, t)〉 d3~r
) (2.46)
GCC,2(τ) =
∫
V ′
∫
V
W2(~r)W1(~r
′) Φ(~r, ~r ′, τ) d3~r d3~r ′(∫
V
W1(~r) 〈C(~r, t)〉 d3~r
) (∫
V
W2(~r) 〈C(~r, t)〉 d3~r
) . (2.47)
In the standard case the two foci are identical, but shifted by the distance R, so
they are described by the same molecule detection function shifted by R
W1(~r) = exp
(
−2(x
2 + y2)
ω20
− 2z
2
z20
)
(2.48)
W2(~r) = exp
(
−2((x−R)
2 + y2)
ω20
− 2z
2
z20
)
. (2.49)
Translational Diﬀusion
For the case of only translational diﬀusion we use eq. (2.22) for the concentration
correlation function and get for the model function
GCC,i(τ) =
1
〈C(~r, t)〉Veﬀ
1
1 + 4D τ
ω20
1√
1 + 4D τ
z20
exp
( −R2
ω20 + 4D τ
)
. (2.50)
Here both cross-correlations are identical, because molecules diﬀuse into all direc-
tions.
Translational Diﬀusion and Active Transport
In the case of active transport we use the concentration correlation function from
eq. (2.33) and get for the model functions
GCC,1(τ) =
1
〈N〉
1
1 + 4D τ
ω20
1√
1 + 4D τ
z20
exp
(
−v
2 τ 2 +R2 − 2Rv τ cos(α)
ω20 + 4D τ
)
(2.51)
GCC,2(τ) =
1
〈N〉
1
1 + 4D τ
ω20
1√
1 + 4D τ
z20
exp
(
−v
2 τ 2 +R2 + 2Rv τ cos(α)
ω20 + 4D τ
)
(2.52)
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in case that the ﬂow is perpendicular to the optical axis (vz=0) and the deﬁnition
for v in eq. (2.36). The angle α is the angle between the ﬂow velocity and the
vector between the two foci. The second equation is the backward and the ﬁrst the
forward cross-correlation, which shows a peak, due to the ﬂuorophores transported
from volume one to volume two by the ﬂow.
2.5 Dual-Color Fluorescence Cross-Correlation Spectroscopy
To study the interaction of molecules with autocorrelation is problematic, because
the interaction can only be determined by a change in the diﬀusion coeﬃcient. For
globular proteins the diﬀusion coeﬃcient is approximately proportional to the cu-
bic root of the molecular mass, and therefore a change of the molecular weight by
at least an order of magnitude is necessary to determine the interaction precisely
[7]. Dual-color ﬂuorescence cross-correlation spectroscopy enhances the sensitiv-
ity and resolution dramatically. Two spectrally separated laser lines are focussed
into the same spot (Fig. 2.6(a)). The ﬂuorescence from two spectrally distinct
ﬂuorophores diﬀusing through the confocal volume (Fig. 2.6(b)) is collected, spec-
trally separated and detected in two channels. Both intensity traces (Fig. 2.6(c))
are auto- and cross-correlated (Fig. 2.6(d)). If both ﬂuorophores interact and
diﬀuse together through the confocal volume, there is a correlation between the
spectral channels, which give rise to a positive cross-correlation. Therefore, dual-
color FCCS is a powerfull tool to study binding, because it measures dynamic
colocalization.
In analogy to the spatial cross-correlation the cross-correlation for dual-color
FCCS is deﬁned. Instead of having ﬂuorescence signals from two separated vol-
umes, in dual-color FCCS there are ﬂuorescent signals from two spectral channels,
here called `red' (r) and `green' (g)
GAC,g(τ) =
〈δFg(t) · δFg(t+ τ)〉
〈Fg(t)〉〈Fg(t)〉 (2.53)
GAC,r(τ) =
〈δFr(t) · δFr(t+ τ)〉
〈Fr(t)〉〈Fr(t)〉 (2.54)
GCC,gr(τ) =
〈δFg(t) · δFr(t+ τ)〉
〈Fg(t)〉〈Fr(t)〉 (2.55)
GCC,rg(τ) =
〈δFr(t) · δFg(t+ τ)〉
〈Fg(t)〉〈Fr(t)〉 . (2.56)
The ﬂuorescent signal in one spectral channel arises from all molecules which
carry the distinct label, that is from all molecules having this label alone, and addi-
tionally from all which carry both labels. Therefore, the ﬂuorescence ﬂuctuations
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Figure 2.6: Principle of dual color FCCS: (a) Two spectrally separated
laser lines are focussed into the same focus, and the collected ﬂuorescence is
spectrally separated by a dichroic beam splitter and emission ﬁlters into two
spectral channels. (b) Spectrally distinct ﬂuorophores, which diﬀuse to the
detection volume, give rise to two ﬂuctuating intensity traces (c). (d) Auto-
(red, green) and cross-correlation (blue) curves calculated from the intensity
traces. Only two diﬀerent ﬂuorophores which diﬀuse together give rise to the
cross-correlation curve.
(eq. (2.10)) are
δFg(t) =
∫
V
Wg(~r) ηg δ(Cg(~r, t) + Cgr(~r, t)) d
3~r (2.57)
δFr(t) =
∫
V
Wr(~r) ηr δ(Cr(~r, t) + Cgr(~r, t)) d
3~r . (2.58)
In the general case the two detection volumes described by Wg and Wr do not
overlap completely and have diﬀerent sizes. Here the correlation functions for the
simpliﬁed case of two identical detection volumes are shown
GAC,g(τ) =
〈Cg〉Mg(τ) + 〈Cgr〉Mgr(τ)
(〈Cg〉+ 〈Cgr〉)2 Veﬀ (2.59)
GAC,r(τ) =
〈Cr〉Mr(τ) + 〈Cgr〉Mgr(τ)
(〈Cr〉+ 〈Cgr〉)2 Veﬀ (2.60)
GCC(τ) =
〈Cgr〉Mgr(τ)
(〈Cg〉+ 〈Cgr〉) (〈Cr〉+ 〈Cgr〉)Veﬀ , (2.61)
with
Mi(τ) =
1
1 + τ
τD,i
1√
1 + τ
S2 τD,i
(2.62)
for the case of translational diﬀusion.
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Usually the most interesting parameter is the relative cross-correlation ampli-
tude, which can be obtained from the amplitudes of the correlation curves
GAC,g(0) =
1
(〈Cg〉+ 〈Cgr〉)Veﬀ , GAC,r(0) =
1
(〈Cr〉+ 〈Cgr〉)Veﬀ ,
GCC(0) =
〈Cgr〉
(〈Cg〉+ 〈Cgr〉) (〈Cr〉+ 〈Cgr〉)Veﬀ ,
(2.63)
to 〈Cgr〉
〈Cg〉+ 〈Cgr〉 =
〈Ngr〉
〈Ng〉+ 〈Ngr〉 =
GCC(0)
Gr(0)
,
〈Cgr〉
〈Cr〉+ 〈Cgr〉 =
〈Ngr〉
〈Nr〉+ 〈Ngr〉 =
GCC(0)
Gg(0)
.
(2.64)
The amount of interacting particles compared to all green particles can be ob-
tained by dividing the amplitudes of the cross-correlation curve by the amplitude
of the red autocorrelation curve, and the fraction of interacting particles normal-
ized to all red particles is given by the ratio of the cross-correlation amplitude and
the amplitude of the green autocorrelation curve.
2.6 Problems and Artifacts in Fluorescence Correlation
Spectroscopy
Due to the high sensitivity of FCS and the inﬂuence of the sample onto the optical
beampath, the results obtained by FCS can easily be inﬂuenced by artifacts.
Correlation curves can easily be biased, due to the correlation mechanism. If
the measurement time is chosen too short, the shape of the correlation curve will
be distorted, and the slow dynamics will be lost. Especially if slow dynamics shall
be resolved, providing adequately long measurement times is crucial.
2.6.1 Optical Artifacts in Fluorescence Correlation Spectroscopy
The real confocal volume diﬀers from its approximation by a 3D-gauss-model
eq. (2.19). A comparison between the 3D-gauss-approximation and a calculation
of a real confocal volume can be seen in Fig. 2.7. The isosurface, where the
molecule detection function has fallen to 1/e2 ≈ 0.13 of its maximum, looks like
a cylinder with rounded ends [108]. For freely diﬀusing ﬂuorophores in 3D the
deviations from the 3D-gauss model can be neglected. But it has to be kept in
mind that evaluation of the eﬀective volume from a ﬂuorophore, with a known
diﬀusion coeﬃcient, does not describe the actual dimensions of the detection vol-
ume [7]. For the determination of the diﬀusion coeﬃcient of molecules diﬀusing in
a two-dimensional membrane, the deviation of the real detection volume from the
3D-Gauss-model has to be acknowledged, because the x-y sections are larger in
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Figure 2.7: Shape of confocal volumes: (a) The shape of a 3D Gaussion
model. (b) Real shape from a theoretical calculation, both taken from [7].
an out of focus plane compared to the focal plane. Therefore, the z-scan method
should be used [109, 110].
The excitation laser beams are usually linearly polarized. The focussing of
a linearly polarized laser beam with a high-NA objective results in an elliptical
cross-section of the confocal volume, but the deviations from a round cross-section
are really small [108, 111] and can be neglected.
Cover-Slide Thickness
All high NA objectives used today are corrected for the use with a cover-slide. For
FCS, even more elaborated objectives are used, which have a correction ring to
adjust the cover-slide thickness. The eﬀects of a mismatched cover-slide thickness
were studied in [108] showing an error of around 100% for the concentration and
around 30% for the diﬀusion coeﬃcient for 10µm deviation. So the correction
ring has to be adjusted carefully, because even high quality cover-slides have a
thickness variation of ±10µm.
Refractive Index Mismatch
Water-immersion objectives are corrected to image in a medium with the refractive
index of water n=1.333. Most media, like buﬀers and cells, where FCS is used in,
have a slightly diﬀerent refractive index, ranging from 1.333 to 1.380. This leads to
an error in the concentration estimation of 600% and for the diﬀusion coeﬃcient
of 50% [108]. For the calculation in [108] it was considered that the focus is
200µm deep in the sample, because the longer the distance which the light travels
through a refractive index mismatched medium, the stronger are the disturbances
of the focal volume and the bigger are the errors. Measuring FCS close to the
cover-slide, as it is done for example in adherent cells, strongly reduces these errors
[112]. The errors induced by refractive index mismatch can be corrected at least
partially by an adjustment of the cover-slide thickness correction ring [113]. Even
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better result would be obtained by using an objective with a correction ring for
the refractive index.
Laser Beam Astigmatism
Laser beam astigmatism describes the non-ﬂatness of the optical wave-front, due
to mirror curvature or the usage of optical waveguides. The errors are in the
range of the errors of a mismatched cover-slide thickness and are biggest when
using overﬁlling laser beams to create diﬀraction limited spots [108].
2.6.2 Triplet Blinking and Saturation
The eﬀects of saturation and photobleaching (see section 2.6.4) are mostly present
simultaneously. Saturation increases the apparent diﬀusion time, photobleaching
decreases it. Which eﬀect is the more dominant one, depends on the excitation
laser power, the geometry of the sample, the diﬀusion coeﬃcient and the photo-
physical properties of the ﬂuorophore. While for ﬂuorophores freely diﬀusing in
3D saturation eﬀects dominate, the opposite is seen for ﬂuorophores diﬀusing in
a 2D membrane [7].
In section 2.3.2 the model function for triplet blinking was developed for the
approximated case that the triplet rates are intensity independent. The errors
due to this approximation are usually small, but the occupation of a triplet state
Figure 2.8: Eﬀect of saturation: (a) Dependence of mean particle number
〈N〉 from the excitation power, with the increase of 〈N〉 due to saturation. (b)
The same dependence for the diﬀusion time τD. Both measured with Alexa 488
on a home-built setup.
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increases the saturation, due to the longer oﬀ-time of the ﬂuorophores.
For the development of the triplet model function (eq. (2.41)) in section 2.3.2, it
was assumed that the emission proﬁle is the same as the excitation proﬁle. Even for
low excitation intensities this assumption can be violated. The ﬂuorophores in the
center of the confocal volume, which are excited with the highest intensities, can
not absorb more photons, because the electronic ground state is already depleted.
This leads to ﬂattening of the emission proﬁle, which is then approximated with
a broader gaussian distribution, leading to longer apparent diﬀusion times τD
and lower apparent concentration values (Fig. 2.8). The eﬀect of saturation was
studied in [106, 114, 115]. While in [114] a simple saturation model is used to
explain the power dependence of the measured diﬀusion time and mean particle
number, in [106] a simple model is derived to extract the correct parameters
from an experimental autocorrelation curve, which was measured at modest laser
powers. Excitation with pulsed laser increase saturation eﬀects compared to cw-
excitation [115]. The best way is of course to avoid saturation eﬀects as much as
possible, by the usage of modest excitation powers, where saturation eﬀects are
low.
2.6.3 Uncorrelated Background
Uncorrelated background inﬂuences the amplitude of the correlation curve and
thereby the apparent concentration. The apparent diﬀusion coeﬃcient is not in-
ﬂuenced. There are many sources for uncorrelated background. At low count
rates, the detector dark counts may be important, but also excitation light reach-
ing the detector, due to insuﬃcient blocking, stray light, or Raman scattering can
play a role. In biological samples, the main source of uncorrelated background is
autoﬂuorescence. This is residual ﬂuorescence from non-labeled molecules.
The correction is simply derived from eq. (2.5) by replacing the measured ﬂu-
orescence intensity F with the real ﬂuorescence intensity F˜ and the uncorrelated
background signal B
F (t) = F˜ (t) +B . (2.65)
This leads to the following corrected or real correlation curves G˜(τ)
G˜(τ) =
(〈F˜ 〉+B)2
〈F˜ 〉2 G(τ) (2.66)
and for cross-correlation
G˜CC(τ) =
〈F˜1〉+B1
〈F˜1〉
〈F˜2〉+B2
〈F˜2〉
GCC(τ) . (2.67)
In the case of dual-color cross-correlation `1' has to be replaced by `g' and `2' by
`r'.
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2.6.4 Photobleaching
The property of ﬂuorophores to photobleach leads to two types of photobleaching
artifacts in FCS: Bleaching in the detection volume and depletion of ﬂuorophores
in the reservoir. The photobleaching probability is excitation intensity depen-
dent, therefore artifacts due to photobleaching are usually present at high exci-
tation laser powers. In in vitro measurements photobleaching can be reduced by
the usage of anti-bleaching reagents, like ascorbic acid and 2-mercaptoethylamine
(MEA) [116]. Also the reduction of oxygen in the buﬀer can prevent photobleach-
ing, but leads usually to a strong built up of the triplet state population, because
oxygen is known to quench the triplet states [116, 117]. Another approach to pre-
vent bleaching, especially in samples with small diﬀusion coeﬃcients, is scanning
FCS [21, 22, 28].
Photobleaching in the Detection Volume
If the reservoir of the ﬂuorophores outside the detection volume can be consid-
ered as inﬁnite, the bleaching of ﬂuorophores in the detection volume reduces the
measured diﬀusion time, while the global concentration is not reduced. Due to
the irreversible oﬀ-switching of the ﬂuorophore, for the autocorrelation analysis
it seems as the ﬂuorophore has left the detection volume earlier, and therefore
the estimated diﬀusion time τD is reduced. Usually autocorrelation curves with
bleaching are ﬁtted with the following model [117119]
G(τ) =
1
〈N〉
(
1− fB + fB e−kPB τ
) 1
1 + τ
τD
1√
1 + τ
S2 τD
, (2.68)
with the bleaching fraction fB and the photobleaching rate kPB. Due to the in-
tensity dependence of the photobleaching rate, this is only a very approximate
approach, and due to the fact that the highest excitation intensities are in the
center of the detection volume, a central hole is burnt in the ﬂuorophore distribu-
tion. Therefore, photobleaching should be avoided by using low enough excitation
laser powers.
Depletion of Fluorophores due to Photobleaching
If the reservoir of ﬂuorophores can not be considered as inﬁnite, like in cells, photo-
bleaching will lead to a depletion of ﬂuorophores. In this case the autocorrelation
curve is mainly inﬂuenced by the decreasing count rate, which leads to a strong
distortion of the correlation curve. There are two ways to correct for this eﬀect. In
the ﬁrst way the ﬂuorescence intensity is divided into shorter pieces with a weaker
decay. These pieces are autocorrelated, and the correlation curves are averaged
[120]. This works only if the depletion is not too strong. A more general way is to
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correct the ﬂuorescence intensity before calculating the correlation curve. There-
fore, the shape of the ﬂuorescence intensity is ﬁtted with one or more exponential
functions, and the ﬂuorescence intensity is transformed/rectiﬁed as described in
[104, 120].
2.6.5 Detector Afterpulsing and Dead Time
Two detector artifacts play a role in FCS. The dead time is the time window in
which a detector can not detect a second photon, after it detected the ﬁrst one.
This limits the temporal resolution and the maximal detectable ﬂuorescence. The
dead time artifact can be seen in the correlation curve as an anti-correlation at
short time scales. For modern actively quenched APDs the dead time is around
100 ns, and therefore plays only a small role in present FCS experiments. The
best way to avoid this artifact is to use the detector in its linear regime, which
can be found for modern APDs below a ﬂuorescent count rate of 500 kHz.
The second and more important artifact is afterpulsing. Here the detector cre-
ates a spurious pulse immediately after the detection of a photon. This leads to
strong correlation on short time scales and is predominantly seen for low ﬂuo-
rescent count rates. It can be avoided by splitting the ﬂuorescent signal on two
detectors and calculating the cross-correlation curve, because the afterpulsing is
not correlated between detectors. But this reduces the ﬂuorescent intensity more
than twice per detector, and therefore may be crucial in some experiments. In
[121] a simple way is described how autocorrelation curves can be corrected for
afterpulsing. Therefore, the afterpulsing probability of the detector has to be de-
termined. Therefor, the autocorrelation curve G0(τ) with a totally uncorrelated
light source, like a battery driven LED, is obtained for the APD. Then the cor-
rected autocorrelation curve G˜(τ) can be calculated from the measured curve G(τ)
with the following formula
G˜(τ) = G(τ)− 〈F0〉〈F 〉 G0(τ) , (2.69)
with the average ﬂuorescence intensity 〈F0〉 of the calibration measurement, where
G0(τ) was obtained and the average ﬂuorescence intensity 〈F 〉 during the mea-
surement of G(τ).
2.6.6 Problems of Fluorescence Correlation Spectroscopy in vivo
For FCS measurements in biological samples, especially in cells, some additional
problems can occur. The problem of autoﬂuorescence, which usually leads to an
uncorrelated background, is treated in section (2.6.3). Often also a really slow
diﬀusing or even immobilized fraction of ﬂuorescent molecules exists, which is
bleached in the beginning of the experiment. Artifacts in the correlation curves
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due to this bleaching can be avoided by pre-bleaching the measurement spot:
positioning the laser beam on the measurement spot for some seconds, without
acquiring a correlation curve.
Especially by measurements in cellular compartments it happens that the com-
partment is smaller than the confocal volume. For this case completely new models
have to be derived, which can be found in [122, 123].
The correlation curves measured in cells often decay slower than it would be
expected in case of simple diﬀusion. This occurs, because the diﬀusion of the
molecules can be hindered due to unspeciﬁc interactions or due to the crowded
environment which is found in cells. This eﬀect is often called anomalous diﬀusion
[124129], a concept were the mean square displacement grows slower than for free
diﬀusion, usually as ∼ tα, with 0 < α < 1. This concept is a rather mathematical
model called fractional Brownian motion [130], without any particular underlying
physical mechanism. The model function is derived in [7]
G(τ) =
1
〈N〉
1
1 + (τ/τD)α
1√
1 + S−2 (τ/τD)
α
. (2.70)
Due to the lacking underlying physical mechanism and no improvement in the
ﬁtting of our in vivo FCCS data by the anomalous diﬀusion model (2.70) compared
to a two component model (2.32), the latter one is preferred in this work, as in
[131].
2.6.7 Artifacts in Fluorescence Cross-Correlation Spectroscopy
The artifacts in ﬂuorescence cross-correlation spectroscopy are crosstalk from one
detection channel to the other and, for the case of dual-color FCCS, an imperfect
overlap of the two detection volumes.
Spatial Crosstalk in 2f-FCCS
The major problem in two-focus FCCS is spatial crosstalk. Due to the gaussian
intensity distribution perpendicular to the optical axis, the two foci overlap. The
overlap decreases with increasing distance R and leads to spatial crosstalk. In
a simple picture the ﬂuorophores in the overlapping region are excited by both
lasers simultaneously and the ﬂuorescence of these ﬂuorophores is detected in both
channels and leads to positive cross-correlation for short lag times, called `pseudo
auto-correlation curve' [14]. This is not included in the theoretical derivation
of the model function and has to be removed from the experimental data. In
case of ﬂow measurements larger distances R can be used, because many ﬂuo-
rophores travel through both volumes and give rise to the cross-correlation curve,
due to their directed motion. By subtracting the backward from the forward cross-
correlation curve the crosstalk can be totally removed, but this procedure also
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removes completely the diﬀusion inﬂuence on the cross-correlation curve. In the
case of stronger ﬂows this is negligible, because the probability that ﬂuorophores
diﬀuse back against the ﬂow is nearly zero. In the case of absolute measurements
of the diﬀusion coeﬃcient the distance R is small, and the problem of spatial
crosstalk is solved by pulsed interleaved excitation (PIE) [16, 22].
Spectral Crosstalk in dual-color FCCS
A major problem in dual-color ﬂuorescence cross-correlation spectroscopy is spec-
tral crosstalk. Due to the long tail towards longer wavelengths in the emission
spectra of organic ﬂuorophores, detection of ﬂuorescence from the `green' ﬂuo-
rophore in the `red' channel is not avoidable. `Green' and `red' stands for shorter
and longer emission wavelengths, respectively. Spectral crosstalk can be avoided
by pulsed interleaved excitation (PIE) [132, 133]. In most commercial FCS sys-
tems only continuous wave (cw) excitation is implemented, and therefore PIE can
not be used to avoid spectral crosstalk. For this reason the recorded FCCS curves
or the resolved ﬁt parameters have to be corrected afterwards with the following
formalism.
The measured ﬂuorescence F depends on the emitted ﬂuorescence F˜ by the
following equations
Fg = F˜g + γ F˜r Fr = F˜r + β F˜g , (2.71)
with γ and β the crosstalk from the `red' ﬂuorophore into the `green' channel
and vice versa, respectively. The crosstalk (leakage) coeﬃcients γ and β can be
determined by exciting only one kind of ﬂuorophore, measuring the ﬂuorescence
in both channel and dividing the signal in the wrong channel by the signal from
the correct channel. So γ = Fg/Fr measured with `red' ﬂuorophores only and
β = Fr/Fg measured with `green' ﬂuorophores only. The real emitted ﬂuorescence
F˜ can be calculated with
F˜g =
Fg − γ Fr
1− γ β F˜r =
Fr − β Fg
1− γ β . (2.72)
The measured correlation curveG(τ) is deﬁned as in eq. (2.5), with the measured
ﬂuorescent intensities F
Gi,j(τ) =
〈Fi(t)Fj(t+ τ)〉 − 〈Fi〉 〈Fj〉
〈Fi(t)〉〈Fj(t)〉 (2.73)
and the real correlation curve G˜(τ) with the emitted ﬂuorescence intensities F˜
G˜i,j(τ) =
〈F˜i(t) F˜j(t+ τ)〉 − 〈F˜i〉 〈F˜j〉
〈F˜i(t)〉〈F˜j(t)〉
. (2.74)
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Inserting eq. (2.72) gives for the real `red' autocorrelation
G˜r(τ) =
〈(Fr(t)− β Fg(t)) (Fr(t+ τ)− β Fg(t+ τ))〉 − 〈Fr(t)− β Fg(t)〉2
〈Fr(t)− β Fg(t)〉2 (2.75)
and with the assumption 〈Fr(t)Fg(t + τ)〉 = 〈Fg(t)Fr(t + τ)〉 and some simple
mathematics follows
G˜r(τ) =
〈Fr(t)Fr(t+ τ)〉 − 〈Fr(t)〉2 + β (〈Fg(t)Fg(t+ τ)〉 − 〈Fg(t)〉2)
〈Fr(t)− β Fg(t)〉2
− −2 β (〈Fg(t)Fr(t+ τ)〉 − 〈Fg(t)〉 〈Fg(t)〉)〈Fr(t)− β Fg(t)〉2 . (2.76)
With the deﬁnition from eq. (2.73) this can be written as
G˜r(τ) =
〈Fr(t)〉2Gr(τ) + β2 〈Fg(t)〉2Gg(τ)− 2 β〈Fr(t)〉 〈Fg(t)〉 GCC(τ)
〈Fr(t)− β Fg(t)〉2 (2.77)
and analog follows for the real `green' autocorrelation curve
G˜g(τ) =
〈Fg(t)〉2Gg(τ) + γ2 〈Fr(t)〉2Gr(τ)− 2 γ〈Fg(t)〉 〈Fr(t)〉 GCC(τ)
〈Fg(t)− γ Fr(t)〉2 . (2.78)
For the real cross-correlation curve follows from eq. (2.74) with eq. (2.72)
G˜CC(τ) =
〈(Fg(t)− γ Fr(t)) (Fr(t+ τ)− β Fg(t+ τ))〉
〈Fg(t)− γ Fr(t)〉 〈Fr(t)− β Fg(t)〉
− 〈Fg(t)− γ Fr(t)〉 〈Fr(t)− β Fg(t)〉〈Fg(t)− γ Fr(t)〉 〈Fr(t)− β Fg(t)〉 (2.79)
and with the assumption 〈Fr(t)Fg(t + τ)〉 = 〈Fg(t)Fr(t + τ)〉 and some simple
mathematics follows
G˜CC(τ) =
(1 + γ β) (〈Fg(t)Fr(t+ τ)〉 − 〈Fg(t) 〉 〈Fr(t)〉)
(1 + γ β) (〈Fg(t)〉 〈Fr(t)〉) · · ·
· · · −β (〈Fg(t)Fg(t+ τ)〉 − 〈Fg(t)〉
2)− γ (〈Fr(t)Fr(t+ τ)〉 − 〈Fr(t)〉2)
−β 〈Fg(t)〉2 − γ 〈Fr(t)〉2 (2.80)
With the deﬁnition from eq. (2.73) for the real cross-correlation curve follows
G˜CC(τ) =
(1 + γ β) 〈Fg(t) 〉 〈Fr(t)〉GCC(τ)− β 〈Fg(t)〉2Gg(τ)− γ 〈Fr(t)〉2Gr(τ)
(1 + γ β) (〈Fg(t)〉 〈Fr(t)〉)− β 〈Fg(t)〉2 − γ 〈Fr(t)〉2 .
(2.81)
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In most cases there is no crosstalk from the `red' ﬂuorophores into the `green'
channel, so γ = 0 and eq. (2.77), (2.78) and (2.81) simplify to
G˜g(τ) = Gg(τ) (2.82)
G˜r(τ) =
〈Fr(t)〉2Gr(τ) + β2 〈Fg(t)〉2Gg(τ)− 2 β〈Fr(t)〉 〈Fg(t)〉 GCC(τ)
〈Fr(t)− β Fg(t)〉2 (2.83)
G˜CC(τ) =
〈Fg(t) 〉 〈Fr(t)〉GCC(τ)− β 〈Fg(t)〉2Gg(τ)
〈Fg(t)〉 〈Fr(t)〉 − β 〈Fg(t)〉2 . (2.84)
Imperfect Overlap of Detection Volumes in 2f-FCCS
The dual-color FCCS model functions in eq. (2.59)-(2.61) were derived for the case
of perfectly overlapping detection volumes. In reality this is often not the case.
Due to diﬀerent beam waist and diﬀerent divergence of the excitation laser beams
the detection volumes are shifted along the optical axis and have diﬀerent sizes.
In case of not shifted, but diﬀerent sized detection volumes the maximum of the
relative cross-correlation amplitude (eq. (2.64)) to the smaller volume increase
and can even exceed one. For an explicit analytical treatment of this case see
[104, 134].
Any shift of the detection volumes reduces the maximum of the relative cross-
correlation amplitude, and therefore reduces the dynamic range of the cross-
correlation measurements. This can be analytically handled using the formalism
for 2f-FCCS from section 2.4.
The usual way to correct for imperfect detection volume overlap is to normalize
all relative cross-correlation amplitudes to the relative cross-correlation amplitude
of a cross-correlation standard. Highly puriﬁed double stranded DNA or RNA,
where each strand carries one ﬂuorophore is often used as a cross-correlation stan-
dard.
2.7 Data Evaluation
To extract the relevant parameters from a measured FCS curve a model function
is ﬁtted to the experimental data. This model has to be carefully selected by
the experimenter, because the proper choice of a model is extremely important
to obtain meaningful and stable parameters. This model is usually ﬁtted to the
experimental data using a nonlinear least square ﬁtting algorithm. Such a ﬁtting
algorithm ﬁts a model function G(τ, pk), depending on the model parameters pk =
[N, fT, τT, τD, . . .], to the experimental data Gi(τi), with τi the single measured
time points, by minimizing the squared residuals
resi = Gi −G(τi, pk) . (2.85)
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To minimize the value r(pk)
r(pk) =
N∑
i=1
res2i , (2.86)
which is the sum of the squared residuals, the nonlinear least square algorithm
iteratively varies the model parameters pk, beginning from start parameters p0,k.
Here the start parameters have to be carefully selected, otherwise the ﬁtting al-
gorithm may converge to a local instead of the global minimum or not at all.
The quality of a ﬁt is usually measured by the reduced χ2-value, which is deﬁned
by
χ2 =
1
N − p− 1
N∑
i=1
(
Gi −G(τi, pk)
σi
)2
. (2.87)
p is the number of model parameters pk and σi the standard deviation at the
data point i. For the reduced χ2-value the ﬁt residual at the data point i is
compared with the statistical noise at the same point. In a ﬁt, with a model
perfectly describing the experimental data, the residuals are only given by the
statistical noise, and therefore χ2 is around one. If the model can not describe the
experimental data completely, χ2 is bigger than one, and if a χ2 lower than one is
achieved, the model contains too many parameters pk and is able to ﬁt some part
of the statistical noise.
In FCS experiments many temporal orders of magnitude are covered. To avoid
huge amounts of data and to limit the calculation time, multiple-tau correlators
are used to calculate the correlation curves. In multiple-tau correlators the channel
width increases with increasing lag times, and as a result the standard deviation
σ depends on the lag time τ . The amplitude of the statistical noise is higher for
short lag times compared to longer ones [135]. Therefore, the standard deviation
σi has to be estimated for every data point i. There are several possibilities to
estimate the standard deviation σ [104]:
• If the correlation curve is calculated by a software algorithm, the statistical
noise can be extracted as well.
• The standard deviation can be estimated from the spread of diﬀerent corre-
lation curves, measured under the same conditions.
• The experimental curve is approximated by a smoothed curve G¯ and the
standard deviation is evaluated by the standard deviation of δGj = Gj −
G¯(τj) with j running in a window around τi.
Due to the dependence of the standard deviation on the lag time τ a weighted
ﬁtting algorithm is advantageous in FCS. To perform a weighted ﬁt, the residuals
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are multiplied with a weight wi. In a weighted ﬁt
r(pk) =
N∑
i=1
(resiwi)2 =
N∑
i=1
((Gi −G(τi, pk))wi)2 (2.88)
is minimized. Usually the inverse of the standard deviation is used as a weight
wi = 1/σi. For this case the weighted nonlinear least square ﬁtting algorithm
minimizes χ2. The scattering width of weighted residuals is then equal for all lag
times.
Modern nonlinear least square algorithms, as they are implemented in Matlab,
report conﬁdence intervals for the model parameters. These conﬁdence intervals
report the range where the value of the parameter pk is still compatible with the
statistical noise of the data. They indicate the minimal uncertainties of the model
parameters. For in vivo measurements the ﬁtted parameters are averaged over
several samples for example cells, and much bigger errors are calculated from the
sample distribution of the parameters.
Two important issues should be mentioned. The ﬁrst is cross dependence, this
means that at least two model parameters are not independent from each other,
so that a change in one parameter can be balanced by the other one. These
parameters show big conﬁdence intervals. In FCS this can be seen, for example,
while ﬁtting a correlation curve which contains afterpulsing, with a two-component
model including triplet. Then the triplet part ﬁts partially the afterpulsing. To
compensate for the missing triplet part, the fast diﬀusion fraction is moved to
shorter lag times, what has to be balanced by the slow diﬀusion fraction, which
has orders of magnitude slower dynamics than the afterpulsing.
The second issue to be mentioned is over-estimation. This can easily be achieved
by the usage of too many free model parameters. This reduces the χ2 value, but
the physical meaning behind the model parameters is lost. Therefore, the number
of free model parameters should be reduced as much as possible, either by using
a simpler model or by ﬁxing some parameters to values obtained by calibration
measurements. This will probably increase χ2 and the ﬁt will look worse, but the
values of the parameters are more reliable.
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3 Resolving the Flow Proﬁle of a Micro-Pump by
Two-Focus FCCS
3.1 Introduction
Miniaturization in biomedical and chemical engineering has greatly advanced from
microfabrication technology, which was initially designed for microelectronics and
computer technology. Propelled by the vision of a fully-functional, miniaturized
laboratory on a single chip, called Lab-on-Chip (LoC) and micro Total Analysis
System (µTAS) [136], this ﬁeld has rapidly developed.
A key requirement for most of these miniaturized system is the handling and
manipulation of ﬂuid volumes in the micro- and nanoliter range. The present
approaches [137] all lack behind the demand, either they show a pulsed mode
of action (micromechanical pumps), may harm sensitive biological samples (elec-
troosmotic and electrophoretic pumping) or are still macroscopic (syringe pumps).
One way to circumvent these disadvantages is the application of electrohydrody-
namic pumping [138, 139]. Laminar ﬂow velocities of up to 80µm/s could be
achieved outside the pumping region [139], while in the regions where the pump
electrodes are present, highly stable turbulent ﬂow patterns were recognized. If
microparticles were present in the ﬂuid, a particle agglomeration occurred in well-
deﬁned regions of the pump.
Here the ﬂow proﬁle inside the pump was studied in detail by two-focus ﬂuores-
cence cross-correlation spectroscopy (2f-FCCS), to use it for further optimization
of the micropump and to study the possibility to accumulate and ﬁlter micropar-
ticles with a micropump.
The theory of ﬂuorescence correlation spectroscopy (FCS) in samples with di-
rected motion was developed in 1978 [140]. The standard FCS scheme with one
detection volume was used to map ﬂow velocities in microstructures [141143], but
it lacks the ability to detect the ﬂow direction and can only be applied in samples,
where the transition time due to ﬂow is much shorter than these for diﬀusion. As
an extension the technique and theory of spatial or two-focus ﬂuorescence cross-
correlation spectroscopy (2f-FCCS) was developed by Brinkmeier et al. [14]. The
use of two foci (Fig. 2.5 (p. 17)) provide direction dependent information and
the distance R between the two foci introduce an additional ruler, which allows
calibration free measurements. 2f-FCCS was used to study ﬂow proﬁles [14, 144],
conformational changes of DNA hairpin structures [145, 146] and the photochem-
istry of Kaede [80]. To suppress the spatial crosstalk, two photon excitation, with
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interleaved pulses was used [147]. Although 2f-FCCS was developed for ﬂow mea-
surements, it can be used in combination with pulsed interleaved excitation to
measure absolute diﬀusion coeﬃcients [16].
3.2 The Micropump
3.2.1 Theory of Electrohydrodynamic Pumping
Electrohydrodynamic pumping achieves a motion of the ﬂuid through the inter-
action of the electric ﬁeld with the dielectric ﬂuid medium. The electric force ~fel
per ﬂuid volume element for an incompressible ﬂuid can be expressed by
~fel = ρel ~E − 1
2
E2∇ε , (3.1)
where ρel is the electric volume charge, ~E is the electric ﬁeld and ε is the medium
permittivity [148]. The ﬁrst term describes the Coulomb force, where the electric
ﬁeld acts on the free charges in the ﬂuid medium and the second term represents
the force due to the interaction of the electric ﬁeld with polarization charges. The
free charges can be generated through three mechanisms: inhomogeneities within
the ﬂuid, dissociation and direct charge injection, called induction, conduction,
and injection, respectively.
Polarization forces as well as the induction mechanism require a gradient in the
electric properties of the ﬂuid. Thus, polarization and induction both depend on
inhomogeneities in the electric properties of the ﬂuid. The induction of charges in
a inhomogeneous ﬂuid can be best explained for a simple system containing two
layered ﬂuids with diﬀerent electric properties (Fig. 3.1). The current density ~j
has to fulﬁll the continuity equation ∇ j = 0, so the current density perpendicular
to the interface j⊥ ist the same on both sides. With the Maxwell equations and
Figure 3.1: Schematic interface be-
tween two ﬂuids with diﬀerent con-
ductivities σ1/2 exposed to an electric
ﬁeld ~E. Only the tangential compo-
nents of the electric ﬁeld are contin-
uous across the interface This leads
to a buildup of charges at the inter-
face. With the shown orientation of
the electric ﬁeld and for σ1 < σ2 these
charges are negative.
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~j = σ ~E the surface charge is given by
ρS = E1⊥
(
ε2
σ1
σ2
− ε1
)
= j⊥
(
ε2
σ2
− ε1
σ1
)
. (3.2)
With equal permittivities and σ1 < σ2 as in Fig. 3.1 the charges forming at the
interface are negative. From the second part of equation (3.2) the charge relaxation
time τch = ε/σ can be deﬁned and it follows that diﬀerent charge relaxation times
τch are a precondition for the formation of net charges in the ﬂuid bulk.
One way to induce diﬀerent charge relaxation times are temperature gradients,
because permittivity ε and conductivity σ of most liquids are temperature depen-
dent. Temperature gradients are normally induced by ohmic heating, but also
other methods like warming and cooling on diﬀerent sides of the samples can be
applied.
The formation of a double layer in liquids close to a charged solid surface also
generates charges. Due to the Coulomb forces counter-ions are attracted to the
charged surface, while co-ions are repulsed. At zero temperature the charges would
perfectly cancel out each other, but at ﬁnite temperature thermal ﬂuctuations lead
to the formation of a charged layer of ﬁnite thickness.
The conduction process can also create a charged layer near the electrodes. Neu-
tral electrolytic species can dissociate and recombine. The convection, diﬀusion,
and migration of the generated ions in the electric ﬁeld induce a current density,
which gives the process its name. In strong electric ﬁelds the dissociation rate
can exceed that of the recombination and create a non-equilibrium, heterocharge
layer.
Charges can also be transferred directly from the electrodes into the ﬂuid, what
is called injection. To transfer charges from metal electrodes high ﬁeld strength
are required, therefore the injection process mainly occurs on the edges of the
electrodes. This process is inadequate for many applications, because it often
coincides with bubble formation, which may damage the electrodes. Addition-
ally the charge injection changes the electric properties of the ﬂuid and induce
signiﬁcant pH gradients.
To achieve a net ﬂow in one direction a traveling electric wave is applied on
the electrodes (Fig. 3.2). Such a wave creates charges by induction and conduc-
tion and for higher voltages also by injection. The electric ﬁeld generates positive
charges in the ﬂuid below electrodes with positive potential and negative charges
below electrodes with negative potential by induction and injection, while by the
conduction mechanism opposite charges are generated. While the conduction and
injection mechanisms only create charges close to the electrodes, the charges gen-
erated by induction span through the whole ﬂuid, due to the overall temperature
mechanism. If the electric wave travels a quarter period, a force is applied on
the generated charges by the new electric ﬁeld, leading to a net ﬂow against the
traveling wave direction for induction and injection and with the wave direction
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Figure 3.2: Traveling electric wave. In space periodical potentials are ap-
plied to the electrodes at a time point t1 (black). On a later time point t2 the
potentials moved a quarter of the period to the left (red), forming a traveling
electric wave.
for conduction. Which process is dominant depends on the used parameter set and
determines the direction of the net ﬂow. Most crucial is the synchronization of
the travel velocity with the diﬀerent charge relaxation and reaction times. These
times can be inﬂuenced by adjusting the permittivity and conductivity of the ﬂuid.
The travel velocity depends on the frequency of the applied electric potential.
3.2.2 Manufacturing and Controlling of the Micropump
The micropump was designed by Maika Felten and her colleagues at the Fraun-
hofer Institute of Bio-Medical Techniques, Potsdam [148]. The channel is 200µm
Figure 3.3: Micropump: The chip
containing the micropump is mounted
on a black metal plate, acting as a
heat sink. The electrodes are con-
nected with generator via the green
circuit boards.
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wide in the area of the electrodes and 100µm elsewhere. 24 planar electrodes are
on the roof of the channel and 36 on the bottom. The electrodes form stripes,
stretch over the complete channel width, are 10µm wide and the spacing between
them is 10µm. The micropump was manufactured by Gesim GmbH, Rossendorf.
First the electrodes were structured by standard photo-lithographical techniques
from Pt with an adhesion layer of Ti. Outside the channel the electrodes were
passivated by a layer of silicon nitride. The channel was formed by a photo sen-
sitive polymer layer and the channel was closed with a micro-patterned thin glass
(170µm) by a face to face adhesion technology, with positioning resolution better
than 5µm.
The traveling electric wave is generated by four rectangular signals, where the
signal between neighboring electrodes is shifted by pi/2 (Fig. 3.4). The rectangular
signals are created by a high frequency generator, with four diﬀerent phasings
(Cytocon400, Cytoman-1, Evotec Technologies GmbH, Hamburg). The frequency
is adjustable between 1 kHz and 12MHz and is used to control the travel speed
of the wave. The amplitude could be varied between 0V and 10V. By a wiring
board between the generator and the micropump, every fourth electrode is driven
with the same signal, having the same phase.
The in- and outlet of the micropump and a syringe were connected to a 4-way
valve in such a way that either the pump could be ﬁlled by the syringe, or a closed
loop was formed.
The laminar ﬂow speeds outside the electrode array, were measured by ﬂuo-
rescence imaging of tracer beads on standard ﬂuorescent microscope and the ﬂow
Figure 3.4: Micropump with applied electric potentials. Schematic
drawing of the micropump with indication which potential is applied on which
electrode. (For better visibility only bottom electrodes are shown.) Time course
(lower right) of the applied potentials on four successive electrodes. Four rect-
angular potentials with phase shifts of pi/2 are used.
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speeds were estimated by a standard tracking algorithm. Inside the electrode array
the complex ﬂow patterns were mapped by two-focus ﬂuorescence cross-correlation
spectroscopy (2f-FCCS).
3.3 Two-focus Fluorescence Cross-Correlation inside the
Micropump
3.3.1 Theoretical Considerations
The model functions for 2f-FCCS in the case of active transport were derived in
section 2.4
GAC(τ) =
1
〈N〉
1
1 + 4D τ
ω20
1√
1 + 4D τ
S2 ω20
exp
( −v2 τ 2
ω20 + 4D τ
)
(3.3)
GCC,1(τ) =
1
〈N〉
1
1 + 4D τ
ω20
1√
1 + 4D τ
z20
exp
(
−v
2 τ 2 +R2 − 2Rv τ cos(α)
ω20 + 4D τ
)
(3.4)
GCC,2(τ) =
1
〈N〉
1
1 + 4D τ
ω20
1√
1 + 4D τ
z20
exp
(
−v
2 τ 2 +R2 + 2Rv τ cos(α)
ω20 + 4D τ
)
.
(3.5)
The forward cross-correlation curve (eq. (3.4)) shows a characteristic peak (Fig.
3.5) and the position of the maximum directly corresponds to the ﬂow velocity.
In case of no diﬀusion (D = 0) the ﬂow velocity v is given by the simple relation
v =
R cos(α)
τmax
. (3.6)
10−6 10−4 10−2 100 102
0
0.2
0.4
0.6
0.8
1
τ [s]
G
(τ)
 ω0 = 0.25 µm
 z0 = 1.5 µm
 R  = 2 µm
 D  = 20 µm2/s 
 α  = 0°
 
 
AC v=200 µm/s
CC v=200 µm/s
AC v=20 µm/s
CC v=20 µm/s
AC v=0 µm/s
CC v=0 µm/s
10−6 10−4 10−2 100 102
0
0.02
0.04
0.06
0.08
0.1
τ [s]
G
(τ)
Figure 3.5: 2f-FCCS curves: Calculated auto- and cross-correlation curves
for pure diﬀusion (v=0) and ﬂow velocities of 20 and 200µm/s.
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Figure 3.6: Position and amplitude of the cross-correlation peak: The
position (lag time τ) and the amplitude of the cross-correlation peak in depen-
dence on the ﬂow velocity v over diﬀusion coeﬃcient D is shown for decreasing
distances of R = 4, 2, 1, and 0.5µm.
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To ﬁnd the best experimental realization, the dependence of the resolvable ve-
locity on the diﬀusion coeﬃcient D and the distance R has to be studied. The
results can be seen in Fig. 3.6 and show the position (lag time τ) and the amplitude
of the cross-correlation peak for several distances R and several ﬂow velocities v.
It is clearly visible in the graphs that the velocity resolution increases with de-
creasing diﬀusion coeﬃcient. For an increasing distance R the peak positions get
more separated, but in contrast the amplitude of the peak decreases. For this
reason, here a compromise has to be found that the peak is not lost in the noise
of an experimental correlation curve.
The direction of ﬂow only inﬂuences the amplitude of the cross-correlation peak
and not the position (Fig. 3.7). Therefore, the direction of ﬂow is only roughly
distinguishable, because the peak amplitude is strongly inﬂuenced by experimental
artifacts.
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Figure 3.7: Direction dependence of the peak position: The position
(lag time τ) and the amplitude of the cross-correlation peak in dependence on
the ﬂow direction α.
To conclude these theoretical considerations: A distance R between 1 and 2µm
would be a good compromise, between enough resolution of the peak position and
a high enough peak amplitude. The resolution increases with decreasing diﬀusion
coeﬃcient, but decreasing diﬀusion coeﬃcient means increasing particle size and
thereby stronger direct inﬂuence of electric ﬁelds created by the micropump. The
direction of the ﬂow can only be roughly determined, if it is parallel or antipar-
allel to the vector between the two foci, because the amplitude of the peak is
additionally inﬂuenced by experimental artifacts. For better direction estimation
it is necessary to turn the sample, to ﬁnd the angular position with the highest
peak amplitude.
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3.3.2 Experimental Realization
As a good compromise between a slow diﬀusion and not to big particles, CdSe/ZnS
quantum dots (Adirondack Green, Evident Technologies) with a size of 20 nm at
a concentration of 100 nM were used as ﬂuorescent species. The aqueous solution
had a conductivity of 35mS/m. A driving voltage of 8V and a frequency of 7MHz
was applied to the 36 electordes on the bottom (z=0) of the pump. All 2f-FCCS
measurements were performed on a home-built setup (Fig. 3.8). The quantum
dots were excited by the 488 nm line from an Ar-Kr-laser (Inova 70, Coherent).
The laser beam was split and recollected by two beam splitters, creating two laser
beams, which enter the objective (UPlanApo 60x/1.2 W, Olympus) with a small
angular diﬀerence. Two foci with a distance R of 2.2µm are created. Each foci was
Figure 3.8: Home built 2f-FCCS setup: Two laser beams enter the ob-
jective with a small angular diﬀerence, creating two laser foci. The emitted
ﬂuorescence is collected with the same objective, spectrally ﬁltered, directed
onto a double-core multi-mode Y-ﬁber and detected with two APD. The sig-
nals from the APDs are correlated with a hardware correlator and evaluated
with a PC.
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3.3µm high and 560 nm wide and had an eﬀective volume of 0.73 ﬂ. The emitted
ﬂuorescent light (λ=520 nm) was separated from the excitation light by a dichroic
beam splitter (Q 505 LP, AHF, Tuebingen, Germany) and ﬁltered by an emission
ﬁlter (HQ 532/70, AHF). The ﬂuorescent light from both foci was directed onto
the one-end side of a double-core multi-mode Y-ﬁber, which splits into two ﬁber
containing one core each, a so called bifurcated ﬁber (Avantes, RB Eerbeek, The
Netherlands). The distance between the two cores was nominal 125µm, which
corresponds to a distance R of 2.1µm between the two foci. The real distance
of 2.2µm was measured by imaging the foci with a CCD camera, therefor the
imaging light path was calibrated with a ruler slide. The light from each core was
detected by an avalanche photodiode (APD) (SPCM-CD 3017, Perkin Elmer). A
hardware correlator (Flex-02-12D/B, Correlator.com, Bridgewater, NJ) processed
the the signals from the APDs to obtain an autocorrelation curve from each spot
and two cross-correlation curves, one in backward and one in forward direction.
The ﬂuorescent signals were collected 6 times for 60 s each at each position in the
micropump.
The correlation curves were evaluated with a self-written Matlab script (The
Mathworks). To remove the spatial crosstalk, the backward cross-correlation curve
was subtracted from the forward cross-correlation curve, leading to the ﬂow cross-
correlation curve, as it is described by Brinkmeier et al. [14]. The ﬂow cross-
correlation curve and the autocorrelation curves were ﬁtted globally with the
model functions (3.3) and (3.4). As ﬁt algorithm a weighted nonlinear least square
algorithm was used. For a better estimation of the ﬂow velocity the residuals of
the ﬂow cross-correlation curve were ﬁve times more weighted, than the residuals
of the autocorrelation curves.
3.4 Results
The ﬂow far away from the electrode array was already measured by detecting the
tracks of ﬂuorescent beads in the µm size using a standard ﬂuorescent microscope
and shows a laminar Poiseuille ﬂow proﬁle [139]. For the parameter set which
we used for the 2f-FCCS measurements the maximum Poiseuille ﬂow speed was
48µm/s. Above the electrode array the ﬂow pattern were too complex to be
resolved by the usage of tracer beads (Fig. 3.9). Additionally tracer beads of µm
size are aﬀected by dielectrophoretic forces directly, so that their motion can not
be attributed to hydrodynamic drag forces alone. For the quantum dots, with a
diameter of 20 nm which were used for the 2f-FCCS measurements the inﬂuence
of the dielectrophoretic forces can be neglected.
Representative correlation curves are shown in Fig. 3.10. These curves were
measured at position x=280µm, y=100µm, z=10µm. The calculated ﬂow cross-
correlation curve and its ﬁt is plotted in addition to the measured auto-, forward
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Figure 3.9: Accumulation of particles. Fluorescent particles with a diam-
eter of 200 nm become trapped due to the interaction of hydrodynamic and
dielectrophoretic forces. (Measurement by Maika Felten, Fraunhofer-IBMT,
Potsdam.)
Figure 3.10: Two-focus correlation curves. Correlation curves measured
at position x=280µm, y=100µm, z=10µm. In addition to the measured for-
ward and backward cross-correlation curves (CC) the ﬂow cross-correlation
curve (FCC) is plotted, which is calculated by subtraction of the backward
from the forward cross-correlation curve. The autocorrelation curves (AC) are
plotted in the inset. The correlation curves were ﬁtted as described in the text
and a ﬂow velocity of 126µm/s was determined. The weighted residuals of the
ﬁt are plotted in the lower graph.
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Figure 3.11: 2f-FCCS ﬂow proﬁles. Flow velocities in direction along the
channel measured with 2f-FCCS along three mutually perpendicular lines above
the electrode array. The ﬂow above the electrode array is less regular than the
Poiseuille ﬂow proﬁle outside the electrode array. The ﬂow direction changes
in the x-scan (a) and the z-scan (c). Negative signs indicate a ﬂow opposite to
the direction of the net ﬂow. The maximum ﬂow velocity of the Poiseuille net
ﬂow outside the electrode array is indicate by the dashed line in (a).
and backward cross-correlation curves. The lower graph shows the weighted resid-
uals from the global ﬁt. The ﬁtting algorithm resolved a ﬂow velocity of 126µm/s
at this position.
To map the velocity proﬁle in the micropump above the electrode array the
position of the two foci was systematically scanned through the channel volume.
The results from all 2f-FCCS measurements are summarized in Fig. 3.11. The
graphs represent scans along three mutually perpendicular axes. Positive velocity
values indicate a ﬂow in the direction of the net ﬂow measured outside the electrode
array. The x-scan along the channel axis was detected 10µm above the electrode
plane at half of the channel width. Position x=20µm is in the middle between
the ﬁrst and second electrode (electrodes are 10µm wide and uncovered room
between the electrodes is also 10µm wide). Above the left part of the electrode
array, the ﬂow runs opposite to the direction of the net ﬂow (Fig. 3.11(a)). For
x-values larger than 200µm, i.e. behind the tenth electrode, the ﬂow direction
reverses and coincides with the net ﬂow direction. Between 500 and 700µm, the
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Figure 3.12: Scheme of ﬂow pattern. Flow pattern as derived from visual
particle tracking and from 2f-FCCS measurement. Additionally the forces are
drawn, which act on the particles. The vortical streaming exerts hydrodynamic
forces on the particles. These forces cause the motion of the particles away from
the cores of the vortices. The particles move towards the regions between two
adjacent vortices. Additionally, DEP forces act on the particles. They prevent
the particles from approaching the channel bottom and push them from the
channel center towards the sidewalls, where the electric ﬁeld is lower.
ﬂow is fastest and reaches velocities of up to 300µm/s. This is approximately six
times the maximum ﬂow velocity of the Poiseuille ﬂow outside the electrode array
(line in Fig. 3.11(a)).
The y-scan was also measured 10µm above the electrodes at x = 600µm (Fig.
3.11(b)). The distribution of measured ﬂow velocities is well approximated by a
parabolic proﬁle.
Along the z-direction, a reversal of the ﬂow is observed for larger z-values (Fig.
3.11(c)). Here, the zero-crossing point is located in the middle of the channel.
However, the ﬂow showing a positive sign and being closer to the electrodes is
approximately two times faster than the backﬂow observed near the channel top.
Consequently, more liquid is transported along the positive x-direction than in the
opposite direction. This pattern is compatible with the positive net ﬂow.
Figure 3.12 summarizes the ﬂow pattern obtained from the 2f-FCCS measure-
ments together with the results of tracer bead imaging above the electrode array.
The sketch shows a ﬂowline pattern, which features two vortices of diﬀerent size
rotating in opposite directions. The front vortex rotates in the direction of the net
ﬂow and the planes that are associated with closed ﬂow lines are tilted. The rear
vortex rotates against the net ﬂow direction and the planes of the closed ﬂow lines
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are bent. The ﬂuorescence cross-correlation spectroscopy (FCCS) measurements
showed the existence of the vortices and their rotation direction, while the particle
imaging resolved the positioning, tilting and bending of the vortices.
3.5 Discussion
A complex ﬂow behavior was observed in the electrohydrodynamic micropump,
where ﬂuidic transport is usually dominated by laminar ﬂow lines. Propagating
electric ﬁelds generated by arrays of microelectrodes act in a complex manner not
only on the ﬂuidic medium but also directly on the particles, if they are bigger
than 50 nm to 100 nm. For this reason, 2f-FCCS was applied to determine the ﬂow
proﬁle, as it allows the introduction of probes that are not aﬀected by the electric
ﬁeld. Quantum dots with a diameter of 20 nm were used as these probes. Since
the dielectrophoretic force is proportional to the particle volume, they experienced
an electric force which was by more than one order of magnitude below that on
the smallest particles which exhibited accumulation. Hence, the application of
2f-FCCS allowed us to distinguish between forces that act on volume elements of
the ﬂuid medium and forces directly acting on particles. In addition to electric
forces, thermal convection may also play a role, as the ﬁeld distribution leads to
localized ohmic heating.
The observation of the particle ﬂow and the 2f-FCCS both provide evidence for
the occurrence of two ﬂow vortices above the electrodes. They rotate in opposite
direction (Fig. 3.12). The rear vortex is probably formed by the combination of a
localized force ﬁeld above the electrode array and the ﬂow resistance in the con-
ﬁned microchannel geometry. At the rear end of the array, the accelerated ﬂuid
elements experience a strong ﬂow resistance. The ﬂow evades into that part of
the channel, where the electrohydrodynamic forces are too weak to counteract the
ﬂow resistance. The 2f-FCCS data do not allow integrating the ﬂow density over
the entire cross-section of the channel. However, the higher positive ﬂow veloci-
ties measured in the lower half of the microchannel close to the electrode array
are compatible with the positive net ﬂow measured distant from the electrodes
(Fig. 3.11). A vertical component of the ﬂow proﬁle may be due to temperature
convection. Its action might be most eﬀective just at the rear end of the array
where the ﬂow experiences a strong resistance.
At the front vortex, the ﬂow proﬁle as measured using 2f-FCCS contradicts the
theoretical predictions [148]. It remains unclear which physical eﬀect contributes
to the generation of the front vortex.
The ability to generate a well-deﬁned vortical ﬂow on a micrometer scale pro-
vides the possibility to manipulate nanosized particles through hydrodynamic
forces. To explain the accumulation of particles, the behavior of a particle in
a vortical ﬂow is considered. When a particle is exposed to a vortex, radial forces
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act on the particle [149], e.g., centrifugal force, pressure gradient force, and Stokes
drag. The crucial parameter determining whether the resulting radial force com-
ponent points towards the center of the vortex or in the outward direction is the
ratio between the liquid density ρl and that of the particle ρp. For ratios ρl/ρp < 1,
theory predicts the ejection of particles from the vortex center [150, 151] which was
conﬁrmed by several experimental investigations [152, 153]. Here, ρl/ρp = 0.95,
what suggests that particles should accumulate between the vortices. An enrich-
ment was observed in this region. However the particles were conﬁned to the
channel wall opposite to the electrode array. This behavior is explained by dielec-
trophoretic forces. In the applied frequency regime, negative dielectrophoresis acts
on the particles such that the force vector points against the ﬁeld gradient and
particles are repelled away from the array towards the upper channel wall. As the
strength of the dielectrophoretic force is proportional to the volume of particles,
the process of accumulation is more eﬀective for larger particles than for smaller
ones.
The micropump has to be further optimized to function as an eﬀective ﬁltering
or enrichment device. A more complex design of the electrode arrays may oﬀer
various options for deﬁning regions in the channel where enrichment or depletion
of particles prevail. Narrow side channels that enter at positions where maximum
particle density is achieved are considered as design elements that allow to con-
tinuously extract particles for producing concentrated particle suspension. For
example this could be used to accelerated the still complex and tedious task of
enriching viruses from diluted samples for testing purposes.
The formation of vortices reduces the eﬃciency of the electrohydrodynamic
pumping. If one runs the device as a pump, the elimination or reduction of these
vortices is desirable. A more complex electrode pattern may suppress the forma-
tion of vortices. To ascertain the most eﬀective way of avoiding the vortices, more
complex simulations together with design variations of the device are necessary.
For both optimization directions all kinds of FCS, which can measure ﬂow,
like 2f-FCCS or scanning FCS [26, 154] may be used to discriminate between
hydrodynamic and dielectrophoretic forces.
3.6 Conclusion
The ﬂow pattern inside a pumping microdevice was analyzed by 2f-FCCS. The
microdevice allows the generation of an electric traveling wave along a linear array
of microelectrodes in a ﬂuidic channel, which can be used to pump small volumes
of liquid media through microﬂuidic channels and to ﬁlter and accumulate micro-
and nanoparticles from suspensions.
Such a microdevice using the electrohydrodynamical principle displays a com-
plex ﬂow proﬁle, which is not resolvable by common techniques. Additionally
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dielectrophoretic forces act on particles larger than 50 nm to 100 nm, preventing
the elucidation of the pure electrohydrodynamic forces. Here the ﬂow proﬁle of
such a pump was mapped by 2f-FCCS using small (20 nm) quantum dots as ﬂuo-
rescent particles. The combination of the ﬂow velocity map, resolved by 2f-FCCS
with the results from the bead imaging allowed the reconstruction of a complex
ﬂow pattern, consisting of two vortices of diﬀerent sizes and opposite directions of
rotation. This ﬂow pattern explained the observed complex particle trajectories
in the force ﬁeld and the accumulation of particles in well-deﬁned regions above
the microelectrode array. Only the high precision of 2f-FCCS in measuring ﬂow
velocities even with small ﬂuorescent particles made it possible to separate the
electrohydrodynamic forces acting on the solvent from the dielectrophoretic forces
acting on larger particles. This allowed the elucidation of the correct ﬂow pattern
inside the micropump.
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4.1 The Discovery of RNA Interference
Small double stranded RNAs (dsRNAs) have emerged as key regulators of gene
expression, acting in an evolutionary conserved group of post-transcriptional gene
silencing (PTGS) pathways found in eukaryotes. The discovery of these PTGS
mechanisms especially of RNA interference (RNAi), where dsRNAs trigger the
degradation of complementary messenger RNAs (mRNAs) revolutionized loss-of-
function studies in many organisms. RNAi is now commonly used to study the
role of a gene and has a great perspective in medical applications due to its high
speciﬁcity.
Early experiments in plants and the worm C. elegans found a dramatic reduction
in gene expression, if additional copies, antisense or sense RNA strands of this
gene were introduced in the organism [155157]. The mechanism leading to this
strong silencing of gene expression was not understood, until Fire et al. discovered
RNA interference in 1998 [158]. They injected dsRNA into C. elegans and found
knock down of the corresponding genes, with much higher eﬃciency than single
stranded sense or antisense RNA alone. In the following years RNAi was found
in Drosophila [159], zebraﬁsh [160, 161] and in mammals [162, 163].
The real eﬀector molecules of RNAi were ﬁrst identiﬁed in plants [164] and
later also found in animals [165, 166]. These, around 20 nt long dsRNAs, are
called short interfering RNAs (siRNAs).
In the early years RNAi was induced by long dsRNAs. In mammals these
long dsRNAs lead to the activation of the unspeciﬁc interferon mediated immune
response, which results in an overall block of translation and ﬁnally in Apoptosis.
Therefore, RNAi experiments were impossible in mammals until Elbashir and
coworkers demonstrated that siRNAs can induce RNAi in mammalian cells [167].
The second class of short RNAs the micro RNAs (miRNAs) was discovered 1993
in C. elegans [168]. Lee et al. found a 21 nt and a 61 nt long RNA encoded in the
gene lin-4 and complementary sequences in the 3' untranslated region (UTR) of the
gene lin-14. They proposed that lin-4 regulates lin-14 by a RNA-RNA-interaction.
Many more miRNAs were identiﬁed in C. elegans, Drosophila melanogaster and
humans [169171], many of them are widely conserved among these animals. Now
it is known that miRNA-mediated gene silencing is a strongly conserved mecha-
nism, with over 800 known human miRNAs [172] regulating more than 60% of all
human gene coding sequences [173175].
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4.2 Biogenesis of Small RNAs
There are many diﬀerent types of short RNAs, e.g. siRNAs, miRNAs, piRNAs
etc. They diﬀer in their origin, their maturation pathways and in their mode of
gene regulation inside cells. The best characterized small double stranded RNA
silencing triggers are siRNAs and miRNAs. Therefore, this chapter focusses an
these two. siRNAs derive from long double stranded RNAs, have nearly per-
fect complementarity to their target, are loaded in the RNA-induced silencing
complex (RISC), and induce cleaveage of the targeted mRNA. This mechanism
called RNAi is conserved among eucaryotes, because it is a powerful immune re-
sponse against viral infections and protects the genome against transposons. In
contrast miRNAs are endogenous short single stranded RNAs that form hairpin
like structures which contain mismatches and bulges. They are found in algae,
plants, protists, animals, and viruses [179, 180]. miRNAs are involved in temporal
and spatial development, in tissue maintenance [181], and regulate gene expres-
sion by repression of translation and mRNA degradation. The following chapter
will focus on the origin, maturation and eﬀector step of short RNAs in animals,
especially in mammals (mainly humans) and ﬂies (Drosophila melanogaster).
4.2.1 Origin of Long dsRNAs
siRNAs are produced from long double stranded RNAs, which can be of endoge-
nous or exogenous origin. Endogenous dsRNAs in mammals were only found in
gonads and early embryos, where they derive from transposons [182184] (Fig.
4.1(a)). In contrast in ﬂies endogenous dsRNAs were found in gonads and soma,
where they also originate from heterochromatic regions [185189].
Exogenous dsRNAs are either of synthetic origin or are the natural replication
products of viruses, as has been shwon in ﬂies [190192].
4.2.2 Nuclear Maturation of micro RNAs
The precursors of miRNAs originate in the nucleus, where the production and ﬁrst
maturation step takes place. The primary transcript of miRNA genes is a capped
and polyadenylated mRNA that folds into clearly deﬁned local hairpin structures
[193195]. These, so called primary miRNAs (pri-miRNAs) are transcribed from
Figure 4.1 (facing page): Origin, maturation and eﬀector steps of siRNAs
and miRNAs in human. Diﬀerences of the short RNA maturation in ﬂies from
the human system are indicated in square brackets. A detailed description of
the various RNAi processing and activity steps can be found in sections 4.2
and 4.3. The symbols for Dicer and Ago are inspired from the structure and
function of these proteins described in [176178].
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miRNA genes by polymerase II in a highly tissue speciﬁc manner [196198], al-
though a minor group of miRNAs associated with Alu-repeats is transcribed by
polymerase III [199]. The hairpin structures contain a highly conserved double-
stranded stem, which is 30 base pairs (bp) long (Fig. 4.1(b)) [200202].
pri-miRNAs are processed to precursor miRNAs (pre-miRNAs) by the so called
microprocessor complex (Fig. 4.1(b)) [203, 204]. The microprocessor complex
consists of the RNase III class II protein Drosha and DGCR8 (in ﬂies called
Pasha) [205208]. DGCR8 binds the single-stranded double-stranded junction of
the pri-miRNA with its two dsRNA binding domains (dsRBDs) [206, 207, 209] and
directs Drosha to its cleavage site 11 nt (one helical turn) away from the junction
on the double-stranded stem [210]. The two RNase III domains of Drosha form
an intramolecular dimer with two active sites forming one processing center. The
RNase III domain A cleaves the 3' strand, leaving the 3' end of the pre-miRNA
with a 2 nt overhang and a hydroxyl group, while the RNase III domain B cleaves
the 5' strand, leaving a monophosphate [204, 207]. The microprocessor complex
discriminates its substrate from other secondary mRNA structures by the length of
the double stranded stem and the number and size of the contained bulges [211], it
was proposed that DGCR8 performs this discrimination, because its two dsRBDs
form a structure which binds al 33 bp long double-stranded stem [209, 212].
A Drosha independent pre-miRNA maturation pathway, called the mirtron
pathway was found in 2007. The intron encoded pre-miRNA is directly cut out
by the Spliceosome, leading to a branched pre-mirtron which is the excised intron.
This pre-mirtron is then debranched and sometimes trimmed by exonucleases to
form a pre-miRNA (Fig. 4.1(c)) [213215].
All the diﬀerent pathways produce pre-miRNAs having a double-stranded stem
around 20 nt long, containing the miRNA and a terminal loop. The 3' end has a
2 nt long overhang with a hydroxyl group and the 5' end contains a monophos-
phate. For the next maturation step these pre-miRNAs have to be exported
to the cytoplasm, what is performed by Exportin5/RanGTP (Fig. 4.1(d)). Ex-
portin5/RanGTP binds all dsRNAs with a stem longer than 14 bp and having
3' overhangs or blunt ends. They are transported through the nuclear envelope,
where the GTP is hydrolyzed and the short RNA is released into the cytoplasm
[216219].
4.2.3 Small RNA Processing in the Cytoplasm
The production of short RNA duplexes, which can be loaded in the Ago proteins,
is performed by Dicer in the cytoplasm. Dicer is a RNase III class III protein
[220] which is highly conserved among eucaryotes. Dicer cleaves dsRNAs and
pre-miRNAs 21-23 nt away from the terminus, leaving a 2 nt long overhang and a
hydroxyl group at the 3' end and a monophosphate at the 5' end [166, 221] (Fig.
4.1(e,f)). The cleavage reaction depends on Mg2+ ions, and is in most cases ATP
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independent [221, 222]. The association of Dicer with its substrates relies on Dicers
dsRBD and PAZ domain. The PAZ domain binds the terminus of the dsRNA or
pre-miRNA, preferential a terminus with a 2 nt long 3' overhang [223227]. The
PAZ, the DUF283, and a part of the RNase III domain A form the internal
ruler for the cleavage after ∼22 nt. As in Drosha the RNase III domains form an
internal dimer, containing one processing center with two active sites. RNase III
domain A cleaves the 3' strand leaving a hydroxyl group and a 2 nt long overhang,
while domain B cleaves the 5' strand leaving a monophosphate [176, 177, 228].
Recombinant Dicer can produce short RNA duplexes alone [222, 229, 230], but is
normally found together with dsRNA-binding proteins in vivo.
In humans only one Dicer protein exists. It associates with the dsRNA-binding
proteins TRBP [229, 231] and PACT [230] to process dsRNA into siRNAs (Fig.
4.1(e)). Both proteins increase the activity of Dicer [232] by the reduction of
autoinhibition by Dicers helicase domain [233]. Human pre-miRNAs are processed
to miRNA duplexes by the RISC loading complex (RLC), composed of Dicer,
TRBP, PACT, and one of the four human Ago proteins (Fig. 4.1(f)) [230, 234
236]. This complex also loads the miRNA into RISC (see section 4.2.4).
In contrast to humans two Dicer proteins exist in ﬂies which have distinct roles.
A complex of Dicer-1 and the PB-isoform of the dsRNA-binding protein Loqua-
cious (LOQS-PB), also known as R3D1, process pre-miRNAs into miRNA du-
plexes (Fig. 4.1(f)) [237240]. Dicer-1 is very similar to human Dicer and does
not need ATP for its activity. LOQS-PB activates the pre-miRNA processing of
Dicer-1 and restrains Dicer-1 from dsRNA processing [241]. The second dicer of
ﬂies, Dicer-2 processes in a complex with the PD-isoform of Loquacious (LOQS-
PD) [240, 242] dsRNA into siRNAs in an ATP dependent manner (Fig. 4.1(e))
[243, 244]. Dicer-2 contains instead of a PAZ domain a DExH domain.
4.2.4 RISC Loading and Passenger Strand Separation
For the generation of a fully functional RISC, the siRNA and miRNA duplexes
have to be loaded in the Ago proteins. The loading is performed by the RISC
loading complex (RLC) which binds the duplexes and senses the hybridization
energy of the ﬁrst four nucleotides from each terminus (Fig. 4.1(h,i)). The RLC
can diﬀerentiate between hybridization energies that diﬀer only by 0.5 kcal/mol.
The strand with the less tightly bound 5' end is loaded into the Ago protein,
and therefore becomes the guide strand [245, 246]. The cleavage competent Ago2
proteins in ﬂies and humans, cleave the passenger strand of siRNAs [247250],
accelerating the release of the passenger strand from Ago2 (Fig. 4.1(j)). In ﬂies
the activation of RISC is accelerated by the endonuclease C3PO which removes
the cleavage products [251]. For miRNAs and the other cleavage incompetent Ago
proteins a bypass mechanism is proposed (Fig. 4.1(k)) [248], which does not need
ATP [235, 252]. A potential protein for the unwinding of the passenger strand
53
4 RNA Interference
in the bypass mechanism, was found in RNA Helicase A [253]. In all cases the
passenger strand is released from the Ago protein and degraded in the cytoplasm.
Due to the diﬀerent number of Dicer and Ago proteins in humans and ﬂies, the
loading mechanism diﬀers between them in detail. In ﬂies siRNAs and miRNAs
are released from the Dicer proteins after cleavage (Fig. 4.1(g)) and are rebound
by the diﬀerent RISC loading complexes [254] which facilitate the loading into dif-
ferent Ago proteins [255]. The interaction of the two Dicer proteins with the short
RNA duplexes depend on the number of mismatches and bulges inside the du-
plex. While Dicer-1 and Dicer-2/R2D2 compete for short RNA duplexes, which
contain only some mismatches [256], Dicer-2/R2D2 refuses miRNAs, especially
these with mismatches in the cleavage region [257] and binds perfectly comple-
mentary siRNAs [243, 256, 258]. The dsRNA binding protein R2D2 interacts with
the tighter bound 5' end and senses thereby the 5' monophosphate of the passen-
ger strand end, while Dicer-2 interacts with the other end. The R2D2/Dicer-2
complex loads the siRNA duplex into Ago2 (see Fig. 4.1(h)) [259263]. Dicer-1
interacts with all short RNAs and tries to load them into Ago1. Perfectly comple-
mentary siRNAs are rejected by Ago1, so that only miRNAs are loaded into Ago1
(Fig. 4.1(i)) [241, 256]. The loading of miRNA-duplexes into Ago1 is an ATP
dependent process, while the following unwinding and passenger strand release is
ATP independent and facilitated by mismatches outside the cleavage region of the
miRNA-duplex [257].
In humans siRNAs and miRNAs are loaded to the same extend to all four
Ago proteins [264267] by the RLC. As for Drosophila Ago1 all four human Ago
Proteins prefer short RNA duplexes with mismatches in the central region. The
loading of short RNA duplexes in to the Ago protein is ATP dependent, while the
following unwinding is ATP independent and is facilitated by mismatches outside
the cleavage region (Fig. 4.1(i)). Only the cleavage competent human Ago2 can
unwind perfectly complementary siRNAs, by cleaving the passenger strand (Fig.
4.1(h)) [252].
Earlier publications [234236, 268] found that the minimal human RLC is com-
posed of Dicer, TRBP and one of the four Ago proteins and that the loading of
siRNAs is ten times less eﬃcient than the loading of pre-miRNAs. A very re-
cent publication [252], showed that in cell lysate the loading eﬃciency is equal
for siRNAs, miRNAs, and pre-miRNAs, suggesting that the before found minimal
RLC is not the canonical RLC, but reﬂects a complex which performs bypass
incorporation of single-stranded forms of small RNA duplexes and hairpin RNAs
[229, 252, 269].
From crystal structures the picture evolves that the short RNA is ﬁrst bound to
the PAZ domain of Ago [226, 227, 270, 271]. Due to conformational changes the
ﬁrst 5' basepair of the guide strand is opened, and this guide strand end is inserted
into the 5' binding pocket. There the 5' phosphate is bound by a Mg2+ ion. The
ﬁrst ﬁve 5' terminal nucleotides of the guide strand interact with the conserved
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region around the binding pocket in a sequence independent way [178, 271274].
4.3 Gene Regulation by Small RNAs
The maturation steps of small RNAs described in the previous sections, create
an active RNA-induced silencing complex (RISC). RISC is a big cellular complex
which consists of many diﬀerent proteins [275]. The core protein of all RISCs is
an Ago protein [255, 276278], which is loaded with a single stranded short RNA
[269, 277, 279] (see Fig. 4.1(l)). To regulate the expression of genes, the active
RISC interacts with mRNAs. If the mRNA contains a complementary sequence
to the Ago loaded single stranded RNA, both RNAs hybridize. In dependence
of the RISC composition, the Ago protein will then regulate the gene expression
by either mRNA cleavage, translational repression, or mRNA degradation. Due
to the separation of transcription and translation in the nucleus and cytoplasm,
respectively, transcriptional gene silencing is a nuclear process and translational
repression a cytoplasmic process. The cleavage of RNAs was found both in the
cytoplasm and in the nucleus [280, 281].
4.3.1 Target Recognition
For the identiﬁcation of complementary target RNAs, the active, guide strand
containing, RISC has to interact with mRNAs. Crystal structures of guide strands
bound to Ago and Piwi proteins show that the ﬁrst ten nucleotides of the 5'-end
form an A-helix [271, 273, 274]. The nucleotides 2 to 8 are exposed to the solvent,
thereby forming the primary pairing region, called the seed region. To ﬁnd the
complementary site on the targeted RNA, RISC does not scan the targeted RNA
unidirectional [282, 283], but interacts in a nonspeciﬁc way with single stranded
RNA to promote the sequence speciﬁc pairing of the seed region with the targeted
RNA [284]. The complete process of target recognition is accelerated nine times
by RISC, compared to the pairing of guide strand to its targeted mRNA without
RISC [284]. Target recognition by RISC is ATP independent [285], and active
translation of the targeted mRNA is not necessary [282, 283]. A stable pairing
of the seed region induces translational repression (see section 4.3.3) [286, 287].
Incase of fully complementary strands, hybridization propagates to the 3' end,
while the Ago protein undergoes big conformational changes [288290], and the
3'end of the guide strand is released from the PAZ domain [291].
Target recognition and thereby also the later eﬀector step depends strongly on
the secondary structure of the targeted mRNA at the complementary site. Hair-
pin structures, where the targeted site forms a duplex, but also other secondary
structures inhibit the binding of active RISC. The higher the number of paired
nucleotides of the target sequence, the stronger the inhibition of RISC activity
[284, 292295].
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4.3.2 Messenger RNA Cleavage
The cleavage of targeted mRNAs by RISC is the best understood RNA mediated
gene regulation process. Ago2 is the only cleavage competent Ago protein found
in mammals and ﬂies [249, 265, 266, 296], so only RISC containing Ago2 proteins
can perform gene regulation by mRNA cleavage. If the guide strand nearly per-
fectly matches the target site (at least nucleotides 2-15) and forms at least one
complete turn of an A-form double helix, the targeted mRNA will be cleaved by
Ago2 independent from the maturation pathway of the guide strand (Fig. 4.1(m))
[278, 297299]. siRNAs which derive from dsRNAs, show normally such a high
complementarity to their target sites, but also some miRNAs have enough com-
plementarity to mediate cleavage of their targets [300, 301]. The targeted mRNA
is cleaved between the bases which pair the 10th and 11th nucleotide of the guide
strand, counted from the 5' end [299, 302]. This cleavage position is given by
the Ago internal distance between the 5' binding pocket and the catalytic site
[272, 290]. The catalytic site is located in the Piwi-domain, resembles a RNase
H domain [303] and is a Asp-Asp-His (DDH) motif [269]. The cleavage reaction
is an ATP-independent hydrolysis, leaving a 3' hydroxyl group and a 5' phos-
phate terminus [285, 304], catalyzed by two Mg2+ ions [305, 306]. The cleavage
competent RISC is a true multiple turnover enzyme, which can catalyze several
rounds of target-RNA cleavage [278, 299]. After cleavage the products are released
and rapidly degraded by exonucleases [279]. The 5' cleavage product is degraded
from its 3' end by the Exosome, which needs the Ski-complex to bind the RNA.
While the 3' cleavage product is degraded from its 5' end by XRN1 (Fig. 4.1(n))
[307, 308].
RNA cleavage is sequence speciﬁc down to one nucleotide in the region around
the cleavage site (nucleotides 9-12) [302, 309]. Mismatches and bulges are well
tolerated at the 3' end of the guide strand [298, 310], while the limited space in
the region of the Ago protein that anchors the seed region, allows only very few
mismatches in the pairing of the seed region [290].
siRNAs can have oﬀ-target silencing eﬀects. The short length of only 8 nt,
makes the seed region relative unspeciﬁc. Thereby pairing with sequences similar
to the targeted RNA can trigger RISC mediated gene silencing, causing oﬀ-target
silencing eﬀects [311314].
4.3.3 Translational Repression and mRNA Degradation
The huge majority of the over 800 known miRNAs mediate translational repres-
sion and mRNA degradation. Both are summarized under the name miRNA-
mediated gene silencing [315317]. miRNA-mediated gene silencing is the second
gene regulation mechanism of RISC and plays a great role in temporal and spatial
development and in tissue maintenance [181]. The human genome contains more
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than 45000 conserved miRNA target sites, covering 60% of all human gene coding
sequences [173175].
In humans all four Ago proteins can induce miRNA-mediated gene silencing
[265, 278, 318, 319]. The miRNA loaded RISC is bigger than 900 kDa and contains
many diﬀerent proteins [275]. The best studied accompanying protein is GW182,
also known as TNRC6 [234, 267, 275]. GW182 contains a GW/WG rich region,
called the Ago-hook, which interacts with the 5' binding pocket of Ago, without
disturbing the binding of the miRNA 5' end [320, 321], and thereby strongly
increases miRNA-mediated gene silencing [320, 322, 323].
In ﬂies, miRNAs are mainly loaded into Ago1 [255], therefore Ago1 containing
RISC is the major miRNA-mediated gene silencing complex in this organism. In
case of highly complementary miRNAs and endogenous siRNAs, which are not
full complementary to their target RNA, also Ago2 can induce miRNA-mediated
gene silencing [188, 324]. As in humans GW182 plays an essential role, and the
miRNA-loaded RISC contains many more proteins [308, 323].
The inhibition of mRNA cleavage by mismatches between the guide strand and
the targeted mRNA causes miRNA-mediated gene silencing, independent from the
biogenesis of the loaded short RNA [297, 325]. miRNA target sites are normally
found in the 3' untranslated region (UTR) of the targeted mRNA [204, 326328],
although it has been shown that target sites in the 5' UTR and even the coding
region exists and exhibit silencing and repression activity [287]. The number of
miRNA-target sites, regulate the strength of gene silencing. One target site is not
enough to induce measurable silencing eﬃciencies, for example the let-7 targeted
lin-41 mRNA contains two target sites, which are both necessary for gene silencing
[287]. The eﬀect of more target sites seems to be more than additive, four binding
sites silence the gene four times stronger than two binding sites [325].
To perform miRNA-mediated gene silencing the miRNA-loaded RISC forms
a stable association with the targeted RNA [267, 329331]. In huge proteomic
screens and also in other experiments it was seen that there are two diﬀerent
mechanisms for miRNA-mediated gene silencing - translational repression and
mRNA degradation [332335]. Both mechanisms are independent, but inﬂuence
each other in vivo [335] and are described in the following sections.
Translational Repression
Translational repression describes a mechanism, where miRNA-loaded RISC in-
hibits the translation of the mRNA into a protein, without changing the level of the
mRNAs inside the cell (Fig. 4.1(o)). It is independent from the key mechanisms
of mRNA degradation - deadenylation and decapping [335337] and functions also
in the absence of processing bodies (P-bodies) [332]. The achieved gene silencing
by repression of translation is only modest [333, 334].
There are two mechanisms for translational repression of miRNA-loaded RISC
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[338]. The earlier found mechanism is the inhibition of translation elongation,
where the production of the peptide is stalled somewhere after the initiation pro-
cess of translation [339, 340]. This mechanism is supported by the fact that
most miRNAs were found on actively translated mRNAs [341, 342]. In the sec-
ond mechanism translation is repressed, by the inhibition of translation initiation
[343]. In this mechanism RISC interacts with the cap structure of the targeted
mRNA [323, 344] and interferes with the binding of translation initiation factors,
because mRNAs lacking the m7GpppG cap [345347] and mRNAs bound to the
translation initiation factors eIF4E and eIF4G [348] could not be repressed.
In ﬂies it was recently shown that Ago1 containing RISC blocks a step after cap
recognition, while Ago2 binds to eIF4E and blocks the eIF4E-eIF4G interaction,
which points to the fact that the mechanism of translation repression can also
depend on the Ago protein [324].
In at least one case it was shown that miRNA-repressed mRNAs were released
from translational repression and entered again the translation machinery under
changing environmental conditions [349].
mRNA Degradation
The second mechanism of miRNA-mediated gene silencing is mRNA degradation.
It is involved in the silencing of all genes, which show a silencing of more than
3-fold, for highly repressed genes mRNA degradation is the major silencing mech-
anism [333]. In ﬂies 60% of all miRNA-targeted mRNAs are degraded [335].
The miRNA-mediated mRNA degradation takes place in so called processing
bodies (P-bodies) (Fig. 4.1(p)). P-bodies are cellular organelles, where the com-
plete mRNA dergradation, also the miRNA independent one, takes place [350].
Many proteins involved in mRNA degradation are found in P-bodies [351, 352],
including the proteins that are involved in miRNA-mediated gene silencing, for ex-
ample all four human Ago proteins [348, 353, 354] and GW182 [234, 308, 322, 355].
In ﬂies only Ago1 containing RISC can trigger mRNA degradation in P-bodies,
but not Ago2 containing RISC [324].
miRNA targeted mRNAs can localize to P-bodies in the presence of the miRNA
together with the complete RISC (Fig. 4.1(o)). There the targeted mRNAs are
stored and degraded. The degradation starts with deadenylation of the poly(A)-
tail by the CCR4:NOT complex, with the deadenylases CAF1 and NOT1 [320, 335,
336] and is followed by decapping, which is executed by the decapping complex
Dcp1:Dcp2 [320, 335, 337, 353]. After decapping the mRNA is degraded in a 5'
to 3' manner by XRN1 [335, 351, 356].
In yeast miRNA targeted mRNAs shuttle between P-bodies (translation repres-
sion) and polysomes (active translation) in a cell state and cell stress dependent
manner [357].
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4.3.4 Transcriptional Gene Silencing
The third major gene silencing mechanism, is transcriptional gene silencing (TGS)
(reviewed in [358, 359]). In contrast to mRNA cleavage, translational repression
and miRNA-mediated mRNA degradation, which function post-transcriptional,
TGS directly interferes with the transcription of a gene, and is therefore a nu-
clear process. TGS is induced by perfectly or imperfectly matching short RNAs
which are complementary to the promoter sequence or the transcription start
site sequence of the targeted gene [360362]. These RNAs are called antigene
RNAs (agRNAs), and the involved protein complex is called RNA-induced tran-
scriptional silencing complex (RITS). In humans Ago1 and Ago2 loaded with
an agRNA together with TRBP associate with the actively transcribed promoter
site [363, 364] and interact directly with the actively transcribing Polymerase
II [364, 365]. The agRNA guide strand hybridizes with the promoter sequence
on an extended 5' UTR in the transcript and not on the template [360, 361].
RITS initiates then DNA- and/or Histone methylation. For DNA-methylation
the DNA methyltransferase DNMT3a is activated by RITS and methylates CG
dinucleotides [365, 366]. In Histone methylation, the Histone methyltransferase
EZH2 performs Histone H3 lysine-9 di-methylation (H3K9) and Histone H3 lysine-
27 tri-methylation (H3K27), which were found up to 720 bp downstream from the
promoter sequence [364, 365]. Histone methylation can lead to the formation of
heterochromatin.
4.4 Chemical Modiﬁcations
The wide usage of RNAi in reverse genetics and its growing usage as a thera-
peutic reagent is based on the following advantages of this technique. RNAi is
highly speciﬁc, siRNAs as reagents are easily available and simply to design. The
knowledge of an organisms genomic sequence permits rapid design and a genome-
wide coverage. The disadvantages of RNAi are the relatively short lifetime of the
silencing trigger, the dependency on the protein half-life due to targeting of the
mRNA and the diﬀerent delivery eﬃciencies among diﬀerent tissues [368].
Nearly from the discovery of RNAi in mammalian cells [167] on, chemical mod-
iﬁcations of siRNAs were studied to overcome these disadvantages. Many of these
chemical modiﬁcations are well known from antisense drug research, a technology
where single stranded antisense oligonucleotides are used to interfere with mRNA
expression. The numerousness number of possible modiﬁcations [369, 370] can be
classiﬁed in modiﬁcations of the phosphate backbone, modiﬁcations of the ribose
and modiﬁcations of the nucleic base. Here the focus will be on four chemical
modiﬁcations of RNA which have been already intensively studied to characterize
their usefullness for RNAi based therapeutics. The chemical structure and the
intracellular localization of these chemical modiﬁed siRNAs is shown in Fig. 4.2.
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Figure 4.2: Chemical modiﬁcations and their intracellular localiza-
tion: The upper row shows the chemical formulas of DNA, RNA, 2'-O-methyl
modiﬁed RNA, 2'-ﬂuoro modiﬁed RNA and phosphorothioate modiﬁed RNA
(from left to right), and the lower row shows the respective intracellular lo-
calization patterns of short (21 nt) double stranded DNA/RNAs with 2 nt 3'
overhang [367].
The replacement of RNA nucleotides with DNA nucleotides is known from the
early beginning of siRNA usage [302] (Fig. 4.2). For a long time, they were used to
replace the two 3' terminal nucleotides which form the overhang. The replacement
of a complete siRNA strand with a complementary DNA strand abolished silencing
activity [302]. A recent study shows that more nucleotides than the terminal ones
can be replaced, without the loss of silencing activity. It is possible to replace the
complete seed sequence of the guide strand, remaining the full silencing activity
and additionally suppressing oﬀ-target silencing [371].
The substitution of the hydroxyl group at the second position of the ribose ring
with a methylated oxygen is called the 2'-O-methyl modiﬁcation (Fig. 4.2). It
is like DNA a natural occurring modiﬁcation known from transfer and ribosomal
RNAs and also the 3' terminal nucleotide of Piwi-interacting RNAs (piRNAs)
is 2'-O-methyl modiﬁed [372375]. The dominantly cytoplasmic localization of
2'-O-methyl modiﬁed siRNAs is the same as for unmodiﬁed siRNAs (Fig. 4.2)
[367].
Several studies show that 2'-O-methyl modiﬁcations of up to four consecutive
nucleotides per strand at several positions are well tolerated. Longer consecutive
2'-O-methyl modiﬁcations decrease silencing activity [376378]. Modiﬁcations on
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the passenger strand are more tolerated than on the guide strand. siRNAs with
completely 2'-O-methyl modiﬁed passenger strands were found, which show nor-
mal silencing activity [378, 379]. siRNAs with every second nucleotide modiﬁed,
or with completely modiﬁed passenger strand show strongly increased serum sta-
bility combined with normal silencing activity [310, 378, 380]. In one case for a
siRNA with every odd nucleotide 2'-O-methyl and every even 2'-ﬂuoro modiﬁed
a 500-fold increase in silencing activity was observed [380].
Completely 2'-O-methyl modiﬁed oligonucleotides bind to RISC loaded with
a complementary guide strand and inhibit target mRNA cleavage and miRNA-
mediated gene silencing [381, 382].
The 2'-O-methyl modiﬁcation of the second guide strand nucleotide from the
5' end strongly reduce oﬀ-target silencing, probably due to weakening the pairing
with targeted mRNA, and thereby reducing the binding to not perfect comple-
mentary targets [383]. On siRNAs missing the 5' phosphate, the 2'-O-methyl
modiﬁcation prevents the phosphorylation. Therefore, the 2'-O-methyl modiﬁca-
tion of the ﬁrst sense strand nucleotide can be used to reduce the loading of the
sense strand and to favor the loading of the antisense strand [384].
In 2'-ﬂuoro modiﬁed RNA the hydroxyl group at the second position of the
ribose is replaced by a ﬂuorine (Fig. 4.2). 2'-ﬂuoro modiﬁcation show a strong
nuclear localization, with a slight localization in P-bodies, in contrast to the 2'-O-
methyl modiﬁcation [367]. The 2'-ﬂuoro modiﬁcation of several single nucleotides
and up to three consecutive nucleotides has nearly no negative eﬀect on the si-
lencing activity and in some cases increased the serum stability of the siRNA and
the persistence of RNAi [298, 377, 378, 385387].
The substitution of an oxygen in the phosphate backbone by a sulfur is called
phosphorothioate modiﬁcation. As for the 2'-ﬂuoro modiﬁcation also for the
phosphorothioate modiﬁcation a strong accumulation of the modiﬁed siRNAs
in the nucleus is noted (Fig. 4.2) [367, 385]. The modiﬁcation of several single
nucleotides and up to four consecutive nucleotides does not interfere with silenc-
ing. For longer modiﬁcations typically a decrease in silencing activity is observed
[376, 378, 385, 386]. The complete phosphorothioate modiﬁcation of the antisense
strand strongly reduced or abolished silencing, while the complete sense strand
modiﬁcation was tolerated [377, 379, 385]. In some studies cytotoxicity of longer
phosphorothioate modiﬁcation was observed [376, 386].
Bigger modiﬁcations on the termini of the siRNA strands, like the attachment
of biotin or ﬂuorophores are tolerated on both 3' termini and the 5' terminus of
the sense strand, but not on the 5' terminus of the antisense strand [310, 388, 389].
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5.1 Introduction
Short interfering RNAs (siRNAs) are the eﬀector molecules of an evolutionary
conserved gene silencing mechanism called RNA interference (RNAi) [165167].
These usually 21 nt long double stranded RNA molecules are loaded into the RNA-
induced silencing complex (RISC), which contains an Argonaute protein. During
the loading mechanism, the selection of the later called guide strand is governed by
the thermodynamic stability of the duplex termini and stays in the now activated
RISC [245, 246]. The recognition of targeted mRNAs by RISC is guided by the
single stranded RNA on the basis of sequence complementarity. In case of nearly
perfect complementarity between the guide strand and the targeted mRNA, RISC
cleaves the mRNA, which gets subsequently degraded by exonucleases [266, 279,
302]. A detailed description of the complete RNAi mechanism can be found in
chapter 4.
The identiﬁcation of siRNAs as triggers of RNAi in mammalian cells [167]
yielded in the development of chemically synthesized siRNAs. The speciﬁcity
and simplicity of RNAi opened the wide ﬁeld of therapeutic usage to siRNAs
[390392]. To improve the pharmacokinetic and pharmacodynamic1 properties of
siRNAs various modiﬁcations, e.g. the phosphorothioate backbone modiﬁcation,
2'-O-methyl and 2'-ﬂuoro sugar modiﬁcation, have been comprehensively evalu-
ated. These modiﬁcations and their eﬀects in RNAi can be found in section 4.4.
So far, the eﬀects of chemical modiﬁcations on siRNA mediated silencing have
been studied by classical silencing readouts either by targeting an endogenous gene
analyzed by western blot, qRT-PCR or by standard reporter assays, e.g. mRFP/
EGFP expression or the dual luciferase assay [298, 310, 367, 376, 377, 385]. Little
is known about the mechanism of silencing inhibition by modiﬁed nucleotides
which can e.g. aﬀect aﬃnity to RISC, strand separation, cleavage activity and/or
the stability of the incorporated guide strand. In addition, the direct analysis of
the RNAi mechanism in vivo in real time at the early phase of RISC activation
(1-6 h) can result in a more detailed characterization of modiﬁed siRNAs, needed
to further improve RNAi-based pharmaceuticals.
Here, dual-color ﬂuorescence cross-correlation spectroscopy (FCCS) was used to
directly access strand separation, guide strand incorporation and the duration of
incorporation as well as RISC-target-RNA interaction in vivo. In contrast to the
1Pharmacodynamics explores what the drug does to the body, while pharmacokinetics explores
what the body does to the drug.
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classical silencing readouts, the high sensitivity of FCCS allowed the localization
of individual steps of silencing inhibition, without the use of reporter systems or
the requirement of translational regulation or knock down of mRNA or protein.
The positional eﬀects of the chemical modiﬁcations were characterized with high
sensitivity in diﬀerent cellular compartments in real time.
5.2 Material and Methods
Cell Culture
ER293 cells stably transfected with the pERV3 vector (Stratagene) were cul-
tured at 37◦C in DMEM (high glucose, Sigma) with 10% FBS (PAA Labora-
tories GmbH), 2mM glutamine (Gibco), and 0.3mg/ml G418 (50mg/ml, Gibco).
The stably expressing EGFP-Argonaute2 cell line 10G was generated by Thomas
Ohrt (details can be found in [368]) and cultured at 7◦C in DMEM (high glucose,
Sigma) with 10% FBS, 2mM glutamine, 0.3mg/ml G418, and 0.4mg/ml Hy-
gromycin B. All cells were regularly passaged at subconﬂuency and were plated
with 1-5 ·104 cells/ml density.
Target and siRNA Sequences
All RNA strands were obtained from IBA GmbH (Goettingen) as single strands
with 5'-phosphate, a 3'-amino group and labeled with Cy5 succinimidyl ester
(Cy5-NHS, Amersham Biosciences) on the ﬁrst nucleotide from the 3' end. Du-
plex siRNAs were prepared by mixing complementary sense siRNA and antisense
siRNA at equimolar ratio, incubating at 80◦C for 2 min followed by a cooling
step at 1◦C/min to 15◦C. The annealing procedure was performed in the Mas-
tercycler epGradientS (Eppendorf) in 110mM K-gluconate, 18mM NaCl, 10mM
HEPES, pH 7.4, and 0.6mM MgSO4 with 1060mM siRNA concentrations. The
quality of the duplex siRNAs was checked by agarose gel electrophoresis and high-
performance liquid chromatography. The prepared siRNA duplexes were stored
at -20◦C.
Target-RNA sequence is derived from the pRL-TK vector (Promega) containing
the target sequence for siTK3: CCA GAA GAA UUU GCA GCA UAU CUU
GAA CCA UUC AAA GAG AAA GGU GAA GU, 2'-O-methyl modiﬁcations at
positions 1-7 and 44-50 and Cy5 at the 3' end.
The siTK3 siRNAs were ordered with 2'-O-methyl modiﬁcations at several dif-
ferent positions, at least including the ﬁrst four nucleotides from the 3' end.
antisense siTK3: UGA AUG GUU CAA GAU AUG CUG
sense siTK3: GCA UAU CUU GAA CCA UUC AUU
antisense siTK3-bulge: UGA AUG GUC AUA GAU AUG CUG
sense siTK3-bulge: GCA UAU CUA UGA CCA UUC AUU
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For luciferase experiments SilencerTM Negative control #2 (NegsiRNA) from
Ambion was used.
Luciferase Assay
Dual-luciferase assays (Promega GmbH) were performed 24-48 h after transfection
according to the manufacturer's protocol for 24-well chambers and detected with
a TD20/20 luminometer (Turner designs). Pp-luc target vector (pGL2-Control,
Promega) was co-transfected with the control vector Rr-luc (pRL-TK, Promega
GmbH). Lipofectamine 2000 (Invitrogen GmbH) was used for the triple trans-
fection of the dual luciferase assay vectors pGL2-control (contains the cDNA of
Fireﬂy luciferase (FL)) and pRL-TK (contains the cDNA of Renilla luciferase
(RL)) together with the siRNAs. The desired amount of each siRNA was mixed
with 0.9µg pGL2-control and 0.1µg pRL-TK. The cells were transfected with the
indicated amounts of siRNAs, 100µl Opti-MEM, and 2µl Lipofectamine 2000.
3-5 h after transfection the medium was replaced by 500µl fresh growth medium.
The ratios of target (pRL-TK) to control (pGL2-control) luciferase concentra-
tions were normalized to the NegsiRNA control.
Target-RNA Stability Assay
To test the target-RNA stability, double-labeled target-RNA (3'end-Alexa488,
5'end-Cy5) was incubated for several incubation times between 0 and 180min
in HeLa S20 extract at 37◦C. To stop the degradation aliquots were stored on
ice. Analysis of target-RNA after incubation was done by denaturing polyacry-
lamide gel electrophoresis (PAGE), containing urea and 18% polyacrylamide. The
amount of intact target-RNA was quantiﬁed by measuring the mean intensity of
the yellow band, containing both labels.
Microinjection
For the loading assay, 5-10 ·104 10G cells were transferred onto MatTek cham-
bers coated with Fibronectin (25µg/ml in PBS including CaCl2 and MgCl2,
Roche) 24 h before microinjection. Immediately before microinjection the growth
medium in the MaTek chamber was replaced by microinjection buﬀer (150mM
NaCl, 20mM HEPES pH 7.4, 15mM Glucose, 150µg/ml BSA, 20mM Trehalose,
5.4mM KCl, 0.85mM MgSO4, 0.45mM CaCl2). The micropipette (Femtotip
2, Eppendorf) is loaded with 1.5-4µM labeled siRNAs in 110mM K-gluconate;
18mM NaCl; 10mM HEPES pH 7.4 and 0.6mM MgSO4. The micromanipula-
tor consists of a FemtoJet and InjectMan NI2 which is mounted directly on a
microscope. Working pressure for injection was between 20-40 hPa for 0.1 s and
a holding pressure of 15 hPa. siRNAs were allways injected into the cytoplasm.
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After microinjection the mircoinjection buﬀer was replaced with growth medium
again and cells were put back into an incubator for diﬀerent times.
For target-interaction assay, 18 ·104 10G cells were transferred onto a Fibro-
nectin coated MatTek chamber. For transfection with unlabeled siRNAs, 9µl of
the indicated siRNA (concentration 20µM), together with 4µl Lipofectamin 2000
and 300µl Opti-MEM were added to cells covered with 1.5ml growth medium.
3 h after transfection the medium was replaced by 2ml fresh growth medium.
Between 10 and 18 h after transfection the labeled target-RNA was microin-
jected with the same procedure as for the labeled siRNAs, but instead of la-
beled siRNAs 1.5-4µM labeled target-RNA in 110mM K-gluconate; 18mM NaCl;
10mM HEPES pH 7.4 and 0.6mM MgSO4 was used.
FCCS Data Acquisition
For the FCCS measurements the growth medium was replaced by air buﬀer
(150mM NaCl, 20mM HEPES pH 7.4, 15mM Glucose, 150µg/ml BSA, 20mM
Trehalose, 5.4mM KCl, 0.85mM MgSO4, 0.6mM CaCl2). FCCS was performed
on a commercial system consisting of a Confocor 3 attached to a LSM510 (Zeiss,
Jena, Germany) at room temperature. The 488 nm Ar-laser-line was used to ex-
cite EGFP and the 633 nm line of a HeNe-laser was used to excite Cy5. Both laser
lines were attenuated by an acousto-optical tunable ﬁlter to 3.5 and 1.05 kW/cm2,
respectively, in order to minimize photobleaching and cellular damage. Both exci-
tation laser lines were directed by a 488/633 dichroic mirror (HFT) onto the back
aperture of a Zeiss C-Apochromat 40x, N.A.=1.2, water immersion objective. The
ﬂuorescence light was collected by the same objective, separated from the excita-
tion light by a 488/633 dichroic mirror (HFT), passing a confocal pinhole (70µm
in diameter) and split into two spectral channels by a second dichroic beam split-
ter (LP635). After removing residual laser light by a 505-610 nm bandpass or
655 nm longpass emission ﬁlter, respectively, the ﬂuorescence light was recorded
by avalanche photodiodes (APDs). Before each experiment the setup was adjusted
using Alexa488/Cy5 double labeled siRNA, yielding cross-correlation amplitudes
of 75 (±5%). The discrepancy to 100% is due to imperfect overlap of the detec-
tion volumes and/or imperfect labeling of the siRNA. In each cell, FCCS was
measured in the nucleus and the cytoplasm. For each measurement, 8 runs, each
30 seconds long, were collected. Only cells that exhibited a higher number of red
than green ﬂuorophores in the focal volume were used, to avoid that a too low
siRNA concentration limits the amount of cross-correlation.
For the localization of the cytoplasm and nucleus a picture of each measured
cell was taken by laser scanning microscopy (LSM) using the same instrument,
with the same beampath and APDs as detectors.
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FCCS Data Analysis
The ﬂuorescence signals of each run were software correlated following the deﬁni-
tion of auto- and cross-correlation (see also eq. (2.53)-(2.56))
Gi,j(τ) =
〈δFi(t) · δFj(t+ τ)〉
〈Fi(t)〉〈Fj(t)〉 . (5.1)
Runs showing signiﬁcant photobleaching or intracellular movement were dis-
carded from the data evaluation. A model (eq. (5.2)) including two diﬀusing
species and a term accounting for the photophysics (more details in sections 2.3.2
and 2.5) was ﬁtted to the two autocorrelation and the cross-correlation curves, us-
ing a weighted Marquardt non-linear least square ﬁtting algorithm (more details
in section 2.7). The cross-correlation curve was the average of the two cross-
correlation curves (red vs. green and green vs. red channel).
Gi,j(τ) = Gi,j(0)
(
1 +
fT
1− fT exp
(
− τ
τT
))
·
 f1(
1 + τ
τ1
) √
1 + τ
S2 τ1
+
1− f1(
1 + τ
τ2
) √
1 + τ
S2 τ2
 (5.2)
fT represents the fraction of molecules in the dark state, τT the lifetime of the dark
state, τ1 and τ2 are the diﬀusion times of the two species, f1 is the fraction of the
ﬁrst specie and S is the form factor, which is the ratio of axial (z0) over the radial
radius (ω0). During the ﬁt, the lifetime of the dark state τT was ﬁxed to 130µs and
70µs for EGFP and Cy5, respectively. These values were determined in preceding
experiments with EGFP and Cy5 in vivo. The triplet fraction fT of the cross-
correlation curve was ﬁxed to zero. The amplitudes Gi,j(0)) were corrected for
spurious autoﬂuorescent background of the cells, using the mechanism described
in section 2.6.3
G˜i,j(0) =
〈Fi〉
〈Fi〉 −Bi
〈Fj〉
〈Fj〉 −Bj Gi,j(0) . (5.3)
Here, 〈F 〉 is the measured count rate and B the measured background count rate,
which were determined in unlabeled ER293 cells. The background in the green
channel was between 5 and 10% of the measured ﬂuorescent signal and for the red
channel between 1 and 2%. In addition, background corrected amplitudes G˜i,j(0),
were corrected for spectral crosstalk. Spectral crosstalk was only encountered from
the green into the red channel, with an amount of β=0.7%. Subsequently, the
green amplitude is unaﬀected, while the red and the cross-correlation amplitude
need to be corrected for with the mechanism from section 2.6.7. Here 〈F˜ 〉 is the
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background corrected count rate 〈F˜ 〉 = 〈F 〉 −B
Gˆg(τ) = G˜g(τ) (5.4)
Gˆr(τ) =
〈F˜r〉2 G˜r(τ) + β2 〈F˜g〉2 G˜g(τ)− 2 β〈F˜r〉 〈F˜g〉 G˜CC(τ)
〈F˜r − β F˜g〉2
(5.5)
GˆCC(τ) =
〈F˜g 〉 〈F˜r〉 G˜CC(τ)− β 〈F˜g〉2 G˜g(τ)
〈F˜g(t)〉 〈F˜r〉 − β 〈F˜g〉2
. (5.6)
From the corrected amplitudes, the number of ﬂuorescent particles in the de-
tection volume were calculated, which are given by the following set of formulas:
Gg(0) =
1
Ng +Ngr
, Gr(0) =
1
Nr +Ngr
,
GCC(0) =
Ngr
(Ng +Ngr) (Nr +Ngr)
.
(5.7)
Here, Ng is the number of only green labeled particles, Nr the number of only
red labeled particles and Ngr the number of particles which carry both labels.
The amount of cross-correlation was calculated by dividing the number of double
labeled particles by all particles carrying a green label
CC = Ngr
Ng +Ngr
=
GCC(0)
Gr(0)
. (5.8)
5.3 RISC Loading and Interaction with Target studied by
FCCS in vivo
To investigate the inﬂuence of chemically modiﬁed siRNAs onto the formation
and function of RISC, a ER293 based cell line in which hAgo2 is tagged with
EGFP was used [368]. hAgo2 was chosen, because it associates with micro RNAs
(miRNAs) and siRNAs [266, 267], is involved in nuclear RNAi [280, 281] and
shows an endonucleolytical cleavage activity [299, 302]. The characterization of
the 10G cell line, stably expressing EGFP-hAgo2, revealed that the fusion protein
reproduces the enzymatic activity, sub-cellular localization, expression level and
function of endogenous hAgo2 protein [368].
5.3.1 RISC-Loading Studied by Dual-Color FCCS
To study the formation of cleavage active RISC, by asymmetric incorporation of
the guide strand and to show the stability of the activated RISC complex, Cy5-
labeled siRNAs were microinjected in the 10G cell line and the cross-correlation
amplitudes between EGFP-Ago2 and the Cy5-labeled siRNA were measured for
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Figure 5.1: FCCS-incorporation assay. FCCS in vivo assay to study the
asymmetric incorporation of siRNAs into RISC. The incorporation of the la-
beled strand results in increased cross-correlation amplitudes (upper panel),
whereas the incorporation of the non-labeled strand results in low cross-
correlation amplitudes (lower panel)
several incubation times. The incorporation of the labeled strand would result in
increased cross-correlation amplitudes (Fig. 5.1, upper panel), whereas the incor-
poration of the non-labeled strand would lead to low cross-correlation amplitudes
(Fig. 5.1, lower panel).
The ability of the FCCS-incorporation assay to measure the asymmetric in-
corporation of the guide strand was proven by measuring the incorporation of
the siRNA siTK3, which targets the mRNA of Renilla luciferase encoded on the
plasmid pRL-TK. The 5'-end hybridization energies of siTK3 were calculated as
described [245] to deﬁne the guide and passenger strand (Fig. 5.2(a)). Due to its
lower 5'-end hybridization energy, the upper strand in Fig. 5.2(a) forms the guide
strand. siTK3 was used, because it displays a high level of Renilla luciferase silenc-
ing, demonstrating the incorporation of the guide strand into endogenous RISC
(Fig. 5.2(b)). For the in vivo experiments, the siRNA was 2'-O-methyl modiﬁed
at the ﬁrst four nucleotides from the 3' end to increase the binding stability of the
Cy5 label [368]. For comparison the silencing activity of the unmodiﬁed siTK3 is
also plotted.
After microinjection of siTK3 10G cells display a nearly homogenous distri-
bution of the siRNA in the cytoplasm, with a slight accumulation in P-bodies
and an exclusion from the nucleus (Fig. 5.3(a)). The cross-correlation amplitudes
measured up to 12 h after microinjection of the passenger strand labeled siTK3
were between 0% and 5% in the cytoplasm and nucleus (Fig. 5.3(c)). This in-
dicates the exclusion of the passenger strand from RISC. In contrast to the low
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Figure 5.2: Silencing activity of siTK3. (a) Sequence and free energies
of the siRNA siTK3. (b) Silencing activity of indicated amounts of siTK3
(red) and NegsiRNA (black, negative control) measured with a Dual-Luciferase
Assay. siRNAs with a 2'-O-methyl modiﬁcation at the ﬁrst 4 nucleotides from
the 3' ends were used for the in vivo experiments. For comparison the silencing
activity of unmodiﬁed siTK3 is also shown in white (mean of three diﬀerent
experiments ±SD).
cross-correlation levels for the labeled passenger strand, for the guide strand la-
beled siTK3 the cross-correlation levels increased to a values of 20% and 10%
in the cytoplasm and nucleus, respectively. The maximum was reached 6 h after
microinjection followed by slight decline (Fig. 5.3(e)). This indicates the incor-
poration of the labeled guide strand into RISC. Guide strand labeled siRNAs
could be observed for longer time periods compared to passenger strand labeled
siRNAs, due to the loss of the Cy5 signal in labeled passenger strand containing
cells. This most probably results from the stabilization of the guide strand caused
by the interaction with RISC, whereas the passenger strand gets degraded.
Control experiments with EGFP supplemented with guide strand labeled siTK3
exhibited no cross-correlation amplitude (Fig. 5.4(a)), whereas a Alexa488 and
Cy5 double labeled siRNA as positive control resulted in 75% cross-correlation in
vitro (Fig. 5.4(b)).
As the relative cross-correlation amplitude is directly proportional to the con-
centration of the double labeled species (compare eq. (5.8)), these results demon-
strate the speciﬁc incorporation of the guide strand into nuclear and cytoplasmic
RISC, whereas the passenger strand is excluded during the loading process. In-
terestingly, the cross-correlation amplitudes increase and decline synchronously
in the cytoplasm and nucleus, however in the nucleus to a lower extend. There
are two obvious reasons that the cross-correlation amplitudes of the labeled guide
strand (Fig. 5.3(d)) does not reach the maximal measurable amplitude of 75%
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Figure 5.3: Asymmetric guide strand incorporation into RISC. (a)
LSM images of 10G cells 3 h after microinjection of siTK3 (green: EGFP-Ago2,
red: siTK3, right panel: overlay). Scale bars indicate 10µm. (b) Normal-
ized cross-correlation curves of EGFP-Ago2 and the labeled passenger strand
of siTK3 in the cytoplasm for diﬀerent incubation times after microinjection
in 10G cells in vivo. (c) Resulting cross-correlation amplitudes for the labeled
passenger strand in the cytoplasm (ﬁlled boxes) and the nucleus (open circles).
(d) Normalized cross-correlation curves of EGFP-Ago2 and the labeled guide
strand of siTK3 in the cytoplasm for diﬀerent incubation times after microin-
jection in 10G cells in vivo. (e) Resulting cross-correlation amplitudes for the
labeled guide strand in the cytoplasm (ﬁlled boxes) and the nucleus (open cir-
cles). Data are represented as mean±SEM.
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Figure 5.4: Incorporation assay controls. (a) Negative control, normalized
auto- (green and red) and cross-correlation (blue) curves of EGFP (green) and
siTK3-Cy5 (red) in vitro. (b) Positive control, normalized auto- (green and
red) and cross-correlation (blue) curves of a Alexa488 (green) and Cy5 (red)
double-labeled siRNA test sample in vitro.
(Fig. 5.4(a)). The ﬁrst reason is that the cells contain unlabeled endogenous Arg-
onaute proteins (Ago1-4), which binds also to the labeled siRNAs, and thereby
preventing these labeled siRNAs from binding to labeled Ago2. The second reason
is that human cells produce endogenous unlabeled miRNAs, which also become
incorporated into labeled Ago2, and thereby blocking these Ago2 proteins from
loading labeled siRNAs.
Nevertheless, these results demonstrate the suitability of the FCCS-incorpora-
tion assay to study the asymmetric incorporation of siRNAs into RISC.
5.3.2 Interaction Between RISC and Its Target Studied by Dual-Color
FCCS
To probe the interaction of activated RISC with targeted RNAs, a 50 nt long
target-RNA was designed. It contains the siTK3 target site and a Cy5 label at
the 5' end. Seven nucleotides at each end were 2'-O-methyl modiﬁed to protect
the single stranded target-RNA against intracellular RNases. 10 to 18 hours af-
ter the transfection of the 10G cells with the unlabeled siRNA, the Cy5-labeled
target-RNA was microinjected into the cells. This time point was selected, be-
cause siRNA incorporation displayed its maximum between 6 and 24 h (compare
Fig. 5.3(E)). The cross-correlation amplitudes between the loaded and cleavage
activated EGFP-Ago2 and the Cy5-labeled target-RNA were measured for sev-
eral incubation times. If the loaded guide strand does not contain a sequence that
matches the sequence of the target-RNA, the interaction between RISC and the
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Figure 5.5: FCCS assay to measure RISC-target interaction. FCCS
in vivo assay to study the interaction of activated RISC with its target. Three
types of interaction are expectable. First, the target and the loaded guide strand
do not have a complementary sequence. This leads to only a very short inter-
action, and the target is released unchanged from activated RISC and results
in low cross-correlation amplitudes (upper panel). In case of perfect match be-
tween the loaded guide strand and the labeled target, the activated RISC binds
the target and cleaves it. The cleavage products are released from RISC, which
again results in low cross-correlation amplitudes (middle panel). In case of a
matching sequence, but an inhibited cleavage activity, due mismatches, bulges,
or chemical modiﬁcations, RISC and its target form a miRNA-like interaction,
where the target stays bound to RISC, resulting in high cross-correlation am-
plitudes (lower panel).
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Figure 5.6: Stability of target-RNA. (a) PAGE picture of double labeled
target-RNA (3'end-Alexa488, 5'end-Cy5) incubated for the given times with
HeLa S20 cell extract at 37◦C. (b) Fraction of intact target-RNA molecules
over incubation time (Quantiﬁcation from the PAGE picture).
target-RNA is very short and the target-RNA is released unchanged. This results
in low cross-correlation amplitudes (Fig. 5.5, upper panel). In case of a perfect
complementarity between loaded guide strand and target-RNA, RISC cleaves the
target-RNA and the cleavage products are released from RISC. This again results
in a low cross-correlation amplitude (Fig. 5.5, middle panel). In the third case,
there is enough complementarity between guide strand and target-RNA, but the
cleavage activity of RISC is impaired either due to mismatches, bulges, or chem-
ical modiﬁcations. In this case the interaction between RISC and target-RNA is
like a miRNA guided interaction, where the targeted RNA stays bound to RISC.
This lead to high cross-correlation amplitudes (Fig. 5.5, lower panel).
To test the stability of the single stranded target-RNA against intracellular
RNases, the target-RNA was incubated with HeLa S20 cell extract between 5
and 180 minutes at 37◦C. The amount of intact target-RNA was analyzed by
polyacrylamide gel electrophoresis (PAGE) (Fig. 5.6). After 60min of incubation
more than 85% and after 180min more than 70% of target-RNA was intact (Fig.
5.6). The target-RNA was stable enough to test the interaction of loaded RISC
and the target-RNA up to three hours after microinjection.
After microinjection the target-RNA localized to the cytoplasm and displayed
a slight accumulation in the nucleus and even stronger in nucleolar structures
(Fig. 5.7(a)). To study the interaction of siRNA loaded RISC with its target, the
siRNA siTK3-bulge was used, where the bases 9-11 were replaced. This leads to
the formation of a central bulge in the interaction with the siTK3 target site and
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Figure 5.7: Target interaction of siTK3-bulge loaded RISC. (a) LSM
images of 10G cells 1 h after microinjection of target-RNA (green: EGFP-Ago2,
red: target-RNA, right panel: overlay). Scale bars indicate 10µm. (b) Silencing
activity of indicated amounts of siTK3-bulge measured with a Dual-Luciferase
Assay. As controls silencing of NegsiRNA and siTK3 is also shown. Data are
represented as mean±SD. (c) Normalized cross-correlation curves of EGFP-
Ago2 loaded with indicated siRNAs and the Cy5-labeled target-RNA in the
cytoplasm 1 h after microinjection in 10G cells in vivo. (d) Resulting cross-
correlation amplitudes between target-RNA and RISC, loaded with indicated
siRNAs, measured in the cytoplasm (empty bars) and the nucleus (striped bars),
1 h to 3 h after microinjection. Data are represented as mean±SEM.
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thereby trigger a miRNA-like interaction. The results of the silencing assay show
that siTK3-bulge is silencing inactive. It is unable to trigger the cleavage reaction
of RISC (Fig. 5.7(b)). FCCS measurements in non-transfected and NegsiRNA
transfected 10G cells after 1 to 3 h of target-RNA delivery showed no interaction
of RISC with the target-RNA (Fig. 5.7(d)). This illustrates the assay speciﬁcity
and the absence of miRNA target sites within the target-RNA. The transfection
of perfectly matching and cleavage active siTK3 resulted in very low levels of
EGFP-Ago2-target-RNA interaction. In contrast, the transfection of central bulge
forming and silencing inactive siTK3-bulge yielded in high levels of RISC bound
target-RNA in the cytoplasm. In the nucleus however, the interaction levels were
3-fold lower in the beginning but increased with longer incubation almost reaching
cytoplasmic interaction levels after 3 h (Fig. 5.7(d)).
These results demonstrate the short interaction time of RISC loaded with a
perfectly matching siRNA with the target-RNA and that bulges in the center
of the guide-strand-target-RNA hybridization increase the lifetime of the RISC-
target-RNA interaction. Additionally the localization of functional guide-strand
loaded RISC to the nucleus and the accumulation of the cleavage impaired RISC-
target-RNA complex in the nucleus is demonstrated.
Accordingly it was shown that in vivo FCCS is a perfect tool to study the
interaction between siRNA-loaded RISC and targeted RNAs and that siTK3-bulge
can function as a positive control in the following experiments.
5.3.3 Cellular Model for Human RISC Loading and Shuttling
For the understanding of the inﬂuence of chemically modiﬁed siRNAs on the RNAi
pathway it is necessary to have a current model of the intracellular RNAi pathway.
First a summary of the additional results published in our paper [393] will be given
here, to motivate our model.
Mobility measurements of cytoplasmic and nuclear RISC by measuring the dif-
fusion constant of EGFP-hAgo2 with ﬂuorescence correlation spectroscopy (FCS)
revealed that nuclear RISC (nRISC) diﬀuses much faster than cytoplasmic RISC
(cRISC). Control measurements with EGFP in both compartments showed that
this is not an environmental eﬀect, because the diﬀusion of EGFP was the same
in both compartments. With the assumption of spherical proteins the molecular
mass could be calculate for cytoplasmic and nuclear RISC to (3.0±0.6)MDa and
(158±26) kDa, respectively. From these results together with biochemical con-
trol experiments, we concluded that EGFP-Ago2 is part of a huge RISC complex
in the cytoplasm, whereas in the nucleus RISC is most probably formed by the
discrete EGFP-Ago2 protein. The concentration of EGFP-Ago2 was four to ﬁve
times higher in the cytoplasm compared to the nucleus.
To further study nRISC, siRNAs targeting the nuclear RNA 7SK were microin-
jected in 10G cells and the cross-corrleation between EGFP-Ago2 and the guide
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strand labeled siRNA was measured in both cellular compartments. To our sur-
prise, we found an accumulation of loaded RISC in the nucleus for one out of three
7SK targeting siRNAs. A more detailed inspection showed that the accumulating
siRNA targets a region of the 7SK RNA which forms a hairpin structure. This
hairpin structure impairs the cleavage activity of Ago2 and probably leads to a
miRNA-like interaction between nRISC and the targeted 7SK RNA. This miRNA-
like interaction is probably the reason for the accumulation of RISC loaded with
the hairpin targeting siRNA in the nucleus.
The target dependent accumulation of nRISC and the fact that nRISC is to
small to form the RISC loading complex (RLC) (containing EGFP-Ago2, TRBP
Figure 5.8: Human RISC loading and shuttling model. (a) Asymmetric
guide strand incorporation is localized in the cytoplasm only. (b) Guide strand
mediated target recognition in the cytoplasm. (c) A perfect match results in
RISC mediated target degradation, while a more miRNA-like interaction leads
to translational repression and translocation into P-bodies. (d) A fraction of
cytoplasmic RISC is imported into the nucleus to ensure cell wide target regula-
tion. The cytoplasmic co-factors dissociate from hAgo2 protein, thereby form-
ing nRISC. (e) Guide strand mediated target recognition in the nucleus. (f)
A perfect match results in RISC mediated target degradation and reformation
of free nRISC, which can be exported into the cytoplasm, while a miRNA-like
interaction leads to accumulation of RISC in the nucleus resulting in eﬃcient
regulation.
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and Dicer, together around 380 kDa) lead to the hypothesis that RISC is pre-
dominantly loaded in the cytoplasm and shuttled between cytoplasm and nucleus.
Additional reasons for this hypothesis are that siRNAs are to short to contain lo-
calization signals, so RISC has to ﬁnd its target in both compartments and siRNAs
have a cytoplasmic localization, mediated by Exportin 5 [216219, 389]. To test
this hypothesis the loading of RISC with the siRNA targeting the hairpin struc-
ture of 7SK was performed with and without blocking the transport mechanisms
of the nuclear envelope by wheat germ agglutinin (WGA). Without blocking the
nuclear envelope cross-correlation levels of more than 20% were found in both
the cytoplasm and the nucleus. Injecting the siRNA together with WGA into
the cytoplasm, left the cross-correlation in the cytoplasm unchanged but reduced
the nuclear cross-correlation 3-fold down to 7%. The injection of the siRNA to-
gether with WGA into the nucleus changed the localization pattern of the siRNA
from cytoplasmic to nuclear (visualized by LSM) and the cross-correlation level
in the nucleus stayed on the low level, whereas the cytoplasmic cross-correlation
decreased to 12%, due to low siRNA levels in the cytoplasm. These results sup-
port our hypothesis and lead us to formulate the following model (Fig. 5.8) for
the intracellular RNAi pathway.
In our model a predominantly cytoplasmic loading of RISC and a shuttling
mechanism for activated RISC between cytoplasm and the nucleus is proposed.
(a) The RLC is localized and interacts with siRNAs and miRNAs exclusively in
the cytoplasm. It senses the asymmetry of the silencing trigger and speciﬁcally
incorporates the guide strand into hAgo2, thereby forming cRISC. The FCCS
measurements showed the maximum for this incorporation within the ﬁrst 3 to 12
hours, so the incorporation mechanism seems to be regulated. The majority of ac-
tivated cRISC remains in the cytoplasm as a 3MDa complex to regulate the gene
expression of mRNAs. (b) The guide strand mediates the target interaction and
in case of perfectly priming between the guide strand and the target RNA cRISC
guides target degradation (c). In case of a miRNA-like interaction cRISC remains
bound to the targeted mRNA and regulate its expression and/or translocation
to P-bodies. (d) A fraction of cRISC translocates into the nucleoplasm, where it
forms nRISC of ∼ 158 kDa, most likely composed of only hAgo2. This transloca-
tion into the nucleus ensures a cell wide target regulation. (e) Again also in the
nucleus the guide strand mediat the target interaction and in case of a perfect
match nRISC performs target degradation, which leads to the reformation of free
nRISC (f). (g) On the contrary, cleavage impaired nRISC, e.g. caused by double
stranded RNA (dsRNA) regions or bulges, results in the accumulation of this par-
ticularly loaded RISC in the nucleus, facilitated by its prolonging interaction with
the target RNA. Since a concentration increase of nRISC was never detected,
it is reasoned that a stable equilibrium between nRISC and cRISC exists that is
shifted for a particularly loaded nRISC depending on the target interaction.
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5.4 Inﬂuence of Chemical Modiﬁed siRNAs onto the RNAi
Mechanism
5.4.1 FCCS Compatibility of Diﬀerent Chemical Modiﬁcations
The three most commonly used and best characterized RNA-modiﬁcations: 2'-O-
methyl, 2'-ﬂuoro, and phosphorothioate modiﬁcations were already described in
section 4.4. In brief, 2'-O-methyl and 2'-ﬂuoro modiﬁcation are modiﬁcations of
the ribose, where the hydroxyl group at the second position is replaced with a
methylated oxygen or a ﬂuorine, respectively (Fig. 4.2, 3. and 4. column (p. 60)).
The phosphorothioate modiﬁcation is a modiﬁcation of the phosphate backbone,
where an oxygen in the backbone is substituted by a sulfur (Fig. 4.2, 5. column
(p. 60)).
To test the compatibility of these chemical modiﬁcations with the RISC-incorpo-
Figure 5.9: Sub-cellular localization of diﬀerently modiﬁed siRNAs
after microinjection. Sub-cellular localization of siRNAs with 2'-O-methyl
modiﬁcation on the ﬁrst four (upper left panel) and eight (upper right panel)
nucleotides counted from the 3' end. The localization of siRNAs with, where
the ﬁrst four nucleotides counted from the 3' end carry either 2'-ﬂuoro- (lower
left panel) or phosphorothioate (lower right panel) modiﬁcations. Scale bars
indicate 10µm.
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ration- and RISC-target-interaction-FCCS-assay, diﬀerently modiﬁed Cy5-labeled
siRNAs were microinjected into ER293 cells, to study their intracellular localiza-
tion and diﬀusion in vivo. As it was already described in [367], the 2'-ﬂuoro and
phosphorothioate modiﬁed siRNAs show a preferential nuclear localization illus-
trated by a strong and punctuate accumulation of these siRNAs in the nucleus,
compared to the predominantly cytoplasmic localization of 2'-O-methyl modiﬁed
and unmodiﬁed siRNAs (Fig. 5.9).
In vivo FCCS experiments with 3'-4 nt long phosphorothioate and 2'-ﬂuoro mod-
iﬁed siRNAs displayed strong bleaching rates especially in the nucleus, compared
to no or only small bleaching for 2'-O-methyl modiﬁed siRNAs (data not shown).
The strong bleaching of the phosphorothioate and 2'-ﬂuoro modiﬁed siRNAs might
arise from a decreased mobility of these siRNAs leading to a longer dwell time in
the focal volume. The cause for this decreased mobility could be the increased
aﬃnity of these modiﬁed siRNAs to proteins [394]. Therefore, the strong bleach-
ing made it impossible to obtain quantitative results by FCCS for 2'-ﬂuoro and
phosphorothioate modiﬁed siRNAs, but the 2'-O-methyl modiﬁed siRNAs were
suitable for a detailed in vivo FCCS analysis to investigate positional and quan-
tity dependent eﬀects on siRNA aﬃnity to RISC, strand separation, asymmetry,
guide strand incorporation, stability of the guide RNA-RISC interaction, target
RNA recognition and cleavage.
5.4.2 Increased 2'-O-methyl Modiﬁcations on the 3'-end Inhibit Strand
Separation and Target-RNA Cleavage
siTK3 siRNA was used to study the inﬂuence of 2'-O-methyl modiﬁcations on the
incorporation and strand separation of these siRNAs and the interaction of siTK3-
loaded RISC with the target-RNA. siTK3 targets the mRNA of Renilla luciferase
Figure 5.10 (facing page): Silencing, loading, and target interaction
of increasingly 3' end modiﬁed siRNAs (a) Sequence of the used siTK3
with indication of the increasing length of 2'-O-methyl modiﬁed parts. (b) Si-
lencing activity of indicated amounts of 2'-O-methyl modiﬁed siRNAs measured
with a Dual-Luciferase Assay. As controls silencing of NegsiRNA and siTK3 is
also shown. Data are represented as mean±SD. (c) Cross-correlation ampli-
tudes between labeled guide strand and EGFP-Ago2 measured in the cytoplasm
(empty bars) and the nucleus (striped bars), 3 h and 12 h after microinjection.
(d) Cross-correlation amplitudes between labeled passenger strand and EGFP-
Ago2 measured in the cytoplasm (empty bars) and the nucleus (striped bars),
3 h and 12 h after microinjection. (e) Resulting cross-correlation amplitudes be-
tween target-RNA and RISC loaded with indicated modiﬁed siRNAs measured
in the cytoplasm (empty bars) and the nucleus (striped bars), 1 h to 3 h after
microinjection. Data are represented as mean±SEM.
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encoded on the plasmid pRL-TK, but does not show any sequence homology
with endogenous mRNA transcripts. The siTK3 displays a strictly asymmetric
incorporation of the guide strand (Fig. 5.3(c),(e) (p. 71)) and high levels of Renilla
luciferase silencing (Fig. 5.10(b)).
To study the positional eﬀects of 2'-O-methyl modiﬁcations within small RNAs,
siTK3 siRNAs with constantly increasing numbers of 2'-O-methyl modiﬁcations
on the 3' end were generated (Fig. 5.10(a)). To test the silencing activity of these
modiﬁed siRNAs a dual-luciferase assay was performed. The introduction of four
2'-O-methyl modiﬁed nucleotides at the 3'-end resulted in increased silencing ac-
tivity compared to unmodiﬁed siRNAs. On the other side, the introduction of six
2'-O-methyl modiﬁed nucleotides resulted in strongly reduced silencing activity,
and silencing was completely abolished with eight and ten 2'-O-methyl modiﬁed
nucleotides on the 3'-end (Fig. 5.10(b)).
For further characterization of the mechanism of silencing inhibition, the in-
teraction of these diﬀerently modiﬁed siRNAs with Ago2 was tested in vivo by
FCCS. Therefore, guide strand labeled siTK3 duplexes were microinjected, and
the amount of loaded Ago2 was analyzed by FCCS after 3 and 12 h. These two
time points were chosen, because the 3 h value represents the early (still rising
RISC-loading level) and 12 h the late RISC-activation phase (already declining
RISC-loading level) (Fig. 5.3(e) (p. 71)). Therefore, they are ideally suited to
investigate e.g. strand separation or RISC stability as both time points display
almost identical loading levels in the cytoplasm.
Under the used experimental conditions, no diﬀerences could be detected for
the interaction of the guide strand labeled siTK3 duplexes to Ago2 between the
silencing active four nucleotide 2'-O-methyl modiﬁed duplex and the silencing
impaired duplexes containing 6-10 2'-O-methyl modiﬁed nucleotides. All labeled
guide strands were incorporated equally well with cross-correlation amplitudes of
30-35% (Fig. 5.10(c)).
To investigate the eﬀect of 2'-O-methyl modiﬁcations on strand separation and
asymmetric incorporation, the aforementioned modiﬁed siTK3 duplexes labeled
on the passenger strand were microinjected, and the resulting cross-correlation
amplitudes were compared to the amplitudes for guide strand labeled duplexes
(Fig. 5.10(d)). The silencing active duplex containing four 2'-O-methyl modiﬁ-
cations on the 3'-end displayed almost no interaction of RISC with the labeled
passenger strand. With increasing amounts of introduced 2'-O-methyl modiﬁed
nucleotides the interaction of the labeled passenger strand with RISC increases
in the cytoplasm as well as in the nucleus. For the completely inhibited duplexes
containing eight and ten 2'-O-methyl modiﬁed nucleotides almost identical in-
corporation levels in the cytoplasm after 3 h compared to guide strand labeled
duplexes were obtained, whereas after 12 h a clear reduction of RISC passenger
strand interaction could be detected. A collection of cross-correlation curves for
this data is plotted in Fig. 5.11(a).
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This indicates that the silencing inhibition of longer 3' end 2'-O-methyl modiﬁed
siRNAs is not a result of reduced aﬃnities of these 2'-O-methyl modiﬁed siRNAs
to the RLC or of a changed asymmetry in the incorporation process, but they
clearly show that longer 3' end 2'-O-methyl modiﬁcation inhibit the strand sepa-
ration during the activation of RISC. It has been shown that hAgo2 containing
RISC cleaves the passenger strand during activation to facilitate strand separa-
tion [247, 248], so probably the inhibition of strand separation is an inhibition
of the passenger strand cleavage. This is supported by the ﬁnding that the level
of passenger strand labeled duplex bound to RISC strongly decreases after 12 h
compared to 3 h. Which points out that next to the cleavage-mediated passenger
Figure 5.11: Cross-correlation curves and particle numbers (a) Nor-
malized cross-correlation curves of EGFP-Ago2 and the Cy5-labeled strand
of siTK3 siRNAs with diﬀerent amount of 2'-O-methyl modiﬁed nucleotides
measured in the cytoplasm 3h after microinjection. (b) Normalized cross-
correlation curves between the Cy5-labeled target-RNA and EGFP-Ago2 loaded
with the indicated siRNAs measured in the cytoplasm 1 h after microinjection.
(c) Particle numbers of EGFP-Ago2 and Cy5-labeled target-RNA in the cyto-
plasm and nucleus for the target-interaction measurements. The strong decrease
for the target-RNA particles after 1 h in the experiment with 3' 4 nt modiﬁed
siTK3 is probably induced through the strong cleavage reaction of RISC and
the following degradation of the target-RNA.
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strand release a bypass mechanism exists that also results in strand separation
and passenger strand removal. Due to the fact that no reduction of the interac-
tion levels between guide strand-labeled duplexes and RISC could be detected,
a release of the duplex during the incorporation period could be excluded. This
bypass mechanism is much slower compared to the cleavage-mediated mechanism.
The also increasing interaction levels of RISC with the labeled passenger strand
with increasing length of 2'-O-methyl modiﬁcations in the nucleus could have sev-
eral reasons. One reason could be that RISC with bound 2'-O-methyl modiﬁed
siRNA duplex is imported into the nucleus. The reduction of the nuclear interac-
tion levels after 12 h compared to 3 h can in this case be explained by a shuttling
of duplex containing RISC between cytoplasm and nucleus and a working bypass
mechanism in the cytoplasm and/or a working bypass mechanism in the nucleus.
Another reason for the increased interaction levels in the nucleus could also be
the rebinding of labeled passenger strands which were removed from RISC by the
bypass mechanism, but were not degraded due to the increased length of 2'-O-
methyl modiﬁcations and travel as single strands into nucleus.
To elucidate the inﬂuence of increasing amounts of 2'-O-methyl modiﬁcations
on the 3' end onto the interaction of active RISC with its target, the interaction
of RISC with target-RNA was studied in vivo by FCCS (compare Fig. 5.5 (p.
73)). Therefore, a 50 nucleotide long, single stranded, and ﬂuorescently labeled
RNA containing the target sequence for siTK3 and is stabilized by seven 2'-O-
methyl modiﬁed nucleotides on each end, was microinjected in siRNA transfected
10G cells. For the silencing active siTK3 duplex with four 2'-O-methyl modiﬁed
nucleotides, interaction levels close to zero were found, indicating the cleavage
activity of RISC followed by the release of the cleavage products (Fig. 5.10(e)).
For siRNAs with increasing amounts of 2'-O-methyl modiﬁed nucleotides, the
amounts of RISC bound to target-RNA increased in correlation to the aforemen-
tioned silencing activities (Fig. 5.10(b,e)). A collection of cross-correlation curves
is displayed in Fig. 5.11(b). As negative controls the amounts of RISC bound
to target-RNA in non-transfected cells or transfected with a control siRNA shar-
ing no sequence complementarity with the target-RNA (NegsiRNA) are shown.
The values for siTK3-bulge tranfected cells are plotted as positive control (Fig.
5.10(e)). To rule out any concentration mediated eﬀects or changed EGFP-Ago2
expression levels, the average number of particles obtained from the autocorrela-
tion curves are shown in Fig. 5.11(c), clearly demonstrating homogeneous levels
for both species over the time of the experiment, except for the target-RNA in case
of 4 nt modiﬁed siTK3. The strong decrease there after 1 h can be explained by
the strong cleavage reaction of RISC for this siRNA and the following degradation
of the cleaved target-RNA.
Interestingly, RISC loaded with the guide RNAs containing 8-10 2'-O-methyl
modiﬁed nucleotides displayed even higher interaction levels with the target-RNA
than RISC loaded with a bulge-forming guide strand (Fig. 5.10(e)). These higher
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Figure 5.12: Silencing and loading of guide or passenger strand mod-
iﬁed siRNAs (a) Sequence of the used siTK3 with indication of the 2'-O-
methyl modiﬁed parts. (b) Silencing activity of indicated amounts of partially
2'-O-methyl modiﬁed siRNAs measured with a Dual-Luciferase Assay. As con-
trols silencing of NegsiRNA and siTK3 containing 4 modiﬁed nucleotides on
both strands is also shown. Data are represented as mean±SD. (c) Cross-
correlation amplitudes between labeled strand and EGFP-Ago2 measured in
the cytoplasm (empty bars) and the nucleus (striped bars), 3 h and 12 h af-
ter microinjection. The labeled strand is indicated by the cartoon. Data are
represented as mean±SEM.
85
5 RNAi Mechanism studied by FCCS in vivo
amplitudes might result from a stabilization eﬀect of the 2'-O-methyl modiﬁcation
on the RISC-target interaction caused either by the increased aﬃnity due to the
complete hybridization of the guide-target RNA duplex or by the protection of
the guide strand against nucleases.
From the measured silencing inhibition of the siRNAs containing eight or ten
2'-O-methyl modiﬁed nucleotides (Fig. 5.10(b)) the question arose, if this inhibi-
tion is caused by the modiﬁcation on the guide or passenger strand. Therefore,
the silencing activity of only partial modiﬁed siRNA duplexes were measured (Fig.
5.12(a)). The siRNA containing eight 2'-O-methyl modiﬁed nucleotides on the
passenger strand displayed no inhibition of silencing and reached levels compara-
ble to the positive control, whereas the modiﬁcation on the guide strand resulted
in an almost complete loss of the silencing activity (Fig. 5.12(b)).
To investigate the inﬂuence of a strand speciﬁc 2'-O-methyl modiﬁcation in
vivo, siRNAs, that were either modiﬁed with eight nucleotide long 2'-O-methyl
modiﬁcations on the guide or passenger strand only, were microinjected in 10G
cells. The passenger strand release was investigate after 3 h and 12 h. In agreement
with the silencing experiments, strand separation was mainly inhibited, when the
guide strand of the duplex was modiﬁed, whereas the modiﬁed passenger strand
showed only marginal eﬀects (Fig. 5.12(c)).
5.4.3 2'-O-methyl Modiﬁcations on the 5'-end Lead to Destabilization of
the RISC-Guide RNA Interaction
After characterizing the eﬀect of 2'-O-methyl modiﬁcations on the 3'-end, the in-
ﬂuence of two 2'-O-methyl modiﬁed nucleotides on the 5'-end (Fig. 5.13(a)) was
tested. In the silencing readouts a strong decrease of silencing activity of the 5' end
modiﬁed siRNA was detected (Fig. 5.13(b)). To identify if the inhibition results
from the guide or the passenger strand only, duplexes with either guide or passen-
ger strand were also analyzed. The duplex with 5'-end guide strand modiﬁcation
showed the same silencing inhibition as the dual modiﬁed siRNA, whereas the
modiﬁcation on the passenger strand had no impact on the silencing activity (Fig.
5.13(b)). To analyze the aﬃnity of the 5'-end modiﬁed siRNA to RISC, the guide
strand labeled siRNA-duplex was microinjected in 10G cells. After 3 h the same
amount of guide strand loaded RISC was found for the 5' end modiﬁed siRNA
and for the only 3'-end modiﬁed one. So the aﬃnity of 5'-end modiﬁed duplex
to RLC/RISC is not aﬀected. However, after 12 h a strong decrease by one third
(34% down to 22%) of guide strand loaded RISC approximately was detected,
whereas the levels of only 3'-end modiﬁed siRNA remained stable (Fig. 5.13(c)).
This result shows that the 5'-end 2'-O-methyl modiﬁcation destabilizes the inter-
action of RISC with the modiﬁed guide strand. Passenger strand removal was not
inhibited, because no increased levels of passenger strand-RISC interaction could
be detected. This destabilization might cause the relatively strong silencing inhi-
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Figure 5.13: Silencing, loading, and target interaction of 5' end modi-
ﬁed siRNA (a) Sequence of the used siTK3 with indication of the 2'-O-methyl
modiﬁed parts. (b) Silencing activity of indicated amounts of 5' end 2'-O-methyl
modiﬁed siRNA measured with a Dual-Luciferase Assay. As controls silencing
of NegsiRNA and siTK3 is also shown. Data are represented as mean±SD.
(c) Cross-correlation amplitudes between labeled strand and EGFP-Ago2 mea-
sured in the cytoplasm (empty bars) and the nucleus (striped bars), 3 h and
12 h after microinjection. The labeled strand is indicated by the cartoon. (d)
Resulting cross-correlation amplitudes between target-RNA and RISC loaded
with indicated modiﬁed siRNAs measured in the cytoplasm (empty bars) and
the nucleus (striped bars), 1 h to 3 h after microinjection. Data are represented
as mean±SEM.
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bition measured in the silencing assay (Fig. 5.13(b)). The asymmetry of 5'-end
modiﬁed siRNAs incorporation is not aﬀected as passenger strand labeled duplex
displayed comparable values to the control duplex (Fig. 5.13(c)).
For the elucidation of the impact of the 5'-end 2'-O-methyl modiﬁcation on
the target interaction the ﬂuorescently labeled target-RNA was microinjected in
10G cells which were transfected with the 5'-end modiﬁed siTK3. Clearly an
increased interaction between target-RNA and RISC that was loaded with 5'-end
modiﬁed siTK3 compared to RISC loaded with the negative control (NegsiRNA)
or the cleavage active 4 nt 3'-end modiﬁed siTK3 (3' 4 nt) (Fig. 5.13(d)) could
be measured. The interaction levels were lower as for the siTK3-bulge positive
control, but this can result from the destabilized interaction of the 5'-end modiﬁed
guide strand to RISC. Nevertheless, the 2'-O-methyl modiﬁcation on the 5'-end
has an impact on the stability and cleavage activity of RISC, but does not interfere
with the loading machinery and asymmetry of the duplex.
5.4.4 2'-O-methyl Modiﬁcations at Cleavage Site Have Only Minor
Eﬀects on Silencing Activity and Strand Separation
hAgo2 cleaves the passenger strand and the targeted mRNA between the two
nucleotides which pair the 10th and 11th nucleotide of the guide strand, counted
from the 5' end [299, 302]. Additionally it has been shown in vitro that 2'-O-
methyl modiﬁcations can inhibit passenger strand cleavage and strand separation
at position 9 of the passenger strand [247]. Therefore, the inﬂuence of 2'-O-
methyl modiﬁcations at the cleavage site on RISC activity was studied. A siTK3
siRNA with 2'-O-methyl modiﬁcations at positions 9, 10, and 11 starting from
the 5' end was created (Fig. 5.14(a)). In the dual luciferase silencing assay only
a minor change of silencing activity of less than 8% for the double and the guide
modiﬁed duplex could be detected (Fig. 5.14(b)). Within the accuracy of our
FCCS-assay the internal modiﬁcation had no eﬀect on the siRNA-aﬃnity to RISC
Figure 5.14 (facing page): Silencing, loading, and target interaction
of cleavage site 2'-O-methyl modiﬁed siRNAs (a) Sequence of the used
siTK3 with indication of the 2'-O-methyl modiﬁed parts. (b) Silencing activity
of indicated amounts of cleavage site modiﬁed siRNAs measured with a Dual-
Luciferase Assay. As controls silencing of NegsiRNA and siTK3 is also shown.
Data are represented as mean±SD. (c) Cross-correlation amplitudes between
labeled strand and EGFP-Ago2 measured in the cytoplasm (empty bars) and
the nucleus (striped bars), 3 h and 12 h after microinjection. The labeled strand
is indicated by the cartoon. (d) Resulting cross-correlation amplitudes between
target-RNA and RISC loaded with indicated modiﬁed siRNAs measured in
the cytoplasm (empty bars) and the nucleus (striped bars), 1 h to 3 h after
microinjection. Data are represented as mean±SEM.
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and the asymmetric incorporation. However, increased interaction levels of labeled
passenger strand with the dual modiﬁed, as well as the passenger strand modiﬁed,
duplex compared to the siTK3-3'4nt duplex were detected (Fig. 5.14(c)). The
modiﬁcation on the guide strand only, had no eﬀect on strand separation.
The interaction levels of RISC loaded with cleavage-site modiﬁed siRNA and the
target-RNA were slightly increased compared to the cleavage active siTK3-3'4nt
and lower in relation to the bulge forming siRNA (Fig. 5.14(d)).
Consistent with the moderate eﬀects measured in the silencing assays the in
vivo FCCS analysis detected only small inhibitory changes in strand separation
and target interaction. Nevertheless, it also demonstrates the high sensitivity of
the FCCS assays in vivo, as even small changes in silencing activity of less than
8% are clearly visible and allow for the clear detection of the individual inhibited
steps.
5.4.5 Correlation Between Silencing Activity and in vivo Measured
RISC-target-RNA-Interaction
So far, with decreasing silencing activity increased interaction levels between
siRNA loaded RISC and target-RNA were detected. Therefore, the fraction of
Figure 5.15: Correlation between silencing activity and target inter-
action. The levels of target-RNA bound to EGFP-Ago2 for diﬀerent time
points after microinjection (1 h: black squares, 2 h: red diamonds, 3 h: green
triangles) are plotted against the silencing values obtained for diﬀerent siRNAs
at 1 nM concentration after 48 h.
90
5.5 Discussion
RISC bound target-RNA vs. the silencing activity for 1, 2, and 3 h was plotted,
to see if a correlation exists between silencing activity and target interaction (Fig.
5.15). Interestingly, a linear relationship between the silencing activity and RISC
bound target-RNA at diﬀerent time points was detected. By applying this assay,
it is possible to calculate cleavage activities of modiﬁed siRNAs by the level of
interaction between siRNA loaded RISC with their target-RNA. This plot points
out that the internal modiﬁcation increases the stability of the target-RNA-RISC
complex compared to the 3' and 5' end modiﬁcations. However, the reduction of
the slope might be due to degradation of the target-RNA with increasing incuba-
tion times or translocation into P-bodies.
5.5 Discussion
So far, initial steps of RISC formation occurring in the ﬁrst 1-6 h after siRNA
delivery were mainly inaccessible with conventional assays. To better understand
the RNAi mechanism and the inﬂuence of introduced modiﬁcations on siRNAs,
new in vivo assays are necessary, which are able to analyze RISC formation and
target interactions in their initial and late phase. Several important parts of the
RNAi mechanism could be analyzed in vivo, by the combination of an EGFP-
Ago2 reporter cell line, the speciﬁc delivery of ﬂuorescent RNAs via microin-
jection and FCCS. By the use of guide strand-labeled siRNA duplexes, RISC
aﬃnity, asymmetric incorporation and activated RISC stability could be studied.
Whereas the use of passenger strand-labeled duplexes allowed the investigation of
asymmetric incorporation and passenger strand removal. Target interaction and
RISC-mediated target-RNA cleavage were studied by the transfection of reporter
cells with unlabeled siRNAs, followed by the microinjection of ﬂuorescently la-
beled target-RNA after an incubation period. This combination of speciﬁc RNA
delivery with the high sensitive ﬂuorescent technique of correlation spectroscopy,
made it possible to study the inﬂuence of several diﬀerently 2'-O-methyl modiﬁed
siRNAs onto RISC formation and target interactions in vivo.
The individual mechanistic eﬀects of 2'-O-methyl modiﬁcations at diﬀerent po-
sitions within siRNAs on RISC assembly and activity could be followed in vivo.
It could be shown that 2'-O-methyl modiﬁcations at diﬀerent positions within the
siRNA lead to several ways of RISC activity inhibition. 2'-O-methyl modiﬁcation
were investigated, because phosphorothioate and 2'-ﬂuoro modiﬁcations were in-
compatible with our in vivo FCCS assay due to intense photobleaching resulting
from their strong non-speciﬁc aﬃnity for cellular proteins and structures. This
is consistent with the changed sub-cellular localization of phosphorothioate and
2'-ﬂuoro modiﬁed duplexes reported in [367]. Therefore, such modiﬁed duplexes
or single stranded phosphorothioate or 2'-ﬂuoro modiﬁed RNAs cannot be investi-
gated by standard FCS/FCCS in vivo. Furthermore, 2'-O-methyl nucleotides are
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Figure 5.16: Inhibition of RNAi mechanism by 3' end modiﬁed
siRNAs. (a) Inhibited passenger strand cleavage lead to reduced passenger
strand removal. This can be circumvented by a bypass mechanism on longer
time scales. Inhibited target-RNA cleavage lead to stable RISC target-RNA
interaction in the cytoplasm (b) and nucleus (c).
very interesting siRNA modiﬁcations, as this modiﬁcation represents a naturally
occurring modiﬁcation in transfer and ribosomal RNAs and can be used to specif-
ically increase the lifetime, speciﬁcity, and potency of siRNAs, but also to inhibit
RNA mediated gene silencing.
Standard dual luciferase assays were used to investigate the eﬀect of increasing
amounts of 2'-O-methyl modiﬁcations on the 3'-end. In these assays, it was found
that four 2'-O-methyl nucleotides lead to increased silencing eﬃciency after 48
hours, whereas six 2'-O-methyl modiﬁcations strongly inhibited, and eight to ten
2'-O-methyl insertions completely abolished gene silencing. This is consistent
with previous reports demonstrating the inhibition of fully or highly 2'-O-methyl
modiﬁed siRNAs [298, 310, 376379].
For the ﬁrst time, the mechanism of 2'-O-methyl mediated gene silencing inhi-
bition on the 3'-end could be unraveled. By applying FCCS in vivo, it could be
shown that neither the aﬃnity nor the asymmetry of guide strand incorporation is
aﬀected. By contrast, it could be demonstrated that the removal of the passenger
strand is strongly inhibited, a step that is strictly required for RISC activation
and maturation (Fig. 5.16(a)). Furthermore, the inhibitory eﬀect on passenger
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strand release only occurs when 2'-O-methyl modiﬁed nucleotides are present on
the guide strand. Although it was demonstrated that mainly the cleavage activity
of RISC is aﬀected, which is needed for eﬃcient passenger strand removal, we
could detect passenger strand release of up to 50% of bound siRNA after 12 h of
siRNA supply. This indicates that a less eﬃcient bypass mechanism exists without
passenger strand cleavage leading to guide strand loaded RISC (activated RISC)
[248, 253]. This demonstrates the advantage of the FCCS assay that allows the
measurement of RISC assembly at early and late stages after siRNA supply.
It could be shown that RISC loaded with the cleavage impaired 2'-O-meth-
yl modiﬁed guide strands were still capable of recognizing and binding of their
target-RNA. Due to the impaired targetRNA cleavage a stable miRNA-like in-
teraction between RISC and target-RNA is formed (Fig. 5.16(b,c)). Surprisingly,
they associate to higher extend with the target-RNA compared to a bulge forming
guide strand which also inhibits target-RNA cleavage. Most probably this results
from a stabilization eﬀect of the 2'-O-methyl modiﬁcation on the RISC target
interaction caused either by the increased aﬃnity due to the complete hybridiza-
tion of the guide-target-RNA duplex or by protection of the guide strand against
nucleases. Although it has been already shown that 2'-O-methyl modiﬁcations
inhibits target-RNA cleavage in vitro, at that time it could not be excluded that
passenger strand release was also aﬀected or suﬃcient [298].
The silencing inhibition of siRNAs with 6-10 2'-O-methyl modiﬁed nucleotides
from the 3'end is in agreement with the results fromWang et al. [291], who showed
that hAgo2 mediated cleavage only occurs with guide/target-RNA duplexes larger
than 16 nt. Therefore, the 3'-RNA region from 15-21 of the guide strand seems
to be important for the transition into or stabilization of the active conﬁrmation
which can be inhibited by 2'-O-methyl modiﬁed nucleotides.
The insertion of two 2'-O-methyl modiﬁed nucleotides on the 5'-end inhibited
gene silencing activity if present on the guide strand. It could be demonstrated
that 3 h after siRNA supply, resembling the early stages of RISC assembly, neither
the aﬃnity nor asymmetry was aﬀected. In contrast to the 3'-end modiﬁcation, the
5'-end 2'-O-methyl modiﬁed nucleotides did not interfere with strand separation.
Interestingly, after 12 h a strong decrease in loaded RISC levels was detected,
indicating that the two 2'-O-methyl modiﬁed nucleotides on the 5'-end somehow
destabilize the RISC-guide strand complex. Additionally it was shown that 5'-end
modiﬁcation lead to increased RISC target-RNA interaction levels, pointing out
a reduced target-RNA cleavage eﬃciency.
It seems to be possible that 2'-O-methyl modiﬁcations on the 5'-end leads to
reduced hAgo2 guide strand stability similar to the destabilization with a guide
strand lacking the 5'-phosphate [269]. This would also explain why passenger
strand removal is unaﬀected, whereas target-RNA cleavage seems to be less eﬃ-
cient. Nevertheless, the aﬀect of 2'-O-methyl modiﬁed nucleotides on the 5'-end
could be sequence dependent as other groups reported also no inhibitory function
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of one to two 2'-O-methyl modiﬁed nucleotides on the 5'-end [313, 376].
Surprisingly only marginal eﬀects could be detected for 2'-O-methyl modiﬁed
nucleotides at the cleavage site. While the bulge forming siRNA was cleavage
incompetent, for the siRNA containing three 2'-O-methyl modiﬁed nucleotides
at the position 9, 10, and 11 a reduction of silencing activity of only 8% for the
double and guide modiﬁed duplex could be detected in our standard dual luciferase
assay. Nevertheless minor reductions in strand separation could be detected by
the in vivo FCCS loading assay, which is in agreement with a previous report
[247] showing passenger strand cleavage inhibition for a passenger strand with a
2'-O-methyl modiﬁcation on position nine. The fact that only minor inhibition of
passenger strand release was measured might be due to the fact that Leuschner
et al. [247] used a puriﬁed minimal RISC, which almost represents the single
hAgo2 protein alone, whereas here FCCS was measured in vivo providing optimal
siRNA processing conditions. Even the silencing activity was decreased by only
8% slightly higher levels of RISC target-RNA interaction could be detected, which
are indicative for slightly inhibited target-RNA cleavage process.
5.6 Conclusion
The presented novel in vivo FCCS assays are very well suited to investigate the
RNAi mechanism. The ﬁrst assay allowed the investigation of the individual steps
of RISC assembly, especially the loading of the siRNA duplex, the removal of
the passenger strand, and the stability of the guide strand-RISC interaction. To
study the very important step of target cleavage, the second assay investigated the
interaction of activated RISC with a targeted mRNA mimic. With this assay, a
direct correlation between cleavage activity and target interaction could be shown,
which can also be used to determine cleavage properties of used guide RNAs,
thereby allowing for multi-parameter measurements.
Additionally, the inﬂuence of 2'-O-methyl modiﬁcations at various positions
on RISC assembly and activity was studied. FCCS measurements with modiﬁed
siRNAs, that inhibit silencing, revealed that the main inhibited mechanism is
the cleavage of the targeted RNA. Additionally it was unraveled that the release
of the passenger strand is inhibited, mainly due to the cleavage inhibition of
the passenger strand. But here strong decrease of the interaction between RISC
and the passenger strand was seen with time, pointing to a less eﬃcient bypass
mechanism. It could be shown that 2'-O-methyl modiﬁed 3'-end siRNAs with up
to 8-10 nt can be used to mimic miRNA-like interactions of RISC with its target-
RNA, increasing the stability of the RISC-target-RNA-complex. These results
can lead to the development of a new type of therapeutic small RNAs, as they
allow the application of miRNA-like duplexes with increased aﬃnities to their
target-RNA.
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This dissertation focusses on the utilization of ﬂuorescence cross-correlation spec-
troscopy (FCCS) as sensitive and versatile tool to elucidate the ﬂow proﬁle inside
a micropump and to study the RNA interference (RNAi) mechanism in vivo.
A micropump using the electrohydrodynamical principle displays a complex
ﬂow proﬁle, which is not resolvable by common techniques. Additionally, dielec-
trophoretic forces act on particles larger than 50 nm to 100 nm, preventing the
elucidation of the pure electrohydrodynamic forces. Here, the ﬂow proﬁle of such
a pump was mapped by two-focus FCCS (2f-FCCS) using small (20 nm) quantum
dots as ﬂuorescent particles. The combination of the ﬂow velocity map, resolved
by 2f-FCCS, with the results from the bead imaging allowed the reconstruction
of a complex ﬂow pattern, consisting of two vortices of diﬀerent size and opposite
direction of rotation. This ﬂow pattern explained the observed complex particle
trajectories in the force ﬁeld and the accumulation of particles in well-deﬁned
regions above the microelectrode array. The high precision of 2f-FCCS in mea-
suring ﬂow velocities with small ﬂuorescent particles made it possible to separate
the electrohydrodynamic forces acting on the solvent from the dielectrophoretic
forces acting on larger particles. This allowed the elucidation of the correct ﬂow
pattern inside the micropump. In the future, an optimization of the complex ﬂow
proﬁle, will increase the eﬃciency of the electrohydrodynamical principle in han-
dling small ﬂuid volumes. For the use as a pump the optimization process should
lead to a elimination of the vortices and generate a more laminar ﬂow proﬁle in
the active region. The promotion of particle accumulation could also be an aim of
optimization. This would allow concentration of particle suspensions. For these
possible optimization attempts, 2f-FCCS will be useful techniques to monitor the
ﬂow patterns.
In the second part of this thesis, the mechanism of RNAi was studied by dual-
color FCCS using two novel in vivo FCCS assays. The ﬁrst assay allowed the
investigation of the individual steps of RNA-induced silencing complex (RISC)
assembly, especially the loading of the short interfering RNA (siRNA) duplex,
the removal of the passenger strand, and the stability of the guide strand-RISC
interaction. To study the very important step of target cleavage, the second assay
investigated the interaction of activated RISC with a targeted mRNA mimic.
Using these assays to study diﬀerently 2'-O-methyl modiﬁed siRNAs resolved that
most of the silencing inhibited siRNAs displayed an inhibited passenger strand
removal and an inhibited target-RNA cleavage. It could be shown that the here
presented novel in vivo FCCS assays are very well suited to elucidate, which single
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step of the RNAi machinery assembly and activity is inhibited. This will help to
develop modiﬁed siRNAs with increased stability and full activity in the future.
These assays can also be used to optimize modiﬁcations which feature diﬀerent
beneﬁts, like the addition of cholesterol, which increases the cellular uptake of
siRNAs. In a more general view, the here used principle of studying the interaction
between a labeled protein and labeled DNA or RNA molecules could be used to
unravel other biological questions, such as the detailed mechanisms of mRNA
splicing, DNA repair enzymes, or the role of double-stranded oligo-nucleotides in
auto-immune diseases.
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Abbreviations
2f-FCCS two-focus FCCS
agRNA antigene RNA
APD avalanche photodiode
bp base pair
cw continuous wave
DNA deoxyribonucleic acid
dsRBD dsRNA binding domain
dsRNA double stranded RNA
EGFP enhanced GFP
FCCS ﬂuorescence cross-correlation spectroscopy
(mostly dual-color FCCS)
FCS ﬂuorescence correlation spectroscopy
FBS fetal bovine serum
(fetal calf serum)
GFP green ﬂuorescent protein
ICS image correlation spectroscopy
ISC intersystem crossing
LoC Lab-on-Chip
LSM laser scanning microscopy
miRNA micro RNA
mRNA messenger RNA
µTAS micro Total Analysis System
NA numerical aperture
nt nucleotide
PAGE polyacrylamide gel electrophoresis
P-body processing body
PIE pulsed interleaved excitation
PTGS post-transcriptional gene silencing
piRNA Piwi-interacting RNA
pri-miRNA primary miRNA
pre-miRNA precursor miRNA
RICS raster image correlation spectroscopy
nRISC nuclear RISC
cRISC cytoplasmic RISC
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RISC RNA-induced silencing complex
RITS RNA-induced transcriptional silencing complex
RLC RISC loading complex
RNA ribonucleic acid
RNAi RNA interference
RNase Ribonuclease
SD standard deviation
SEM standard error of mean
siRNA short interfering RNA
TGS transcriptional gene silencing
UTR untranslated region
WGA wheat germ agglutinin
Symbols and Units
α angle between the ﬂow velocity and the vector between the
two foci
B uncorrelated background signal
β relative crosstalk from the `green' ﬂuorophore into the `red'
channel
C(~r, t) concentration
D diﬀusion coeﬃcient
Da Dalton (1Da = 1 u = 1.660538782 · 10−27 kg)
δ ﬂuctuations of
~E electric ﬁeld
ε permittivity
η molecular brightness
ηm viscosity of medium
F ﬂuorescence intensity (usually the measured one)
F˜ emitted ﬂuorescence intensity
fi fraction
~fel electric force per volume
fB bleaching fraction
fT triplet fraction
G(τ) correlation curve or model function
G˜(τ) corrected correlation curve
γ relative crosstalk from the `red' ﬂuorophore into the `green'
channel
Iex(~r) excitation intensity proﬁle
~j current density
K equilibrium constants
k rate constants
98
kB Boltzmann constant
kPB photobleaching rate
κ detector eﬃciency
Λi brightness weighting factor
〈N〉 mean particle number
ω0 lateral radius of the detection volume
pk model parameter
ϕ quantum yield
Φ(~r, ~r ′, τ) concentration correlation function
R distance (between both foci)
R0 hydrodynamic radius
~r position
res residual
ρ density of mass
ρel electric volume charge
S structure parameter
S(~r) normalized collection eﬃciency function
σ conductivity
σ standard deviation
σex extinction coeﬃcient
τ lag time
τD diﬀusion time
τb relaxation time
τch charge relaxation time
τT triplet relaxation time
T temperature
T reaction matrix (constructed from chemical rate coeﬃcients
and equilibrium concentrations of the reactants involved)
t time
V (integration) volume
Veﬀ eﬀective volume
~v(~r, t) ﬂow velocity
W (~r) molecule detection function (normalized)
w weight
z0 half axial extension of the detection volume
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